AU2008236562B2 - Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha - Google Patents
Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha Download PDFInfo
- Publication number
- AU2008236562B2 AU2008236562B2 AU2008236562A AU2008236562A AU2008236562B2 AU 2008236562 B2 AU2008236562 B2 AU 2008236562B2 AU 2008236562 A AU2008236562 A AU 2008236562A AU 2008236562 A AU2008236562 A AU 2008236562A AU 2008236562 B2 AU2008236562 B2 AU 2008236562B2
- Authority
- AU
- Australia
- Prior art keywords
- pyrazolo
- piperazin
- methyl
- phenyl
- pyrimidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 381
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 154
- 201000011510 cancer Diseases 0.000 title claims abstract description 149
- 239000003112 inhibitor Substances 0.000 title claims description 48
- 108091007960 PI3Ks Proteins 0.000 title description 3
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 title description 2
- IAAQUOVTPAMQCR-UHFFFAOYSA-N 1h-pyrido[3,2-d]pyrimidin-2-one Chemical compound C1=CC=C2NC(=O)N=CC2=N1 IAAQUOVTPAMQCR-UHFFFAOYSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 364
- 238000011282 treatment Methods 0.000 claims abstract description 360
- 150000003839 salts Chemical class 0.000 claims abstract description 62
- 239000012453 solvate Substances 0.000 claims abstract description 46
- 239000002246 antineoplastic agent Substances 0.000 claims description 221
- 229940127089 cytotoxic agent Drugs 0.000 claims description 220
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 40
- 230000005855 radiation Effects 0.000 claims description 38
- 238000001794 hormone therapy Methods 0.000 claims description 37
- 238000001356 surgical procedure Methods 0.000 claims description 36
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 30
- 229960002930 sirolimus Drugs 0.000 claims description 30
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 27
- 229930012538 Paclitaxel Natural products 0.000 claims description 26
- 229960001592 paclitaxel Drugs 0.000 claims description 26
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 26
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical group [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 claims description 24
- 229960004562 carboplatin Drugs 0.000 claims description 23
- AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 claims description 21
- 206010006187 Breast cancer Diseases 0.000 claims description 20
- 208000026310 Breast neoplasm Diseases 0.000 claims description 20
- 238000009169 immunotherapy Methods 0.000 claims description 20
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 20
- 239000005551 L01XE03 - Erlotinib Substances 0.000 claims description 19
- 229940123237 Taxane Drugs 0.000 claims description 18
- 229940121647 egfr inhibitor Drugs 0.000 claims description 18
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims description 18
- 229960001433 erlotinib Drugs 0.000 claims description 17
- 206010060862 Prostate cancer Diseases 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 208000005017 glioblastoma Diseases 0.000 claims description 13
- 229940036571 iodine therapy Drugs 0.000 claims description 13
- 230000002285 radioactive effect Effects 0.000 claims description 13
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 12
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 12
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 12
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 12
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 11
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 claims description 11
- 206010033128 Ovarian cancer Diseases 0.000 claims description 11
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 11
- 229940100198 alkylating agent Drugs 0.000 claims description 11
- 239000002168 alkylating agent Substances 0.000 claims description 11
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 10
- 201000001441 melanoma Diseases 0.000 claims description 9
- WDHAAJIGSXNPFO-UHFFFAOYSA-N 8h-pyrido[2,3-d]pyrimidin-7-one Chemical compound N1=CN=C2NC(=O)C=CC2=C1 WDHAAJIGSXNPFO-UHFFFAOYSA-N 0.000 claims description 8
- BUROJSBIWGDYCN-GAUTUEMISA-N AP 23573 Chemical compound C1C[C@@H](OP(C)(C)=O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 BUROJSBIWGDYCN-GAUTUEMISA-N 0.000 claims description 8
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims description 8
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims description 8
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 8
- 229960000235 temsirolimus Drugs 0.000 claims description 8
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 7
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 7
- 206010009944 Colon cancer Diseases 0.000 claims description 7
- 206010014733 Endometrial cancer Diseases 0.000 claims description 7
- 206010014759 Endometrial neoplasm Diseases 0.000 claims description 7
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 7
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 7
- 201000010881 cervical cancer Diseases 0.000 claims description 7
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 7
- 208000015634 Rectal Neoplasms Diseases 0.000 claims description 6
- 208000029742 colonic neoplasm Diseases 0.000 claims description 6
- 206010038038 rectal cancer Diseases 0.000 claims description 6
- 201000001275 rectum cancer Diseases 0.000 claims description 6
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 5
- 206010041067 Small cell lung cancer Diseases 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 5
- 201000002528 pancreatic cancer Diseases 0.000 claims description 5
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 5
- 208000000587 small cell lung carcinoma Diseases 0.000 claims description 5
- 206010051066 Gastrointestinal stromal tumour Diseases 0.000 claims description 3
- 208000033781 Thyroid carcinoma Diseases 0.000 claims description 3
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 3
- 208000002458 carcinoid tumor Diseases 0.000 claims description 3
- 230000002496 gastric effect Effects 0.000 claims description 3
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 claims description 3
- 201000001514 prostate carcinoma Diseases 0.000 claims description 3
- 201000002510 thyroid cancer Diseases 0.000 claims description 3
- 208000013077 thyroid gland carcinoma Diseases 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 claims 1
- -1 cyano, amino Chemical group 0.000 description 334
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 302
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 154
- 229910052740 iodine Chemical group 0.000 description 145
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 131
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 129
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 106
- DRYRBWIFRVMRPV-UHFFFAOYSA-N quinazolin-4-amine Chemical compound C1=CC=C2C(N)=NC=NC2=C1 DRYRBWIFRVMRPV-UHFFFAOYSA-N 0.000 description 75
- 125000000217 alkyl group Chemical group 0.000 description 74
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 58
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 48
- 229910052739 hydrogen Inorganic materials 0.000 description 45
- 239000001257 hydrogen Substances 0.000 description 45
- ANTISGAVDLDNTA-UHFFFAOYSA-N 2-methoxyquinazolin-4-amine Chemical compound C1=CC=CC2=NC(OC)=NC(N)=C21 ANTISGAVDLDNTA-UHFFFAOYSA-N 0.000 description 39
- 150000004985 diamines Chemical class 0.000 description 33
- 125000001072 heteroaryl group Chemical group 0.000 description 32
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 32
- 125000003118 aryl group Chemical group 0.000 description 31
- 125000005843 halogen group Chemical group 0.000 description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 29
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 29
- 125000003545 alkoxy group Chemical group 0.000 description 26
- 125000000753 cycloalkyl group Chemical group 0.000 description 24
- 125000004549 quinolin-4-yl group Chemical group N1=CC=C(C2=CC=CC=C12)* 0.000 description 24
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 22
- 125000000547 substituted alkyl group Chemical group 0.000 description 22
- 201000010099 disease Diseases 0.000 description 21
- FEHLGOYZDFFMND-UHFFFAOYSA-N cyclopropane-1,1-dicarboxamide Chemical compound NC(=O)C1(C(N)=O)CC1 FEHLGOYZDFFMND-UHFFFAOYSA-N 0.000 description 20
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 20
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 description 20
- QUKPALAWEPMWOS-UHFFFAOYSA-N 1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=NC=C2C=NNC2=N1 QUKPALAWEPMWOS-UHFFFAOYSA-N 0.000 description 19
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 18
- 125000003710 aryl alkyl group Chemical group 0.000 description 18
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 18
- 229960004316 cisplatin Drugs 0.000 description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 17
- 125000003107 substituted aryl group Chemical group 0.000 description 17
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 16
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 16
- 125000004122 cyclic group Chemical group 0.000 description 16
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 16
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 description 16
- UHTHHESEBZOYNR-UHFFFAOYSA-N vandetanib Chemical compound COC1=CC(C(/N=CN2)=N/C=3C(=CC(Br)=CC=3)F)=C2C=C1OCC1CCN(C)CC1 UHTHHESEBZOYNR-UHFFFAOYSA-N 0.000 description 16
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 15
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 15
- 150000003254 radicals Chemical class 0.000 description 15
- 239000011734 sodium Substances 0.000 description 15
- 229960000241 vandetanib Drugs 0.000 description 15
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 14
- 125000003282 alkyl amino group Chemical group 0.000 description 14
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 14
- 229960001756 oxaliplatin Drugs 0.000 description 14
- 125000004497 pyrazol-5-yl group Chemical group N1N=CC=C1* 0.000 description 14
- 125000002252 acyl group Chemical group 0.000 description 13
- 125000004663 dialkyl amino group Chemical group 0.000 description 13
- 125000001188 haloalkyl group Chemical group 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 13
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000005511 L01XE05 - Sorafenib Substances 0.000 description 12
- 108091000080 Phosphotransferase Proteins 0.000 description 12
- 125000004429 atom Chemical group 0.000 description 12
- AXLOCHLTNQDFFS-BESJYZOMSA-N azastene Chemical compound C([C@H]1[C@@H]2CC[C@@]([C@]2(CC[C@@H]1[C@@]1(C)C2)C)(O)C)C=C1C(C)(C)C1=C2C=NO1 AXLOCHLTNQDFFS-BESJYZOMSA-N 0.000 description 12
- 229960003668 docetaxel Drugs 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 description 12
- 150000004677 hydrates Chemical class 0.000 description 12
- 125000004252 isoindol-1-yl group Chemical group [H]N1C([H])=C2C([H])=C([H])C([H])=C([H])C2=C1* 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 102000020233 phosphotransferase Human genes 0.000 description 12
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 12
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 12
- 229960003787 sorafenib Drugs 0.000 description 12
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 11
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 11
- 239000003886 aromatase inhibitor Substances 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- 125000001207 fluorophenyl group Chemical group 0.000 description 11
- BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 description 11
- 229940122815 Aromatase inhibitor Drugs 0.000 description 10
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 239000002147 L01XE04 - Sunitinib Substances 0.000 description 10
- 239000002136 L01XE07 - Lapatinib Substances 0.000 description 10
- 125000003302 alkenyloxy group Chemical group 0.000 description 10
- 125000004093 cyano group Chemical group *C#N 0.000 description 10
- 229960004397 cyclophosphamide Drugs 0.000 description 10
- 229960002949 fluorouracil Drugs 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- 125000005017 substituted alkenyl group Chemical group 0.000 description 10
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 9
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical compound NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 9
- BPEGJWRSRHCHSN-UHFFFAOYSA-N Temozolomide Chemical compound O=C1N(C)N=NC2=C(C(N)=O)N=CN21 BPEGJWRSRHCHSN-UHFFFAOYSA-N 0.000 description 9
- 125000004103 aminoalkyl group Chemical group 0.000 description 9
- 229960000397 bevacizumab Drugs 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 125000004438 haloalkoxy group Chemical group 0.000 description 9
- 229960004891 lapatinib Drugs 0.000 description 9
- 125000004546 quinazolin-4-yl group Chemical group N1=CN=C(C2=CC=CC=C12)* 0.000 description 9
- 125000006413 ring segment Chemical group 0.000 description 9
- 229960002920 sorbitol Drugs 0.000 description 9
- 125000001544 thienyl group Chemical group 0.000 description 9
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 8
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 8
- 239000004215 Carbon black (E152) Substances 0.000 description 8
- 239000005517 L01XE01 - Imatinib Substances 0.000 description 8
- 206010039491 Sarcoma Diseases 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 125000002619 bicyclic group Chemical group 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 229960004679 doxorubicin Drugs 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 8
- 229960004296 megestrol acetate Drugs 0.000 description 8
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 8
- 229940002612 prodrug Drugs 0.000 description 8
- 239000000651 prodrug Substances 0.000 description 8
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 8
- 229960001796 sunitinib Drugs 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 229960001603 tamoxifen Drugs 0.000 description 8
- 229960004964 temozolomide Drugs 0.000 description 8
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 8
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 8
- 229960000575 trastuzumab Drugs 0.000 description 8
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 7
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 7
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 7
- HVXKQKFEHMGHSL-GOOCMWNKSA-N 7-[[(3as,6ar)-2-methyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-5-yl]methoxy]-n-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3C[C@@H]4CN(C)C[C@@H]4C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1F HVXKQKFEHMGHSL-GOOCMWNKSA-N 0.000 description 7
- BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 description 7
- 206010025323 Lymphomas Diseases 0.000 description 7
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 7
- 208000009956 adenocarcinoma Diseases 0.000 description 7
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 description 7
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 7
- 229950002826 canertinib Drugs 0.000 description 7
- OMZCMEYTWSXEPZ-UHFFFAOYSA-N canertinib Chemical compound C1=C(Cl)C(F)=CC=C1NC1=NC=NC2=CC(OCCCN3CCOCC3)=C(NC(=O)C=C)C=C12 OMZCMEYTWSXEPZ-UHFFFAOYSA-N 0.000 description 7
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 7
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 7
- 229960005277 gemcitabine Drugs 0.000 description 7
- KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 7
- 229960002411 imatinib Drugs 0.000 description 7
- 125000000336 imidazol-5-yl group Chemical group [H]N1C([H])=NC([H])=C1[*] 0.000 description 7
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 description 7
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 description 7
- 229940090004 megace Drugs 0.000 description 7
- WVUNYSQLFKLYNI-AATRIKPKSA-N pelitinib Chemical compound C=12C=C(NC(=O)\C=C\CN(C)C)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Cl)=C1 WVUNYSQLFKLYNI-AATRIKPKSA-N 0.000 description 7
- 229940120982 tarceva Drugs 0.000 description 7
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 7
- 229960002066 vinorelbine Drugs 0.000 description 7
- GBABOYUKABKIAF-IELIFDKJSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-IELIFDKJSA-N 0.000 description 7
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 6
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 description 6
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 6
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 6
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 6
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 6
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 description 6
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 6
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 description 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 6
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 6
- 229960005395 cetuximab Drugs 0.000 description 6
- 125000001309 chloro group Chemical group Cl* 0.000 description 6
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 6
- 125000004472 dialkylaminosulfonyl group Chemical group 0.000 description 6
- 229960005420 etoposide Drugs 0.000 description 6
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 6
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 6
- 235000008191 folinic acid Nutrition 0.000 description 6
- 239000011672 folinic acid Substances 0.000 description 6
- 229940080856 gleevec Drugs 0.000 description 6
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 6
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 6
- 125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 description 6
- 229960001691 leucovorin Drugs 0.000 description 6
- BMGQWWVMWDBQGC-IIFHNQTCSA-N midostaurin Chemical compound CN([C@H]1[C@H]([C@]2(C)O[C@@H](N3C4=CC=CC=C4C4=C5C(=O)NCC5=C5C6=CC=CC=C6N2C5=C43)C1)OC)C(=O)C1=CC=CC=C1 BMGQWWVMWDBQGC-IIFHNQTCSA-N 0.000 description 6
- 229950010895 midostaurin Drugs 0.000 description 6
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 6
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical group OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 6
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 6
- 229960001972 panitumumab Drugs 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Chemical group OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- 239000003197 protein kinase B inhibitor Substances 0.000 description 6
- UDJFFSGCRRMVFH-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine Chemical compound N1=CN=CC2=CC=CN=C21 UDJFFSGCRRMVFH-UHFFFAOYSA-N 0.000 description 6
- 229960004889 salicylic acid Drugs 0.000 description 6
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 6
- 210000004881 tumor cell Anatomy 0.000 description 6
- 229960003048 vinblastine Drugs 0.000 description 6
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 6
- 229960004528 vincristine Drugs 0.000 description 6
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 6
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 6
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 5
- NPSLABWCQNFJHJ-GOOCMWNKSA-N 7-[[(3as,6ar)-2-methyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-5-yl]methoxy]-n-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3C[C@@H]4CN(C)C[C@@H]4C3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1F NPSLABWCQNFJHJ-GOOCMWNKSA-N 0.000 description 5
- 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 description 5
- 201000009030 Carcinoma Diseases 0.000 description 5
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 5
- 101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 description 5
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 5
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 5
- 239000005411 L01XE02 - Gefitinib Substances 0.000 description 5
- 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 5
- 102100038332 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Human genes 0.000 description 5
- 238000002679 ablation Methods 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 125000004442 acylamino group Chemical group 0.000 description 5
- 125000004423 acyloxy group Chemical group 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 5
- 125000002431 aminoalkoxy group Chemical group 0.000 description 5
- 229940120638 avastin Drugs 0.000 description 5
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 5
- 210000001072 colon Anatomy 0.000 description 5
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 5
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 5
- 229960002584 gefitinib Drugs 0.000 description 5
- 239000003481 heat shock protein 90 inhibitor Substances 0.000 description 5
- 229960001101 ifosfamide Drugs 0.000 description 5
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 229960004768 irinotecan Drugs 0.000 description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 229960000485 methotrexate Drugs 0.000 description 5
- 125000002950 monocyclic group Chemical group 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 238000002271 resection Methods 0.000 description 5
- 229960004641 rituximab Drugs 0.000 description 5
- 206010041823 squamous cell carcinoma Diseases 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 5
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 5
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 5
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 5
- UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 5
- 229960000303 topotecan Drugs 0.000 description 5
- FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 description 4
- 125000001724 1,2,3-oxadiazol-4-yl group Chemical group [H]C1=C(*)N=NO1 0.000 description 4
- 125000004503 1,2,3-oxadiazol-5-yl group Chemical group O1N=NC=C1* 0.000 description 4
- 125000001766 1,2,4-oxadiazol-3-yl group Chemical group [H]C1=NC(*)=NO1 0.000 description 4
- 125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 4
- 125000004509 1,3,4-oxadiazol-2-yl group Chemical group O1C(=NN=C1)* 0.000 description 4
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 4
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 4
- QRCGFTXRXYMJOS-UHFFFAOYSA-N 4h-1,4-benzoxazin-3-one Chemical compound C1=CC=C2NC(=O)COC2=C1 QRCGFTXRXYMJOS-UHFFFAOYSA-N 0.000 description 4
- OONFNUWBHFSNBT-HXUWFJFHSA-N AEE788 Chemical compound C1CN(CC)CCN1CC1=CC=C(C=2NC3=NC=NC(N[C@H](C)C=4C=CC=CC=4)=C3C=2)C=C1 OONFNUWBHFSNBT-HXUWFJFHSA-N 0.000 description 4
- 229940126638 Akt inhibitor Drugs 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VWUXBMIQPBEWFH-WCCTWKNTSA-N Fulvestrant Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 description 4
- 102000014150 Interferons Human genes 0.000 description 4
- 108010050904 Interferons Proteins 0.000 description 4
- 206010024612 Lipoma Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- 108700020796 Oncogene Proteins 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- 108091008611 Protein Kinase B Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229940124674 VEGF-R inhibitor Drugs 0.000 description 4
- 229960000548 alemtuzumab Drugs 0.000 description 4
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 4
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 4
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 4
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 229960002932 anastrozole Drugs 0.000 description 4
- 229940078010 arimidex Drugs 0.000 description 4
- 229940087620 aromasin Drugs 0.000 description 4
- 125000004104 aryloxy group Chemical group 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 150000007942 carboxylates Chemical class 0.000 description 4
- 125000004966 cyanoalkyl group Chemical group 0.000 description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 4
- 125000004212 difluorophenyl group Chemical group 0.000 description 4
- 229940082789 erbitux Drugs 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 229960000255 exemestane Drugs 0.000 description 4
- 229940087476 femara Drugs 0.000 description 4
- 229960000578 gemtuzumab Drugs 0.000 description 4
- 229960003297 gemtuzumab ozogamicin Drugs 0.000 description 4
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 4
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 4
- 229940079322 interferon Drugs 0.000 description 4
- 229940084651 iressa Drugs 0.000 description 4
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229960003881 letrozole Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 229950008835 neratinib Drugs 0.000 description 4
- JWNPDZNEKVCWMY-VQHVLOKHSA-N neratinib Chemical compound C=12C=C(NC(=O)\C=C\CN(C)C)C(OCC)=CC2=NC=C(C#N)C=1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 JWNPDZNEKVCWMY-VQHVLOKHSA-N 0.000 description 4
- HHZIURLSWUIHRB-UHFFFAOYSA-N nilotinib Chemical compound C1=NC(C)=CN1C1=CC(NC(=O)C=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 HHZIURLSWUIHRB-UHFFFAOYSA-N 0.000 description 4
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 4
- 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 description 4
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- 229940063683 taxotere Drugs 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 4
- 229960005267 tositumomab Drugs 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- 230000004614 tumor growth Effects 0.000 description 4
- 229940094060 tykerb Drugs 0.000 description 4
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 3
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 3
- YABJJWZLRMPFSI-UHFFFAOYSA-N 1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-2-benzimidazolamine Chemical compound N=1C2=CC(OC=3C=C(N=CC=3)C=3NC(=CN=3)C(F)(F)F)=CC=C2N(C)C=1NC1=CC=C(C(F)(F)F)C=C1 YABJJWZLRMPFSI-UHFFFAOYSA-N 0.000 description 3
- KUFRQPKVAWMTJO-QSTRRNJOSA-N 17-dmag Chemical compound N1C(=O)\C(C)=C/C=C\[C@@H](OC)[C@H](OC(N)=O)\C(C)=C/[C@@H](C)[C@@H](O)[C@H](OC)C[C@@H](C)CC2=C(NCCN(C)C)C(=O)C=C1C2=O KUFRQPKVAWMTJO-QSTRRNJOSA-N 0.000 description 3
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 3
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 3
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 3
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 3
- UPHOPMSGKZNELG-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carboxylic acid Chemical group C1=CC=C2C(C(=O)O)=C(O)C=CC2=C1 UPHOPMSGKZNELG-UHFFFAOYSA-N 0.000 description 3
- JBIHMFNMKHDTEE-UHFFFAOYSA-N 3,4,6,7,8,8a-hexahydro-2h-pyrrolo[1,2-a]pyrazin-1-one Chemical compound O=C1NCCN2CCCC12 JBIHMFNMKHDTEE-UHFFFAOYSA-N 0.000 description 3
- XLZYKTYMLBOINK-UHFFFAOYSA-N 3-(4-hydroxybenzoyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)C=2C=CC(O)=CC=2)=C1 XLZYKTYMLBOINK-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 3
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 3
- YVOIIFNYZFCVHY-UHFFFAOYSA-N 3-propan-2-yl-1,2-oxazole Chemical compound CC(C)C=1C=CON=1 YVOIIFNYZFCVHY-UHFFFAOYSA-N 0.000 description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 3
- XXJWYDDUDKYVKI-UHFFFAOYSA-N 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline Chemical compound COC1=CC2=C(OC=3C(=C4C=C(C)NC4=CC=3)F)N=CN=C2C=C1OCCCN1CCCC1 XXJWYDDUDKYVKI-UHFFFAOYSA-N 0.000 description 3
- RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 3
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 3
- 208000001446 Anaplastic Thyroid Carcinoma Diseases 0.000 description 3
- 206010002240 Anaplastic thyroid cancer Diseases 0.000 description 3
- QULDDKSCVCJTPV-UHFFFAOYSA-N BIIB021 Chemical compound COC1=C(C)C=NC(CN2C3=NC(N)=NC(Cl)=C3N=C2)=C1C QULDDKSCVCJTPV-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 3
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Chemical group OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 description 3
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- 201000008808 Fibrosarcoma Diseases 0.000 description 3
- JRZJKWGQFNTSRN-UHFFFAOYSA-N Geldanamycin Natural products C1C(C)CC(OC)C(O)C(C)C=C(C)C(OC(N)=O)C(OC)CCC=C(C)C(=O)NC2=CC(=O)C(OC)=C1C2=O JRZJKWGQFNTSRN-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Chemical group OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 3
- 108010069236 Goserelin Proteins 0.000 description 3
- 101150088952 IGF1 gene Proteins 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 239000002067 L01XE06 - Dasatinib Substances 0.000 description 3
- UIARLYUEJFELEN-LROUJFHJSA-N LSM-1231 Chemical compound C12=C3N4C5=CC=CC=C5C3=C3C(=O)NCC3=C2C2=CC=CC=C2N1[C@]1(C)[C@](CO)(O)C[C@H]4O1 UIARLYUEJFELEN-LROUJFHJSA-N 0.000 description 3
- 108010000817 Leuprolide Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Chemical group OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 150000001204 N-oxides Chemical class 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 3
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 3
- 206010033701 Papillary thyroid cancer Diseases 0.000 description 3
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 206010043276 Teratoma Diseases 0.000 description 3
- IWEQQRMGNVVKQW-OQKDUQJOSA-N Toremifene citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 IWEQQRMGNVVKQW-OQKDUQJOSA-N 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 150000001408 amides Chemical group 0.000 description 3
- 230000000573 anti-seizure effect Effects 0.000 description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 3
- 229940092714 benzenesulfonic acid Drugs 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 3
- 230000036983 biotransformation Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 229960004117 capecitabine Drugs 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 125000004181 carboxyalkyl group Chemical group 0.000 description 3
- 229960005243 carmustine Drugs 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 229960002412 cediranib Drugs 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000000973 chemotherapeutic effect Effects 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 125000000068 chlorophenyl group Chemical group 0.000 description 3
- 235000013985 cinnamic acid Nutrition 0.000 description 3
- 229930016911 cinnamic acid Natural products 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 238000002681 cryosurgery Methods 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 229960000684 cytarabine Drugs 0.000 description 3
- 229960003901 dacarbazine Drugs 0.000 description 3
- 229960002448 dasatinib Drugs 0.000 description 3
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical group CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 3
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 3
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 3
- 229940043168 fareston Drugs 0.000 description 3
- 206010016629 fibroma Diseases 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 235000011087 fumaric acid Nutrition 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- QTQAWLPCGQOSGP-GBTDJJJQSA-N geldanamycin Chemical compound N1C(=O)\C(C)=C/C=C\[C@@H](OC)[C@H](OC(N)=O)\C(C)=C/[C@@H](C)[C@@H](O)[C@H](OC)C[C@@H](C)CC2=C(OC)C(=O)C=C1C2=O QTQAWLPCGQOSGP-GBTDJJJQSA-N 0.000 description 3
- 239000000174 gluconic acid Chemical group 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Chemical group 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 229960002913 goserelin Drugs 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 201000011066 hemangioma Diseases 0.000 description 3
- 229940022353 herceptin Drugs 0.000 description 3
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 3
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 3
- 125000002883 imidazolyl group Chemical group 0.000 description 3
- 238000000099 in vitro assay Methods 0.000 description 3
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 3
- 229960004338 leuprorelin Drugs 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 229960002510 mandelic acid Drugs 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 230000002611 ovarian Effects 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 description 3
- BRYCUMKDWMEGMK-UHFFFAOYSA-N piperazine-2-carboxamide Chemical compound NC(=O)C1CNCCN1 BRYCUMKDWMEGMK-UHFFFAOYSA-N 0.000 description 3
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 125000003373 pyrazinyl group Chemical group 0.000 description 3
- 125000003226 pyrazolyl group Chemical group 0.000 description 3
- 125000002098 pyridazinyl group Chemical group 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- 125000000168 pyrrolyl group Chemical group 0.000 description 3
- 229940107700 pyruvic acid Drugs 0.000 description 3
- 229960004622 raloxifene Drugs 0.000 description 3
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 3
- 239000008117 stearic acid Chemical group 0.000 description 3
- 238000011476 stem cell transplantation Methods 0.000 description 3
- 229960001052 streptozocin Drugs 0.000 description 3
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- AYUNIORJHRXIBJ-TXHRRWQRSA-N tanespimycin Chemical compound N1C(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@@H](O)[C@@H](OC)C[C@H](C)CC2=C(NCC=C)C(=O)C=C1C2=O AYUNIORJHRXIBJ-TXHRRWQRSA-N 0.000 description 3
- 229950007866 tanespimycin Drugs 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 3
- 125000000335 thiazolyl group Chemical group 0.000 description 3
- 208000030045 thyroid gland papillary carcinoma Diseases 0.000 description 3
- 208000019179 thyroid gland undifferentiated (anaplastic) carcinoma Diseases 0.000 description 3
- XFCLJVABOIYOMF-QPLCGJKRSA-N toremifene Chemical compound C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 XFCLJVABOIYOMF-QPLCGJKRSA-N 0.000 description 3
- 229960005026 toremifene Drugs 0.000 description 3
- CUCDSXGGOIXQPU-LBPRGKRZSA-N (2s)-2-(benzylamino)-4-methylpentanamide Chemical compound CC(C)C[C@@H](C(N)=O)NCC1=CC=CC=C1 CUCDSXGGOIXQPU-LBPRGKRZSA-N 0.000 description 2
- YAIQLSGJDFUANQ-QMMMGPOBSA-N (2s)-2-(benzylamino)propanamide Chemical compound NC(=O)[C@H](C)NCC1=CC=CC=C1 YAIQLSGJDFUANQ-QMMMGPOBSA-N 0.000 description 2
- SVNJBEMPMKWDCO-KCHLEUMXSA-N (2s)-2-[[(2s)-3-carboxy-2-[[2-[[(2s)-5-(diaminomethylideneamino)-2-[[4-oxo-4-[[4-(4-oxo-8-phenylchromen-2-yl)morpholin-4-ium-4-yl]methoxy]butanoyl]amino]pentanoyl]amino]acetyl]amino]propanoyl]amino]-3-hydroxypropanoate Chemical compound C=1C(=O)C2=CC=CC(C=3C=CC=CC=3)=C2OC=1[N+]1(COC(=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C([O-])=O)CCOCC1 SVNJBEMPMKWDCO-KCHLEUMXSA-N 0.000 description 2
- SWDZPNJZKUGIIH-QQTULTPQSA-N (5z)-n-ethyl-5-(4-hydroxy-6-oxo-3-propan-2-ylcyclohexa-2,4-dien-1-ylidene)-4-[4-(morpholin-4-ylmethyl)phenyl]-2h-1,2-oxazole-3-carboxamide Chemical compound O1NC(C(=O)NCC)=C(C=2C=CC(CN3CCOCC3)=CC=2)\C1=C1/C=C(C(C)C)C(O)=CC1=O SWDZPNJZKUGIIH-QQTULTPQSA-N 0.000 description 2
- SJEBCIIXHFHPRS-UHFFFAOYSA-N 1-n'-[4-[7-[3-(diethylamino)propoxy]-6-methoxyquinazolin-4-yl]oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OCCCN(CC)CC)=CC2=NC=NC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 SJEBCIIXHFHPRS-UHFFFAOYSA-N 0.000 description 2
- AGBUHYGWJRLISC-UHFFFAOYSA-N 2,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-1-one Chemical compound C1CCCC2C(=O)NCCN21 AGBUHYGWJRLISC-UHFFFAOYSA-N 0.000 description 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 description 2
- IBGZJGHEKFEZRG-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=C(N)C2=CC(OC)=CC=C2N=C1C1=CC=C(Cl)C(Cl)=C1 IBGZJGHEKFEZRG-UHFFFAOYSA-N 0.000 description 2
- COMVTJIXFQQFIN-UHFFFAOYSA-N 2-(benzylamino)acetamide Chemical compound NC(=O)CNCC1=CC=CC=C1 COMVTJIXFQQFIN-UHFFFAOYSA-N 0.000 description 2
- LBOHKDOTRDQHGM-UHFFFAOYSA-N 2-[benzyl(methyl)amino]acetamide Chemical compound NC(=O)CN(C)CC1=CC=CC=C1 LBOHKDOTRDQHGM-UHFFFAOYSA-N 0.000 description 2
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 2
- WQYABTZGUVYADK-UHFFFAOYSA-N 2-benzylbenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1CC1=CC=CC=C1 WQYABTZGUVYADK-UHFFFAOYSA-N 0.000 description 2
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 2
- CMOJBVDQMMHOIC-UHFFFAOYSA-N 2-methyl-8h-pyrido[2,3-d]pyrimidin-7-one Chemical compound C1=CC(=O)NC2=NC(C)=NC=C21 CMOJBVDQMMHOIC-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 2
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 2
- SYYMNUFXRFAELA-BTQNPOSSSA-N 4-[4-[[(1r)-1-phenylethyl]amino]-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenol;hydrobromide Chemical compound Br.N([C@H](C)C=1C=CC=CC=1)C(C=1C=2)=NC=NC=1NC=2C1=CC=C(O)C=C1 SYYMNUFXRFAELA-BTQNPOSSSA-N 0.000 description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 2
- 108010012934 Albumin-Bound Paclitaxel Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 201000003076 Angiosarcoma Diseases 0.000 description 2
- 101100297694 Arabidopsis thaliana PIP2-7 gene Proteins 0.000 description 2
- 229940124204 C-kit inhibitor Drugs 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000005461 Canertinib Substances 0.000 description 2
- 239000012623 DNA damaging agent Substances 0.000 description 2
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 2
- 108700012941 GNRH1 Proteins 0.000 description 2
- 101710113436 GTPase KRas Proteins 0.000 description 2
- 208000032612 Glial tumor Diseases 0.000 description 2
- 206010018338 Glioma Diseases 0.000 description 2
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 2
- 208000001258 Hemangiosarcoma Diseases 0.000 description 2
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 2
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 2
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 239000005536 L01XE08 - Nilotinib Substances 0.000 description 2
- 239000003798 L01XE11 - Pazopanib Substances 0.000 description 2
- 208000018142 Leiomyosarcoma Diseases 0.000 description 2
- GQYIWUVLTXOXAJ-UHFFFAOYSA-N Lomustine Chemical compound ClCCN(N=O)C(=O)NC1CCCCC1 GQYIWUVLTXOXAJ-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000034578 Multiple myelomas Diseases 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical group N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 2
- 101100456541 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) MEC3 gene Proteins 0.000 description 2
- 101100483663 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) UFD1 gene Proteins 0.000 description 2
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 2
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
- 102100022596 Tyrosine-protein kinase ABL1 Human genes 0.000 description 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 2
- 208000008383 Wilms tumor Diseases 0.000 description 2
- 102100025093 Zinc fingers and homeoboxes protein 2 Human genes 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 125000005090 alkenylcarbonyl group Chemical group 0.000 description 2
- 125000005193 alkenylcarbonyloxy group Chemical group 0.000 description 2
- 125000004450 alkenylene group Chemical group 0.000 description 2
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 2
- 125000003418 alkyl amino alkoxy group Chemical group 0.000 description 2
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 2
- 125000004949 alkyl amino carbonyl amino group Chemical group 0.000 description 2
- 125000005195 alkyl amino carbonyloxy group Chemical group 0.000 description 2
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000009167 androgen deprivation therapy Methods 0.000 description 2
- 229940045799 anthracyclines and related substance Drugs 0.000 description 2
- 230000000340 anti-metabolite Effects 0.000 description 2
- 229940044684 anti-microtubule agent Drugs 0.000 description 2
- 229940100197 antimetabolite Drugs 0.000 description 2
- 239000002256 antimetabolite Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 229960003005 axitinib Drugs 0.000 description 2
- RITAVMQDGBJQJZ-FMIVXFBMSA-N axitinib Chemical compound CNC(=O)C1=CC=CC=C1SC1=CC=C(C(\C=C\C=2N=CC=CC=2)=NN2)C2=C1 RITAVMQDGBJQJZ-FMIVXFBMSA-N 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 2
- 229960004630 chlorambucil Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 2
- VEQSYQFANVTOGA-UHFFFAOYSA-N cyclobutane-1,1-dicarboxamide Chemical compound NC(=O)C1(C(N)=O)CCC1 VEQSYQFANVTOGA-UHFFFAOYSA-N 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 229960000975 daunorubicin Drugs 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 125000004984 dialkylaminoalkoxy group Chemical group 0.000 description 2
- 125000005202 dialkylaminocarbonyloxy group Chemical group 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003534 dna topoisomerase inhibitor Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 2
- 229960000390 fludarabine Drugs 0.000 description 2
- GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 2
- 229960004421 formestane Drugs 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 208000010749 gastric carcinoma Diseases 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000004415 heterocyclylalkyl group Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000005113 hydroxyalkoxy group Chemical group 0.000 description 2
- YLMAHDNUQAMNNX-UHFFFAOYSA-N imatinib methanesulfonate Chemical compound CS(O)(=O)=O.C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 YLMAHDNUQAMNNX-UHFFFAOYSA-N 0.000 description 2
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 229940043355 kinase inhibitor Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 201000010260 leiomyoma Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229960002247 lomustine Drugs 0.000 description 2
- 229950005069 luminespib Drugs 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- WRIRWRKPLXCTFD-UHFFFAOYSA-N malonamide Chemical compound NC(=O)CC(N)=O WRIRWRKPLXCTFD-UHFFFAOYSA-N 0.000 description 2
- 229950008001 matuzumab Drugs 0.000 description 2
- 229960004961 mechlorethamine Drugs 0.000 description 2
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 2
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 2
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 2
- 229960001924 melphalan Drugs 0.000 description 2
- 206010027191 meningioma Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- UEYDOLOAGHWSPK-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[1-(4-methylphenyl)ethyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C(C)C1=CC=C(C)C=C1 UEYDOLOAGHWSPK-UHFFFAOYSA-N 0.000 description 2
- ONDPWWDPQDCQNJ-UHFFFAOYSA-N n-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;phosphoric acid Chemical compound OP(O)(O)=O.OP(O)(O)=O.C=1C=C2C(C)(C)CNC2=CC=1NC(=O)C1=CC=CN=C1NCC1=CC=NC=C1 ONDPWWDPQDCQNJ-UHFFFAOYSA-N 0.000 description 2
- LBWFXVZLPYTWQI-IPOVEDGCSA-N n-[2-(diethylamino)ethyl]-5-[(z)-(5-fluoro-2-oxo-1h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C LBWFXVZLPYTWQI-IPOVEDGCSA-N 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 229940086322 navelbine Drugs 0.000 description 2
- 229960001346 nilotinib Drugs 0.000 description 2
- 229950010203 nimotuzumab Drugs 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 201000008968 osteosarcoma Diseases 0.000 description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- CUIHSIWYWATEQL-UHFFFAOYSA-N pazopanib Chemical compound C1=CC2=C(C)N(C)N=C2C=C1N(C)C(N=1)=CC=NC=1NC1=CC=C(C)C(S(N)(=O)=O)=C1 CUIHSIWYWATEQL-UHFFFAOYSA-N 0.000 description 2
- 229960000639 pazopanib Drugs 0.000 description 2
- 229950006299 pelitinib Drugs 0.000 description 2
- QOFFJEBXNKRSPX-ZDUSSCGKSA-N pemetrexed Chemical compound C1=N[C]2NC(N)=NC(=O)C2=C1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QOFFJEBXNKRSPX-ZDUSSCGKSA-N 0.000 description 2
- 229960005079 pemetrexed Drugs 0.000 description 2
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 2
- SZFPYBIJACMNJV-UHFFFAOYSA-N perifosine Chemical compound CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1 SZFPYBIJACMNJV-UHFFFAOYSA-N 0.000 description 2
- 229950010632 perifosine Drugs 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011574 phosphorus Chemical group 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 2
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 2
- 229960004618 prednisone Drugs 0.000 description 2
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 2
- 229960000624 procarbazine Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 2
- 125000004944 pyrazin-3-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 2
- 125000004353 pyrazol-1-yl group Chemical group [H]C1=NN(*)C([H])=C1[H] 0.000 description 2
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 2
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 2
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 2
- 125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 229940124617 receptor tyrosine kinase inhibitor Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052701 rubidium Inorganic materials 0.000 description 2
- 229950003647 semaxanib Drugs 0.000 description 2
- WUWDLXZGHZSWQZ-WQLSENKSSA-N semaxanib Chemical compound N1C(C)=CC(C)=C1\C=C/1C2=CC=CC=C2NC\1=O WUWDLXZGHZSWQZ-WQLSENKSSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 201000000498 stomach carcinoma Diseases 0.000 description 2
- 125000005415 substituted alkoxy group Chemical group 0.000 description 2
- 229940034785 sutent Drugs 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- UXXQOJXBIDBUAC-UHFFFAOYSA-N tandutinib Chemical compound COC1=CC2=C(N3CCN(CC3)C(=O)NC=3C=CC(OC(C)C)=CC=3)N=CN=C2C=C1OCCCN1CCCCC1 UXXQOJXBIDBUAC-UHFFFAOYSA-N 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
- 229960003087 tioguanine Drugs 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- 229940044693 topoisomerase inhibitor Drugs 0.000 description 2
- 125000001425 triazolyl group Chemical group 0.000 description 2
- 229950000578 vatalanib Drugs 0.000 description 2
- YCOYDOIWSSHVCK-UHFFFAOYSA-N vatalanib Chemical compound C1=CC(Cl)=CC=C1NC(C1=CC=CC=C11)=NN=C1CC1=CC=NC=C1 YCOYDOIWSSHVCK-UHFFFAOYSA-N 0.000 description 2
- CILBMBUYJCWATM-PYGJLNRPSA-N vinorelbine ditartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC CILBMBUYJCWATM-PYGJLNRPSA-N 0.000 description 2
- JBAXOLUMZMMSFG-AFUMVMLFSA-N (2e)-n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-2-ethoxyiminopropanamide Chemical compound C1=CC(NC(=O)C(/C)=N/OCC)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 JBAXOLUMZMMSFG-AFUMVMLFSA-N 0.000 description 1
- KJJKVQHIEJQPOP-ZMOGYAJESA-N (2e)-n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-2-methoxyiminopropanamide Chemical compound C1=CC(NC(=O)C(/C)=N/OC)=CC=C1OC1=CC=NC2=CC(OC)=C(OC)C=C12 KJJKVQHIEJQPOP-ZMOGYAJESA-N 0.000 description 1
- SLATXJWGHBXASM-UXHLAJHPSA-N (2e)-n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-2-phenylmethoxyiminopropanamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)C(\C)=N\OCC1=CC=CC=C1 SLATXJWGHBXASM-UXHLAJHPSA-N 0.000 description 1
- SKUORLYLDDJDMD-VWLOTQADSA-N (2s)-1-benzyl-n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]pyrrolidine-2-carboxamide Chemical compound C([C@H]1C(=O)NC2=CC=C(C=C2)OC=2C=CN=C3C=C(C(=CC3=2)OC)OC)CCN1CC1=CC=CC=C1 SKUORLYLDDJDMD-VWLOTQADSA-N 0.000 description 1
- CSDMAPGPCQYXCM-NSHDSACASA-N (2s)-2-(benzylamino)-3-methylbutanamide Chemical compound CC(C)[C@@H](C(N)=O)NCC1=CC=CC=C1 CSDMAPGPCQYXCM-NSHDSACASA-N 0.000 description 1
- YXTKHLHCVFUPPT-YYFJYKOTSA-N (2s)-2-[[4-[(2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;(1r,2r)-1,2-dimethanidylcyclohexane;5-fluoro-1h-pyrimidine-2,4-dione;oxalic acid;platinum(2+) Chemical compound [Pt+2].OC(=O)C(O)=O.[CH2-][C@@H]1CCCC[C@H]1[CH2-].FC1=CNC(=O)NC1=O.C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 YXTKHLHCVFUPPT-YYFJYKOTSA-N 0.000 description 1
- MHFUWOIXNMZFIW-WNQIDUERSA-N (2s)-2-hydroxypropanoic acid;n-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1h-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide Chemical compound C[C@H](O)C(O)=O.C1CN(C)CCN1C1=CC(NC2=NNC(C)=C2)=NC(SC=2C=CC(NC(=O)C3CC3)=CC=2)=N1 MHFUWOIXNMZFIW-WNQIDUERSA-N 0.000 description 1
- SYLHDCKBBWIRTH-UHFFFAOYSA-N (4-butylphenyl)-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone Chemical compound C1=CC(CCCC)=CC=C1C(=O)N1CC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)OCC1 SYLHDCKBBWIRTH-UHFFFAOYSA-N 0.000 description 1
- PTHGDVCPCZKZKR-UHFFFAOYSA-N (4-chlorophenyl)methanol Chemical compound OCC1=CC=C(Cl)C=C1 PTHGDVCPCZKZKR-UHFFFAOYSA-N 0.000 description 1
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
- MWWSFMDVAYGXBV-MYPASOLCSA-N (7r,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical compound Cl.O([C@@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-MYPASOLCSA-N 0.000 description 1
- SJELSHSDYSWGLA-VOTSOKGWSA-N (e)-1-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-3-phenylprop-2-en-1-one Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C(=O)\C=C\C1=CC=CC=C1 SJELSHSDYSWGLA-VOTSOKGWSA-N 0.000 description 1
- IJBZFRMMDXVGCU-SNAWJCMRSA-N (e)-3-[4-[4-[5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methyl-3-(2-pyrrolidin-1-ylethylamino)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-enoic acid Chemical compound C1=C(OCC(F)(CF)CF)C=C(N2CCN(CC2)C=2C=3C(\C=C\C(O)=O)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 IJBZFRMMDXVGCU-SNAWJCMRSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- PBIJFSCPEFQXBB-UHFFFAOYSA-N 1,1-dimethylcyclopropane Chemical compound CC1(C)CC1 PBIJFSCPEFQXBB-UHFFFAOYSA-N 0.000 description 1
- XLOVPKCQAPHUKK-UHFFFAOYSA-N 1,2,3,4,4a,5,8,8a-octahydronaphthalene Chemical compound C1C=CCC2CCCCC21 XLOVPKCQAPHUKK-UHFFFAOYSA-N 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- CPDVUYTVYREKJG-UHFFFAOYSA-N 1,3-benzodioxol-5-yl-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C=3C=C4OCOC4=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 CPDVUYTVYREKJG-UHFFFAOYSA-N 0.000 description 1
- SUYQOVLUPLPLGV-UHFFFAOYSA-N 1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-4-(4-chlorophenyl)-n-[3-(diethylamino)propyl]piperidine-4-carboxamide Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1(C(=O)NCCCN(CC)CC)C1=CC=C(Cl)C=C1 SUYQOVLUPLPLGV-UHFFFAOYSA-N 0.000 description 1
- CDCMLAUCQJCJOQ-UHFFFAOYSA-N 1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-n-(4-chlorophenyl)piperidin-4-amine Chemical compound C1=CC(Cl)=CC=C1NC1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 CDCMLAUCQJCJOQ-UHFFFAOYSA-N 0.000 description 1
- UIZIXYPVANHGLF-UHFFFAOYSA-N 1-N'-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxy-5-methylphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)C)=CC(Cl)=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 UIZIXYPVANHGLF-UHFFFAOYSA-N 0.000 description 1
- VGCDUIOWOVIHIG-UHFFFAOYSA-N 1-N'-[3-fluoro-4-[6-methoxy-7-(3-piperazin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 VGCDUIOWOVIHIG-UHFFFAOYSA-N 0.000 description 1
- ZDGOUZKWWHOXBE-UHFFFAOYSA-N 1-N'-[3-fluoro-4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCCCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 ZDGOUZKWWHOXBE-UHFFFAOYSA-N 0.000 description 1
- JNHSNTJJJQXTCP-UHFFFAOYSA-N 1-N'-[6-(6,7-dimethoxyquinolin-4-yl)oxy-2-methylpyridin-3-yl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1C)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 JNHSNTJJJQXTCP-UHFFFAOYSA-N 0.000 description 1
- YYJBPBRJPNTFPS-UHFFFAOYSA-N 1-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-1-(4-chlorophenyl)-4-(dimethylamino)butan-1-ol Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(O)(CCCN(C)C)C1=CC=C(Cl)C=C1 YYJBPBRJPNTFPS-UHFFFAOYSA-N 0.000 description 1
- SPPCFOSOFKDUTG-UHFFFAOYSA-N 1-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-1-(4-fluorophenyl)-n-(furan-2-ylmethyl)-n-methylmethanamine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(C=1C=CC(F)=CC=1)N(C)CC1=CC=CO1 SPPCFOSOFKDUTG-UHFFFAOYSA-N 0.000 description 1
- WCJPMEFJDSKAHZ-UHFFFAOYSA-N 1-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-1-(4-fluorophenyl)-n-methyl-n-(pyridin-2-ylmethyl)methanamine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(C=1C=CC(F)=CC=1)N(C)CC1=CC=CC=N1 WCJPMEFJDSKAHZ-UHFFFAOYSA-N 0.000 description 1
- VEUAGFBTUOWMGS-UHFFFAOYSA-N 1-[2-[2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylphenyl]phenoxy]ethyl]pyrrolidine-2,5-dione Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC=C1OCCN1C(=O)CCC1=O VEUAGFBTUOWMGS-UHFFFAOYSA-N 0.000 description 1
- FEBOQCZDPJAXJB-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-oxazepan-4-yl]ethanone Chemical compound N1=CN=C2C=C(OCC3OCCCN(C3)C(C)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FEBOQCZDPJAXJB-UHFFFAOYSA-N 0.000 description 1
- JXWOGDLXVWLJMH-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-2,2-dimethylpropan-1-one Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C(C)(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 JXWOGDLXVWLJMH-UHFFFAOYSA-N 0.000 description 1
- QHJQGPXGMHCLDZ-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-2-(3-methoxyphenyl)ethanone Chemical compound COC1=CC=CC(CC(=O)N2CC(COC=3C(=CC4=C(NC=5C=C(Cl)C(Cl)=CC=5)N=CN=C4C=3)OC)OCC2)=C1 QHJQGPXGMHCLDZ-UHFFFAOYSA-N 0.000 description 1
- KGRQWBCQDURFIP-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-2-ethylhexan-1-one Chemical compound C1N(C(=O)C(CC)CCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC KGRQWBCQDURFIP-UHFFFAOYSA-N 0.000 description 1
- VBRGKAXLFVNGHF-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-2-methylpentan-1-one Chemical compound C1N(C(=O)C(C)CCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC VBRGKAXLFVNGHF-UHFFFAOYSA-N 0.000 description 1
- TZKZSFJMVHBLGG-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-2-phenylbutan-1-one Chemical compound C=1C=CC=CC=1C(CC)C(=O)N(C1)CCOC1COC(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Cl)C(Cl)=C1 TZKZSFJMVHBLGG-UHFFFAOYSA-N 0.000 description 1
- AKMSPGIAHZAWSW-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-2-propylpentan-1-one Chemical compound C1N(C(=O)C(CCC)CCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC AKMSPGIAHZAWSW-UHFFFAOYSA-N 0.000 description 1
- NQRHMWLUXWPKIS-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-4-methylpentan-1-one Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)CCC(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 NQRHMWLUXWPKIS-UHFFFAOYSA-N 0.000 description 1
- FWOWVRMQIDGFHG-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]butan-2-one Chemical compound C1N(CC(=O)CC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC FWOWVRMQIDGFHG-UHFFFAOYSA-N 0.000 description 1
- SWQHCAPKAPNADM-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]hexan-1-one Chemical compound C1N(C(=O)CCCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC SWQHCAPKAPNADM-UHFFFAOYSA-N 0.000 description 1
- MAJPXTGDUCKEGK-UHFFFAOYSA-N 1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]propan-1-one Chemical compound C1N(C(=O)CC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC MAJPXTGDUCKEGK-UHFFFAOYSA-N 0.000 description 1
- IKBSEBRGSVFUHM-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-4,4,4-trifluorobutan-1-one Chemical compound C1=C(C(=O)CCC(F)(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 IKBSEBRGSVFUHM-UHFFFAOYSA-N 0.000 description 1
- AEPBFFNXZJQDMU-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]butan-1-ol Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(O)CCC)=CC=1NCCN1CCCC1 AEPBFFNXZJQDMU-UHFFFAOYSA-N 0.000 description 1
- OFDSSLFGGWSMMJ-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]butan-1-one Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)CCC)=CC=1NCCN1CCCC1 OFDSSLFGGWSMMJ-UHFFFAOYSA-N 0.000 description 1
- JEWJTXCLTYTKGJ-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]ethanone Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)C)=CC=1NCCN1CCCC1 JEWJTXCLTYTKGJ-UHFFFAOYSA-N 0.000 description 1
- DCNODYHFBSBLGN-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]pentan-1-one Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)CCCC)=CC=1NCCN1CCCC1 DCNODYHFBSBLGN-UHFFFAOYSA-N 0.000 description 1
- DEJZGAXRKVTAOI-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]propan-1-one Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)CC)=CC=1NCCN1CCCC1 DEJZGAXRKVTAOI-UHFFFAOYSA-N 0.000 description 1
- JPGSIPPBCGKIIU-UHFFFAOYSA-N 1-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(2-pyrrolidin-1-ylethylamino)phenyl]butan-1-one Chemical compound C=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)CCC)=CC=1NCCN1CCCC1 JPGSIPPBCGKIIU-UHFFFAOYSA-N 0.000 description 1
- YGRIEMSMFNEFKK-UHFFFAOYSA-N 1-[3-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-4-ethylpiperazin-1-yl]ethanone Chemical compound CCN1CCN(C(C)=O)CC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC YGRIEMSMFNEFKK-UHFFFAOYSA-N 0.000 description 1
- OIXFAIDFIODKDD-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1-(1-hydroxy-3-phenylpropan-2-yl)urea Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(=O)N)C(CO)CC1=CC=CC=C1)F OIXFAIDFIODKDD-UHFFFAOYSA-N 0.000 description 1
- FGOBYJLJQMACOY-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-(2-phenylacetyl)imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C1=O)CCN1C(=O)CC1=CC=CC=C1 FGOBYJLJQMACOY-UHFFFAOYSA-N 0.000 description 1
- QOMCTMPSURDRBN-UHFFFAOYSA-N 1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N1CCNC1=O QOMCTMPSURDRBN-UHFFFAOYSA-N 0.000 description 1
- BWMAIJPCEMKYSE-UHFFFAOYSA-N 1-[4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 BWMAIJPCEMKYSE-UHFFFAOYSA-N 0.000 description 1
- BIJCHRXRGHEMQV-UHFFFAOYSA-N 1-[[1-(3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methyl]-1-[2-(dimethylamino)ethyl]urea Chemical compound BrC1=NNC2=NC=NC(=C21)N2CCC(CC2)C(N(C(=O)N)CCN(C)C)C2=CC=C(C=C2)Cl BIJCHRXRGHEMQV-UHFFFAOYSA-N 0.000 description 1
- MRXUDWFSOWSQJI-UHFFFAOYSA-N 1-benzyl-3-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C1=O)CCN1CC1=CC=CC=C1 MRXUDWFSOWSQJI-UHFFFAOYSA-N 0.000 description 1
- PYCRBAYIHZFPMZ-UHFFFAOYSA-N 1-benzyl-3-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-n'-(4-fluorophenyl)azetidine-3,3-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C(C1)(C(N)=O)CN1CC1=CC=CC=C1 PYCRBAYIHZFPMZ-UHFFFAOYSA-N 0.000 description 1
- SNKDCTFPQUHAPR-UHFFFAOYSA-N 1-fluoropyrimidine-2,4-dione Chemical compound FN1C=CC(=O)NC1=O SNKDCTFPQUHAPR-UHFFFAOYSA-N 0.000 description 1
- HYVJXVJIRRULOF-UHFFFAOYSA-N 1-n'-(4-fluorophenyl)-1-n'-[4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxy-2-methylphenyl]cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C=C1C)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 HYVJXVJIRRULOF-UHFFFAOYSA-N 0.000 description 1
- JKVKPIDJOYBNPM-UHFFFAOYSA-N 1-n'-(4-fluorophenyl)-1-n'-[4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 JKVKPIDJOYBNPM-UHFFFAOYSA-N 0.000 description 1
- QRJRRPAUYVSLCL-UHFFFAOYSA-N 1-n'-(4-fluorophenyl)-1-n'-[6-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxy-2-methylpyridin-3-yl]cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(N=C1C)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 QRJRRPAUYVSLCL-UHFFFAOYSA-N 0.000 description 1
- DWOQXTKRUXEZCD-UHFFFAOYSA-N 1-n'-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC(Cl)=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 DWOQXTKRUXEZCD-UHFFFAOYSA-N 0.000 description 1
- IPSHJWWLYLRUKG-UHFFFAOYSA-N 1-n'-[3-(aminomethyl)phenyl]-1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=C(CN)C=CC=1)C(=O)C1(C(N)=O)CC1 IPSHJWWLYLRUKG-UHFFFAOYSA-N 0.000 description 1
- FDSMHYGVZZSREN-UHFFFAOYSA-N 1-n'-[3-fluoro-4-(6-hydroxy-7-methoxyquinolin-4-yl)oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(O)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 FDSMHYGVZZSREN-UHFFFAOYSA-N 0.000 description 1
- WCZQGHMAMZWIRF-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]oxyphenyl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound N1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 WCZQGHMAMZWIRF-UHFFFAOYSA-N 0.000 description 1
- ZABJHULMZJYUSN-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound N1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 ZABJHULMZJYUSN-UHFFFAOYSA-N 0.000 description 1
- FCGJXAOTZFGHNQ-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 FCGJXAOTZFGHNQ-UHFFFAOYSA-N 0.000 description 1
- CGULPOPMEHIZES-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[6-methoxy-7-(3-piperazin-1-ylpropoxy)quinazolin-4-yl]oxyphenyl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound N1=CN=C2C=C(OCCCN3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 CGULPOPMEHIZES-UHFFFAOYSA-N 0.000 description 1
- MISRBALTMCRTDI-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCCCN3CCCCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 MISRBALTMCRTDI-UHFFFAOYSA-N 0.000 description 1
- WPIPKIAGFZSDSI-UHFFFAOYSA-N 1-n'-[3-fluoro-4-[7-methoxy-6-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 WPIPKIAGFZSDSI-UHFFFAOYSA-N 0.000 description 1
- CULMRPBXAPMGBK-UHFFFAOYSA-N 1-n'-[4-(2-amino-6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC(N)=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 CULMRPBXAPMGBK-UHFFFAOYSA-N 0.000 description 1
- AAKRPIDDXTXZRC-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxy-2-methylquinazolin-4-yl)oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC(C)=NC=1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 AAKRPIDDXTXZRC-UHFFFAOYSA-N 0.000 description 1
- CPKPGNLKKANZNM-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxy-2-methylsulfanylquinolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC(SC)=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 CPKPGNLKKANZNM-UHFFFAOYSA-N 0.000 description 1
- HQVQFFLTAGZOPN-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinazolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 HQVQFFLTAGZOPN-UHFFFAOYSA-N 0.000 description 1
- BUNJNVKZXWPYIQ-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 BUNJNVKZXWPYIQ-UHFFFAOYSA-N 0.000 description 1
- NOSCGNWOQNYCFS-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,3,5-trifluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1F)F)=C(F)C=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 NOSCGNWOQNYCFS-UHFFFAOYSA-N 0.000 description 1
- UXSOORXVNQORDL-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2,5-difluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC(F)=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 UXSOORXVNQORDL-UHFFFAOYSA-N 0.000 description 1
- PBWXANLPWDRNSW-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2-methylphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1C)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 PBWXANLPWDRNSW-UHFFFAOYSA-N 0.000 description 1
- KMEFSPDLCSTMFN-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3,5-difluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=C(F)C=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 KMEFSPDLCSTMFN-UHFFFAOYSA-N 0.000 description 1
- FKZMHDRGYUCWJX-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 FKZMHDRGYUCWJX-UHFFFAOYSA-N 0.000 description 1
- NDHROUHEJNSAQB-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-2-methylphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC(C)=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 NDHROUHEJNSAQB-UHFFFAOYSA-N 0.000 description 1
- UXJDYCVBZLEFIC-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 UXJDYCVBZLEFIC-UHFFFAOYSA-N 0.000 description 1
- KBPSFNZVQAYUGT-UHFFFAOYSA-N 1-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-n'-phenylcyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=CC=CC=1)C(=O)C1(C(N)=O)CC1 KBPSFNZVQAYUGT-UHFFFAOYSA-N 0.000 description 1
- OLCZWPWSTBMVMG-UHFFFAOYSA-N 1-n'-[4-(7-chloroquinolin-4-yl)oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=1C=C(F)C=CC=1N(C=1C=C(F)C(OC=2C3=CC=C(Cl)C=C3N=CC=2)=CC=1)C(=O)C1(C(=O)N)CC1 OLCZWPWSTBMVMG-UHFFFAOYSA-N 0.000 description 1
- NDNPLKPDGDRJDL-UHFFFAOYSA-N 1-n'-[4-(7-chloroquinolin-4-yl)oxyphenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=1C=C(F)C=CC=1N(C=1C=CC(OC=2C3=CC=C(Cl)C=C3N=CC=2)=CC=1)C(=O)C1(C(=O)N)CC1 NDNPLKPDGDRJDL-UHFFFAOYSA-N 0.000 description 1
- TUVLWUHMFPRJDQ-UHFFFAOYSA-N 1-n'-[4-[6,7-dimethoxy-2-(methylamino)quinolin-4-yl]oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC(NC)=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 TUVLWUHMFPRJDQ-UHFFFAOYSA-N 0.000 description 1
- BGQCRXCVLJDBIQ-UHFFFAOYSA-N 1-n'-[4-[6-[3-(diethylamino)propoxy]-7-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OC)C(OCCCN(CC)CC)=CC2=C1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 BGQCRXCVLJDBIQ-UHFFFAOYSA-N 0.000 description 1
- MULHNDJNEMHOQX-UHFFFAOYSA-N 1-n'-[4-[7-[2-(diethylamino)ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OCCN(CC)CC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 MULHNDJNEMHOQX-UHFFFAOYSA-N 0.000 description 1
- VBTBYXPMCYIGIZ-UHFFFAOYSA-N 1-n'-[4-[7-[3-(diethylamino)propoxy]-6-methoxyquinazolin-4-yl]oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OCCCN(CC)CC)=CC2=NC=NC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 VBTBYXPMCYIGIZ-UHFFFAOYSA-N 0.000 description 1
- GEVOLPRCIWKZAL-UHFFFAOYSA-N 1-n'-[4-[7-[3-(diethylamino)propoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OCCCN(CC)CC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 GEVOLPRCIWKZAL-UHFFFAOYSA-N 0.000 description 1
- YKADNBFBHXLNBX-UHFFFAOYSA-N 1-n'-[4-[7-[3-(diethylamino)propoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OCCCN(CC)CC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 YKADNBFBHXLNBX-UHFFFAOYSA-N 0.000 description 1
- LCKWQHJPWIZVRL-UHFFFAOYSA-N 1-n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxy-2-methylpyridin-3-yl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC(C)=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 LCKWQHJPWIZVRL-UHFFFAOYSA-N 0.000 description 1
- GINNKDVFQLUMEX-UHFFFAOYSA-N 1-n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-1-n'-(2-phenylethyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)C1(CC1)C(N)=O)CCC1=CC=CC=C1 GINNKDVFQLUMEX-UHFFFAOYSA-N 0.000 description 1
- QZJQIUNVMJLQMT-UHFFFAOYSA-N 1-n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-1-n'-(4-fluorophenyl)cyclobutane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CCC1 QZJQIUNVMJLQMT-UHFFFAOYSA-N 0.000 description 1
- WFBBYBMEJZKUQC-UHFFFAOYSA-N 1-n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 WFBBYBMEJZKUQC-UHFFFAOYSA-N 0.000 description 1
- PQYLEBQADUCIID-UHFFFAOYSA-N 1-n'-[5-chloro-6-(6-methoxy-7-phenylmethoxyquinolin-4-yl)oxypyridin-3-yl]-1-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Chemical compound C1=CN=C2C=C(OCC=3C=CC=CC=3)C(OC)=CC2=C1OC(C(=C1)Cl)=NC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CC1 PQYLEBQADUCIID-UHFFFAOYSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- WRMZOPANDOHWJU-UHFFFAOYSA-N 1h-indol-6-ylmethanol Chemical compound OCC1=CC=C2C=CNC2=C1 WRMZOPANDOHWJU-UHFFFAOYSA-N 0.000 description 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- UZURTQHPMXADGG-UHFFFAOYSA-N 2,3,3a,4,7,7a-hexahydro-1h-indene Chemical compound C1C=CCC2CCCC21 UZURTQHPMXADGG-UHFFFAOYSA-N 0.000 description 1
- PHXGAJLBHUUAKB-UHFFFAOYSA-N 2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound O1CCC2OCCC21 PHXGAJLBHUUAKB-UHFFFAOYSA-N 0.000 description 1
- LOBKIAQKXWHLPW-UHFFFAOYSA-N 2,3,4-trimethylbenzamide Chemical compound CC1=CC=C(C(N)=O)C(C)=C1C LOBKIAQKXWHLPW-UHFFFAOYSA-N 0.000 description 1
- 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- IFFLKGMDBKQMAH-UHFFFAOYSA-N 2,4-diaminopyridine Chemical compound NC1=CC=NC(N)=C1 IFFLKGMDBKQMAH-UHFFFAOYSA-N 0.000 description 1
- RVZMPNMUBCAPQO-UHFFFAOYSA-N 2,4-dimethoxyquinazoline Chemical compound C1=CC=CC2=NC(OC)=NC(OC)=C21 RVZMPNMUBCAPQO-UHFFFAOYSA-N 0.000 description 1
- KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 description 1
- YNTJKQDWYXUTLZ-UHFFFAOYSA-N 2-(3-chlorophenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=CC(Cl)=C1 YNTJKQDWYXUTLZ-UHFFFAOYSA-N 0.000 description 1
- LWGCBCJFCYHDRU-UHFFFAOYSA-N 2-(4-benzylpiperidin-1-yl)-n-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-2-oxoacetamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1NC(=O)C(=O)N(CC1)CCC1CC1=CC=CC=C1 LWGCBCJFCYHDRU-UHFFFAOYSA-N 0.000 description 1
- XNWJPKXDERVJBQ-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]ethanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)CC=3C=CC(Cl)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 XNWJPKXDERVJBQ-UHFFFAOYSA-N 0.000 description 1
- HFNXJOIRWCQTIZ-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[2-(dimethylamino)ethyl]acetamide Chemical compound CN(C)CCNC(=O)CC1=CC=C(Cl)C=C1 HFNXJOIRWCQTIZ-UHFFFAOYSA-N 0.000 description 1
- WVIBCLFRPZSVGY-UHFFFAOYSA-N 2-(benzylamino)-n-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]acetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1NC(=O)CNCC1=CC=CC=C1 WVIBCLFRPZSVGY-UHFFFAOYSA-N 0.000 description 1
- JPQBZLQAZDHYAS-UHFFFAOYSA-N 2-(benzylamino)-n-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]acetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CNCC1=CC=CC=C1 JPQBZLQAZDHYAS-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- XEMIIPOLFGIISJ-UHFFFAOYSA-N 2-(dimethylamino)ethyl n-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-n-(4-chlorophenyl)carbamate Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1N(C(=O)OCCN(C)C)C1=CC=C(Cl)C=C1 XEMIIPOLFGIISJ-UHFFFAOYSA-N 0.000 description 1
- ABBADGFSRBWENF-UHFFFAOYSA-N 2-[(3-bromo-5-tert-butyl-4-hydroxyphenyl)methylidene]propanedinitrile Chemical compound CC(C)(C)C1=CC(C=C(C#N)C#N)=CC(Br)=C1O ABBADGFSRBWENF-UHFFFAOYSA-N 0.000 description 1
- UQDHVMMMXQWODH-GOSISDBHSA-N 2-[(r)-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chloro-3-fluorophenyl)methoxy]-n,n-dimethylethanamine Chemical compound C1([C@@H](C2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)OCCN(C)C)=CC=C(Cl)C(F)=C1 UQDHVMMMXQWODH-GOSISDBHSA-N 0.000 description 1
- SXDXUUULDWGCHS-FQEVSTJZSA-N 2-[(r)-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]-n,n-diethylethanamine Chemical compound C1([C@@H](C2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)OCCN(CC)CC)=CC=C(Cl)C=C1 SXDXUUULDWGCHS-FQEVSTJZSA-N 0.000 description 1
- HITKNPGYVMWQBV-SFHVURJKSA-N 2-[(r)-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]-n,n-dimethylethanamine Chemical compound C1([C@@H](C2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)OCCN(C)C)=CC=C(Cl)C=C1 HITKNPGYVMWQBV-SFHVURJKSA-N 0.000 description 1
- HITKNPGYVMWQBV-GOSISDBHSA-N 2-[(s)-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]-n,n-dimethylethanamine Chemical compound C1([C@H](C2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)OCCN(C)C)=CC=C(Cl)C=C1 HITKNPGYVMWQBV-GOSISDBHSA-N 0.000 description 1
- KAWYBYQPKRMBPJ-UHFFFAOYSA-N 2-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]oxy-5-chloro-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=1C(Cl)=CC=C(OC2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=1NCCN1CCCC1 KAWYBYQPKRMBPJ-UHFFFAOYSA-N 0.000 description 1
- KCGTXHCPPMDHIJ-UHFFFAOYSA-N 2-[2-[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxyethyl]isoindole-1,3-dione Chemical compound N1=CN=C2C=C(OCCN3C(C4=CC=CC=C4C3=O)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KCGTXHCPPMDHIJ-UHFFFAOYSA-N 0.000 description 1
- HENKTRFJYRXSTF-UHFFFAOYSA-N 2-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-1-phenylethanone Chemical compound N1=CN=C2C=C(OCC3OCCN(CC(=O)C=4C=CC=CC=4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HENKTRFJYRXSTF-UHFFFAOYSA-N 0.000 description 1
- BLDLZCARBOCFMX-UHFFFAOYSA-N 2-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]acetamide Chemical compound N1=CN=C2C=C(OCC3OCCN(CC(N)=O)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 BLDLZCARBOCFMX-UHFFFAOYSA-N 0.000 description 1
- PYAFRFDCPSOBJI-UHFFFAOYSA-N 2-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]ethanol Chemical compound N1=CN=C2C=C(OCC3OCCN(CCO)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PYAFRFDCPSOBJI-UHFFFAOYSA-N 0.000 description 1
- UGBZDDLNHZCSGD-UHFFFAOYSA-N 2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyrazin-2-yl]oxy-n,n-dimethylethanamine Chemical compound CN(C)CCOC1=NC=CN=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 UGBZDDLNHZCSGD-UHFFFAOYSA-N 0.000 description 1
- MVXPRNNRMIKVJP-UHFFFAOYSA-N 2-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyanilino]-2-oxoacetic acid Chemical compound C1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC1=CC=C(NC(=O)C(O)=O)C=C1F MVXPRNNRMIKVJP-UHFFFAOYSA-N 0.000 description 1
- YNUJHJNDAOPBCR-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-1-morpholin-4-ylethanone Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC(=O)N1CCOCC1 YNUJHJNDAOPBCR-UHFFFAOYSA-N 0.000 description 1
- ZREYJYHNHLWXMG-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-3,5,6-trifluoro-n-(3-methylbutyl)pyridin-4-amine Chemical compound CC(C)CCNC1=C(F)C(F)=NC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1F ZREYJYHNHLWXMG-UHFFFAOYSA-N 0.000 description 1
- HXUGITZLWUIORI-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]benzonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC=C1C#N HXUGITZLWUIORI-UHFFFAOYSA-N 0.000 description 1
- DJMBORBQCHGPTO-UHFFFAOYSA-N 2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyridine-3-carbonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CC=C1C#N DJMBORBQCHGPTO-UHFFFAOYSA-N 0.000 description 1
- DZIHBXMVESBFES-UHFFFAOYSA-N 2-[4-[(2-amino-1,3-benzothiazol-6-yl)oxy]-6,7-dimethoxyquinolin-1-ium-1-yl]-1-phenylethanone Chemical compound C=12C=C(OC)C(OC)=CC2=C(OC=2C=C3SC(N)=NC3=CC=2)C=C[N+]=1CC(=O)C1=CC=CC=C1 DZIHBXMVESBFES-UHFFFAOYSA-N 0.000 description 1
- NCQPMNLBSXIPKR-UHFFFAOYSA-N 2-[5-chloro-2-methyl-3-[4-[3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]phenoxy]-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C NCQPMNLBSXIPKR-UHFFFAOYSA-N 0.000 description 1
- HITKNPGYVMWQBV-UHFFFAOYSA-N 2-[[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]-n,n-dimethylethanamine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(OCCN(C)C)C1=CC=C(Cl)C=C1 HITKNPGYVMWQBV-UHFFFAOYSA-N 0.000 description 1
- UFNIERATEHAXDW-UHFFFAOYSA-N 2-[[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-fluorophenyl)methoxy]-n,n-dimethylethanamine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(OCCN(C)C)C1=CC=C(F)C=C1 UFNIERATEHAXDW-UHFFFAOYSA-N 0.000 description 1
- YEJYSZQJKLKMTL-UHFFFAOYSA-N 2-[acetyl(benzyl)amino]-n-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]acetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CN(C(C)=O)CC1=CC=CC=C1 YEJYSZQJKLKMTL-UHFFFAOYSA-N 0.000 description 1
- SJYKSCOBJQUUSK-UHFFFAOYSA-N 2-[methyl(2-phenylethyl)amino]acetamide Chemical compound NC(=O)CN(C)CCC1=CC=CC=C1 SJYKSCOBJQUUSK-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- UOGGGAZFNKLMHJ-UHFFFAOYSA-N 2-benzyl-3-[2-(3,5-dimethoxyanilino)-3h-benzimidazol-5-yl]-3-methoxyisoindol-1-one Chemical compound COC1=CC(OC)=CC(NC=2NC3=CC=C(C=C3N=2)C2(OC)C3=CC=CC=C3C(=O)N2CC=2C=CC=CC=2)=C1 UOGGGAZFNKLMHJ-UHFFFAOYSA-N 0.000 description 1
- GWVCKDGKNUDQHN-UHFFFAOYSA-N 2-benzyl-3-hydroxy-3-(1h-indazol-5-yl)isoindol-1-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3C=NNC3=CC=2)N1CC1=CC=CC=C1 GWVCKDGKNUDQHN-UHFFFAOYSA-N 0.000 description 1
- OYISWWNIAMMJSR-UHFFFAOYSA-N 2-benzyl-3-hydroxy-3-(1h-indazol-6-yl)isoindol-1-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NN=CC3=CC=2)N1CC1=CC=CC=C1 OYISWWNIAMMJSR-UHFFFAOYSA-N 0.000 description 1
- IZUVPXWXVOJERV-UHFFFAOYSA-N 2-benzyl-3-hydroxy-3-(1h-indol-5-yl)isoindol-1-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3C=CNC3=CC=2)N1CC1=CC=CC=C1 IZUVPXWXVOJERV-UHFFFAOYSA-N 0.000 description 1
- WZHGSVOEEQEFNW-UHFFFAOYSA-N 2-benzyl-3-hydroxy-3-(1h-indol-6-yl)isoindol-1-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC=CC3=CC=2)N1CC1=CC=CC=C1 WZHGSVOEEQEFNW-UHFFFAOYSA-N 0.000 description 1
- WCKJQTNVFAFOSR-UHFFFAOYSA-N 2-benzyl-3-hydroxy-3-[2-(methylamino)-3h-benzimidazol-5-yl]isoindol-1-one Chemical compound C=1C=C2NC(NC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC=C1 WCKJQTNVFAFOSR-UHFFFAOYSA-N 0.000 description 1
- SCSQXWFIZNVBID-UHFFFAOYSA-N 2-benzyl-3h-isoindol-1-one Chemical compound C1C2=CC=CC=C2C(=O)N1CC1=CC=CC=C1 SCSQXWFIZNVBID-UHFFFAOYSA-N 0.000 description 1
- WJYUXIGJFHJTRH-UHFFFAOYSA-N 2-benzylcyclopropane-1,1-dicarboxamide Chemical compound NC(=O)C1(C(N)=O)CC1CC1=CC=CC=C1 WJYUXIGJFHJTRH-UHFFFAOYSA-N 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229940013085 2-diethylaminoethanol Drugs 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- FJNLCHNQVJVCPY-UHFFFAOYSA-N 2-n-methoxy-2-n-methyl-4-n,6-n-dipropyl-1,3,5-triazine-2,4,6-triamine Chemical compound CCCNC1=NC(NCCC)=NC(N(C)OC)=N1 FJNLCHNQVJVCPY-UHFFFAOYSA-N 0.000 description 1
- 125000004638 2-oxopiperazinyl group Chemical group O=C1N(CCNC1)* 0.000 description 1
- 125000004637 2-oxopiperidinyl group Chemical group O=C1N(CCCC1)* 0.000 description 1
- FIWLYGQHSKZFAQ-UHFFFAOYSA-N 2-phenyl-3h-isoindol-1-one Chemical compound C1C2=CC=CC=C2C(=O)N1C1=CC=CC=C1 FIWLYGQHSKZFAQ-UHFFFAOYSA-N 0.000 description 1
- BMPSUPGXDFHRFS-UHFFFAOYSA-N 2-phenyl-n-[[4-(1h-pyrazolo[3,4-d]pyrimidin-4-yloxy)phenyl]carbamothioyl]acetamide Chemical compound C=1C=C(OC=2C=3C=NNC=3N=CN=2)C=CC=1NC(=S)NC(=O)CC1=CC=CC=C1 BMPSUPGXDFHRFS-UHFFFAOYSA-N 0.000 description 1
- 125000004362 3,4,5-trichlorophenyl group Chemical group [H]C1=C(Cl)C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- KPVAFIOCAIQMPP-UHFFFAOYSA-N 3-(2-amino-1-tert-butylbenzimidazol-5-yl)-2-benzyl-3-hydroxyisoindol-1-one Chemical compound C=1C=C2N(C(C)(C)C)C(N)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC=C1 KPVAFIOCAIQMPP-UHFFFAOYSA-N 0.000 description 1
- QHAZYBSNQRTYDK-UHFFFAOYSA-N 3-(3h-benzimidazol-5-yl)-2-benzyl-3-hydroxyisoindol-1-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3N=CNC3=CC=2)N1CC1=CC=CC=C1 QHAZYBSNQRTYDK-UHFFFAOYSA-N 0.000 description 1
- RCPMWFKCKLHIEK-UHFFFAOYSA-N 3-(azetidin-3-ylidenemethyl)-4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=C4CNC4)=NNC=3N=CN=2)CC1 RCPMWFKCKLHIEK-UHFFFAOYSA-N 0.000 description 1
- SYZKKTPMLANEMY-UHFFFAOYSA-N 3-[2-(3,5-dimethoxyanilino)-3h-benzimidazol-5-yl]-3-methoxy-2-propan-2-ylisoindol-1-one Chemical compound COC1=CC(OC)=CC(NC=2NC3=CC=C(C=C3N=2)C2(OC)C3=CC=CC=C3C(=O)N2C(C)C)=C1 SYZKKTPMLANEMY-UHFFFAOYSA-N 0.000 description 1
- UIODCBCHOOHDBJ-UHFFFAOYSA-N 3-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]butan-2-one Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(C)C(C)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 UIODCBCHOOHDBJ-UHFFFAOYSA-N 0.000 description 1
- SQMYBMIVKNUFRI-UHFFFAOYSA-N 3-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-2-methylphenyl]-n,n-diethylpropan-1-amine Chemical compound CCN(CC)CCCC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C SQMYBMIVKNUFRI-UHFFFAOYSA-N 0.000 description 1
- XOOIIPHBBUZFOP-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-chloro-5-fluoro-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound ClC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(F)=CC=1NCCN1CCCC1 XOOIIPHBBUZFOP-UHFFFAOYSA-N 0.000 description 1
- VWBUFACHINJXSO-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(2-methylpropoxy)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCC(C)C)=CC=1NCCN1CCCC1 VWBUFACHINJXSO-UHFFFAOYSA-N 0.000 description 1
- JUZOYDZYOULNAP-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(2-phenylethyl)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(CCC=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 JUZOYDZYOULNAP-UHFFFAOYSA-N 0.000 description 1
- AJWFNKDUKOFVSO-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(2-phenylethynyl)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(C#CC=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 AJWFNKDUKOFVSO-UHFFFAOYSA-N 0.000 description 1
- HGCQHRUBKWVKHA-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC1=NOC(C=2C=C(C(C)=C(NCCN3CCCC3)C=2)N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=N1 HGCQHRUBKWVKHA-UHFFFAOYSA-N 0.000 description 1
- WDWOGDISXRDAPH-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(3-methylbutoxy)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCCC(C)C)=CC=1NCCN1CCCC1 WDWOGDISXRDAPH-UHFFFAOYSA-N 0.000 description 1
- PGVQMDPVMHGBQK-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(C=2ON=C(N=2)C=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 PGVQMDPVMHGBQK-UHFFFAOYSA-N 0.000 description 1
- XELODWMJEHJNGC-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound O1C(C)=NC(C=2C=C(C(C)=C(NCCN3CCCC3)C=2)N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=N1 XELODWMJEHJNGC-UHFFFAOYSA-N 0.000 description 1
- BKZVKDVSFQWXCI-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-(oxolan-2-ylmethoxy)-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2OCCC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 BKZVKDVSFQWXCI-UHFFFAOYSA-N 0.000 description 1
- YWUIVMBLSSVYOU-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-methylsulfonyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(S(C)(=O)=O)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 YWUIVMBLSSVYOU-UHFFFAOYSA-N 0.000 description 1
- IHQZZYDEVZEHEN-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-phenyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(C=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 IHQZZYDEVZEHEN-UHFFFAOYSA-N 0.000 description 1
- HEWBPXZYOYWXGF-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-propan-2-yloxy-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OC(C)C)=CC=1NCCN1CCCC1 HEWBPXZYOYWXGF-UHFFFAOYSA-N 0.000 description 1
- CQAFUDZJKLZILE-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-5-propoxy-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCCC)=CC=1NCCN1CCCC1 CQAFUDZJKLZILE-UHFFFAOYSA-N 0.000 description 1
- FQCOMPCVEBMBGQ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(1,3-thiazol-2-yl)aniline Chemical compound C1=C(C=2SC=CN=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 FQCOMPCVEBMBGQ-UHFFFAOYSA-N 0.000 description 1
- CXWRIIBHGFNKAV-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(2,2,2-trifluoroethoxy)aniline Chemical compound C1=C(OCC(F)(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 CXWRIIBHGFNKAV-UHFFFAOYSA-N 0.000 description 1
- HUSVBQWJEQARSD-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(2-trimethylsilylethyl)aniline Chemical compound C1=C(CC[Si](C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 HUSVBQWJEQARSD-UHFFFAOYSA-N 0.000 description 1
- FRSGTYFDKGJXNW-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(3,3,3-trifluoropropoxy)aniline Chemical compound C1=C(OCCC(F)(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 FRSGTYFDKGJXNW-UHFFFAOYSA-N 0.000 description 1
- OTROXNUGLUHDPM-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)-5-(4,4,4-trifluoro-1,1-dimethoxybutyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(CCC(F)(F)F)(OC)OC)=CC=1NCCN1CCCC1 OTROXNUGLUHDPM-UHFFFAOYSA-N 0.000 description 1
- DAGQTIZIUNGONJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzoic acid Chemical compound C1=C(C(O)=O)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 DAGQTIZIUNGONJ-UHFFFAOYSA-N 0.000 description 1
- UUQNWWDBXQLKPN-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-n-propan-2-yl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)NC(C)C)=CC=1NCCN1CCCC1 UUQNWWDBXQLKPN-UHFFFAOYSA-N 0.000 description 1
- OSZJZLURIWBTMR-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OSZJZLURIWBTMR-UHFFFAOYSA-N 0.000 description 1
- ZFGPLQJDDUAPLD-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(1,1-difluorobutyl)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(F)(F)CCC)=CC=1NCCN1CCCC1 ZFGPLQJDDUAPLD-UHFFFAOYSA-N 0.000 description 1
- DRFKNPFAXPCTQG-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(2,2-dimethylpropoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC(C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 DRFKNPFAXPCTQG-UHFFFAOYSA-N 0.000 description 1
- HROXMNKAOQUZSJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(2-fluoro-2-methylpropoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC(C)(C)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 HROXMNKAOQUZSJ-UHFFFAOYSA-N 0.000 description 1
- FNHNYWBZBHUBPV-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(2-methoxyethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCCOC)=CC=1NCCN1CCCC1 FNHNYWBZBHUBPV-UHFFFAOYSA-N 0.000 description 1
- YBPFAYRBOUOWEW-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(3,3-dimethylbut-1-ynyl)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(C#CC(C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 YBPFAYRBOUOWEW-UHFFFAOYSA-N 0.000 description 1
- BZWINHLDUBAFJC-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(3,3-dimethylbutyl)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(CCC(C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 BZWINHLDUBAFJC-UHFFFAOYSA-N 0.000 description 1
- MZMMBFATXSYGDE-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(cyclobutylmethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2CCC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 MZMMBFATXSYGDE-UHFFFAOYSA-N 0.000 description 1
- OFIYBNFGPNSUBZ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(cyclohexylmethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2CCCCC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 OFIYBNFGPNSUBZ-UHFFFAOYSA-N 0.000 description 1
- IYGKFXLAHMDZHD-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(cyclopentylmethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2CCCC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 IYGKFXLAHMDZHD-UHFFFAOYSA-N 0.000 description 1
- GMJSCDCMWJNAQQ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(cyclopropylmethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2CC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 GMJSCDCMWJNAQQ-UHFFFAOYSA-N 0.000 description 1
- AHLOJMPYPHADTE-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(difluoromethoxy)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OC(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 AHLOJMPYPHADTE-UHFFFAOYSA-N 0.000 description 1
- XFVUESCLIPSCDS-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-(ethoxymethyl)-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(COCC)=CC=1NCCN1CCCC1 XFVUESCLIPSCDS-UHFFFAOYSA-N 0.000 description 1
- YYRHQZUDEOMFMB-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-[(2,2-difluorocyclopropyl)methoxy]-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(OCC2C(C2)(F)F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 YYRHQZUDEOMFMB-UHFFFAOYSA-N 0.000 description 1
- QQHQZRLEXUVJBO-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-[2-(dimethylamino)ethylamino]-4-methyl-n-phenylbenzamide Chemical compound C=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C(C)C(NCCN(C)C)=CC=1C(=O)NC1=CC=CC=C1 QQHQZRLEXUVJBO-UHFFFAOYSA-N 0.000 description 1
- SUHQXAOVYOYYQL-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-[2-(dimethylamino)ethylamino]-4-methyl-n-propan-2-ylbenzamide Chemical compound CC(C)NC(=O)C1=CC(NCCN(C)C)=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 SUHQXAOVYOYYQL-UHFFFAOYSA-N 0.000 description 1
- IFJNCEJQABLDMF-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(Cl)=CC=1NCCN1CCCC1 IFJNCEJQABLDMF-UHFFFAOYSA-N 0.000 description 1
- PYBBUIDGGUYWIF-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-ethyl-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(CC)=CC=1NCCN1CCCC1 PYBBUIDGGUYWIF-UHFFFAOYSA-N 0.000 description 1
- LYDIYXALBYBXDU-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-ethylsulfonyl-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(S(=O)(=O)CC)=CC=1NCCN1CCCC1 LYDIYXALBYBXDU-UHFFFAOYSA-N 0.000 description 1
- CYJZDLQSTXXZFE-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-ethynyl-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(C#C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 CYJZDLQSTXXZFE-UHFFFAOYSA-N 0.000 description 1
- TZMWLSHRKGZJIJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-fluoro-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 TZMWLSHRKGZJIJ-UHFFFAOYSA-N 0.000 description 1
- WCYZKEXUAINNCJ-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n,4-dimethyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)NC)=CC=1NCCN1CCCC1 WCYZKEXUAINNCJ-UHFFFAOYSA-N 0.000 description 1
- RQZSAMQVTOQRIM-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n,4-dimethyl-n-propan-2-yl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)N(C)C(C)C)=CC=1NCCN1CCCC1 RQZSAMQVTOQRIM-UHFFFAOYSA-N 0.000 description 1
- SUPTVDNUUOFKOU-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n,4-dimethylbenzamide Chemical compound CNC(=O)C1=CC=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 SUPTVDNUUOFKOU-UHFFFAOYSA-N 0.000 description 1
- WKWKPUVHYAQHRB-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(2-chlorophenyl)-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound C1=C(C(=O)NC=2C(=CC=CC=2)Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 WKWKPUVHYAQHRB-UHFFFAOYSA-N 0.000 description 1
- ZBDHUMHGEAVULE-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(4-chlorophenyl)-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound C1=C(C(=O)NC=2C=CC(Cl)=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 ZBDHUMHGEAVULE-UHFFFAOYSA-N 0.000 description 1
- SIODQEWTENYBSI-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-[2-(dimethylamino)ethyl]-4-methylbenzamide Chemical compound CN(C)CCNC(=O)C1=CC=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 SIODQEWTENYBSI-UHFFFAOYSA-N 0.000 description 1
- DLSVCPCULIRHJL-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-ethyl-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)NCC)=CC=1NCCN1CCCC1 DLSVCPCULIRHJL-UHFFFAOYSA-N 0.000 description 1
- KFEZLXHRIQNJQO-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-tert-butyl-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzamide Chemical compound C1=C(C(=O)NC(C)(C)C)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 KFEZLXHRIQNJQO-UHFFFAOYSA-N 0.000 description 1
- ZYNKXHMLHGWMFA-UHFFFAOYSA-N 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyrazine-2-carbonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CN=C1C#N ZYNKXHMLHGWMFA-UHFFFAOYSA-N 0.000 description 1
- RPVYHDOYPUWJGW-UHFFFAOYSA-N 3-[4-(3-chloro-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-n-(2-methylpropyl)benzamide Chemical compound CC(C)CNC(=O)C1=CC=C(C)C(N2CCN(CC2)C=2C=3C(Cl)=NNC=3N=CN=2)=C1 RPVYHDOYPUWJGW-UHFFFAOYSA-N 0.000 description 1
- DNEVYQASLHDDSQ-UHFFFAOYSA-N 3-[4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-1-methyl-6-(trifluoromethyl)benzimidazol-2-yl]propan-1-ol Chemical compound C1=C(C(F)(F)F)C=C2N(C)C(CCCO)=NC2=C1N(CC1)CCN1C1=NC=NC2=C1C(Br)=NN2 DNEVYQASLHDDSQ-UHFFFAOYSA-N 0.000 description 1
- FVTGZBCGLSOVNH-UHFFFAOYSA-N 3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-yn-1-ol Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C#CCO)=NNC=3N=CN=2)CC1 FVTGZBCGLSOVNH-UHFFFAOYSA-N 0.000 description 1
- FFEQLBRPPNNIIS-UHFFFAOYSA-N 3-[4-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]phenoxy]-n,n-dimethylpropan-1-amine Chemical compound C1=CC(OCCCN(C)C)=CC=C1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 FFEQLBRPPNNIIS-UHFFFAOYSA-N 0.000 description 1
- SMNSMHSHWGBIFH-UHFFFAOYSA-N 3-[4-[4-[5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methyl-3-(2-pyrrolidin-1-ylethylamino)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-yn-1-ol Chemical compound C1=C(OCC(F)(CF)CF)C=C(N2CCN(CC2)C=2C=3C(C#CCO)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 SMNSMHSHWGBIFH-UHFFFAOYSA-N 0.000 description 1
- FZGQSPDGZYNZTQ-UHFFFAOYSA-N 3-[4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-yn-1-ol Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(C#CCO)=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 FZGQSPDGZYNZTQ-UHFFFAOYSA-N 0.000 description 1
- WTMZIIWPBNLGSU-UHFFFAOYSA-N 3-[5-chloro-2-methyl-3-[4-[3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]phenyl]-n,n-diethylpropan-1-amine Chemical compound CCN(CC)CCCC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C WTMZIIWPBNLGSU-UHFFFAOYSA-N 0.000 description 1
- URKNKOFMKSTDIG-UHFFFAOYSA-N 3-[[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]-n,n-dimethylpropan-1-amine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(OCCCN(C)C)C1=CC=C(Cl)C=C1 URKNKOFMKSTDIG-UHFFFAOYSA-N 0.000 description 1
- IXWWBHVXRZPHFS-UHFFFAOYSA-N 3-[[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]methyl]benzonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC1=CC=CC(C#N)=C1 IXWWBHVXRZPHFS-UHFFFAOYSA-N 0.000 description 1
- MYZBUJRZUJOUNX-UHFFFAOYSA-N 3-benzyl-n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1,2,4-oxadiazol-5-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(ON=1)=NC=1CC1=CC=CC=C1 MYZBUJRZUJOUNX-UHFFFAOYSA-N 0.000 description 1
- CMNVIOXBVGGMHC-UHFFFAOYSA-N 3-bromo-4-(4-phenylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC=C1 CMNVIOXBVGGMHC-UHFFFAOYSA-N 0.000 description 1
- BNTQQSCEOKZDMO-UHFFFAOYSA-N 3-bromo-4-(4-pyrazin-2-ylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CN=CC=N1 BNTQQSCEOKZDMO-UHFFFAOYSA-N 0.000 description 1
- ZNZOVFHYHATGSO-UHFFFAOYSA-N 3-bromo-4-(4-pyrimidin-2-ylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CC=N1 ZNZOVFHYHATGSO-UHFFFAOYSA-N 0.000 description 1
- HXDBVSLKASWNMX-UHFFFAOYSA-N 3-bromo-4-[3-methyl-4-(3-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCN1C1=CC=CC(C)=C1 HXDBVSLKASWNMX-UHFFFAOYSA-N 0.000 description 1
- OTFFWCPPHHIFJB-UHFFFAOYSA-N 3-bromo-4-[4-(2,4-dimethoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC(OC)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OTFFWCPPHHIFJB-UHFFFAOYSA-N 0.000 description 1
- ZBVYWTDRJLQJFB-UHFFFAOYSA-N 3-bromo-4-[4-(2,4-dimethylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC(C)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 ZBVYWTDRJLQJFB-UHFFFAOYSA-N 0.000 description 1
- GWRUURCRUCYCEF-UHFFFAOYSA-N 3-bromo-4-[4-(2,5-dichlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC=C(Cl)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 GWRUURCRUCYCEF-UHFFFAOYSA-N 0.000 description 1
- ZXVQZHJGOFVOMR-UHFFFAOYSA-N 3-bromo-4-[4-(2,5-difluorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC1=CC=C(F)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 ZXVQZHJGOFVOMR-UHFFFAOYSA-N 0.000 description 1
- QKVBHDNWWHXBKQ-UHFFFAOYSA-N 3-bromo-4-[4-(2,6-dimethylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=CC(C)=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 QKVBHDNWWHXBKQ-UHFFFAOYSA-N 0.000 description 1
- DWTODKDOZLKTNN-UHFFFAOYSA-N 3-bromo-4-[4-(2-ethylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CCC1=CC=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 DWTODKDOZLKTNN-UHFFFAOYSA-N 0.000 description 1
- CQXAPCMYRSTDGK-UHFFFAOYSA-N 3-bromo-4-[4-(2-methoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC=CC=C1N1CCN(C=2C3=C(Br)NN=C3N=CN=2)CC1 CQXAPCMYRSTDGK-UHFFFAOYSA-N 0.000 description 1
- XFIJPNZKILCLOW-UHFFFAOYSA-N 3-bromo-4-[4-(2-nitrophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound [O-][N+](=O)C1=CC=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 XFIJPNZKILCLOW-UHFFFAOYSA-N 0.000 description 1
- XOTIGRBKZQTNHN-UHFFFAOYSA-N 3-bromo-4-[4-(3,4-difluorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(F)C(F)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 XOTIGRBKZQTNHN-UHFFFAOYSA-N 0.000 description 1
- IGLANVDJAXSNRA-UHFFFAOYSA-N 3-bromo-4-[4-(3,4-dimethylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(C)C(C)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 IGLANVDJAXSNRA-UHFFFAOYSA-N 0.000 description 1
- VUOHNLSILKQOGZ-UHFFFAOYSA-N 3-bromo-4-[4-(3,5-dichlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 VUOHNLSILKQOGZ-UHFFFAOYSA-N 0.000 description 1
- NMMXPVBLDKUDAW-UHFFFAOYSA-N 3-bromo-4-[4-(3,5-dimethoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC(OC)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 NMMXPVBLDKUDAW-UHFFFAOYSA-N 0.000 description 1
- YKAMPLLTQDGYHQ-UHFFFAOYSA-N 3-bromo-4-[4-(3-chloro-4-fluorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C(F)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 YKAMPLLTQDGYHQ-UHFFFAOYSA-N 0.000 description 1
- NJUZQTKLBLLKNB-UHFFFAOYSA-N 3-bromo-4-[4-(3-chlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 NJUZQTKLBLLKNB-UHFFFAOYSA-N 0.000 description 1
- XKKYDENFHXAFLA-UHFFFAOYSA-N 3-bromo-4-[4-(3-methoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 XKKYDENFHXAFLA-UHFFFAOYSA-N 0.000 description 1
- AJETWHHIDCIIFF-UHFFFAOYSA-N 3-bromo-4-[4-(3-methoxypyrazin-2-yl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=NC=CN=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 AJETWHHIDCIIFF-UHFFFAOYSA-N 0.000 description 1
- GJFGRMNSKDWZCR-UHFFFAOYSA-N 3-bromo-4-[4-(4-bromophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=C(Br)C=C1 GJFGRMNSKDWZCR-UHFFFAOYSA-N 0.000 description 1
- JUTQDMDUNSWDQG-UHFFFAOYSA-N 3-bromo-4-[4-(4-chlorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(Cl)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 JUTQDMDUNSWDQG-UHFFFAOYSA-N 0.000 description 1
- OARRIXBHAFQNGW-UHFFFAOYSA-N 3-bromo-4-[4-(4-ethoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(OCC)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OARRIXBHAFQNGW-UHFFFAOYSA-N 0.000 description 1
- CONWTRAMVJTTNB-UHFFFAOYSA-N 3-bromo-4-[4-(4-fluorophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(F)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 CONWTRAMVJTTNB-UHFFFAOYSA-N 0.000 description 1
- CMSOTWVWWGTOCD-UHFFFAOYSA-N 3-bromo-4-[4-(4-nitrophenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 CMSOTWVWWGTOCD-UHFFFAOYSA-N 0.000 description 1
- VXOGMIMOLDTFBZ-UHFFFAOYSA-N 3-bromo-4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 VXOGMIMOLDTFBZ-UHFFFAOYSA-N 0.000 description 1
- SCYVHSCNZKLRPR-UHFFFAOYSA-N 3-bromo-4-[4-[(10-chloroanthracen-9-yl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C12=CC=CC=C2C(Cl)=C(C=CC=C2)C2=C1CN1CCN(C=2C3=C(Br)NN=C3N=CN=2)CC1 SCYVHSCNZKLRPR-UHFFFAOYSA-N 0.000 description 1
- SMJFLKVYHCSZMX-UHFFFAOYSA-N 3-bromo-4-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=C(OC)C(OC)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 SMJFLKVYHCSZMX-UHFFFAOYSA-N 0.000 description 1
- LAUIGFJQDHKXOM-UHFFFAOYSA-N 3-bromo-4-[4-[(2,4-dichlorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC(Cl)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 LAUIGFJQDHKXOM-UHFFFAOYSA-N 0.000 description 1
- CMWCRMHCALHYJC-UHFFFAOYSA-N 3-bromo-4-[4-[(2-chloro-4-fluorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC(F)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 CMWCRMHCALHYJC-UHFFFAOYSA-N 0.000 description 1
- BDYYYDWHUCJFDQ-UHFFFAOYSA-N 3-bromo-4-[4-[(2-chloro-6-fluorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC1=CC=CC(Cl)=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 BDYYYDWHUCJFDQ-UHFFFAOYSA-N 0.000 description 1
- OYDSLMICYSWZKX-UHFFFAOYSA-N 3-bromo-4-[4-[(3,4-dichlorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 OYDSLMICYSWZKX-UHFFFAOYSA-N 0.000 description 1
- KVJZSWRTVBYRFA-UHFFFAOYSA-N 3-bromo-4-[4-[(3,4-dichlorophenyl)methyl]piperidin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C(Cl)=CC=C1CC1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 KVJZSWRTVBYRFA-UHFFFAOYSA-N 0.000 description 1
- BYKDIQSIWVYTNE-UHFFFAOYSA-N 3-bromo-4-[4-[(3-methylphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=CC(CN2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 BYKDIQSIWVYTNE-UHFFFAOYSA-N 0.000 description 1
- BBIRRCVRERKIBS-UHFFFAOYSA-N 3-bromo-4-[4-[(3-phenoxyphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC(C=1)=CC=CC=1OC1=CC=CC=C1 BBIRRCVRERKIBS-UHFFFAOYSA-N 0.000 description 1
- MZVPHNWNBHOGLG-UHFFFAOYSA-N 3-bromo-4-[4-[(4,6-dimethoxypyrimidin-2-yl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound COC1=CC(OC)=NC(CN2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=N1 MZVPHNWNBHOGLG-UHFFFAOYSA-N 0.000 description 1
- KXDOAOYCPFKHPZ-UHFFFAOYSA-N 3-bromo-4-[4-[(4-chloro-2-fluorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC1=CC(Cl)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 KXDOAOYCPFKHPZ-UHFFFAOYSA-N 0.000 description 1
- IEEBJIHGONHDOP-UHFFFAOYSA-N 3-bromo-4-[4-[(4-chloro-3-fluorophenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C(F)=CC(CN2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 IEEBJIHGONHDOP-UHFFFAOYSA-N 0.000 description 1
- PWBOLVFJDQVVCX-UHFFFAOYSA-N 3-bromo-4-[4-[(4-methoxyphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(OC)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 PWBOLVFJDQVVCX-UHFFFAOYSA-N 0.000 description 1
- FVAZAUVZHQUSSX-UHFFFAOYSA-N 3-bromo-4-[4-[(4-phenoxyphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC(C=C1)=CC=C1OC1=CC=CC=C1 FVAZAUVZHQUSSX-UHFFFAOYSA-N 0.000 description 1
- KJJMUWFJYAPAKE-UHFFFAOYSA-N 3-bromo-4-[4-[(4-tert-butylphenyl)methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(C(C)(C)C)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 KJJMUWFJYAPAKE-UHFFFAOYSA-N 0.000 description 1
- JHOISCNSZOEUAW-HXUWFJFHSA-N 3-bromo-4-[4-[(r)-(4-chloro-3-fluorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C(F)=CC([C@H](OCCN2CCCC2)C2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 JHOISCNSZOEUAW-HXUWFJFHSA-N 0.000 description 1
- IXVPPJWNBKDOAE-NRFANRHFSA-N 3-bromo-4-[4-[(r)-(4-chlorophenyl)-(2-piperidin-1-ylethoxy)methyl]piperidin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(Cl)=CC=C1[C@@H](C1CCN(CC1)C=1C=2C(Br)=NNC=2N=CN=1)OCCN1CCCCC1 IXVPPJWNBKDOAE-NRFANRHFSA-N 0.000 description 1
- OFSTUOUKEPYZHT-FQEVSTJZSA-N 3-bromo-4-[4-[(r)-(4-chlorophenyl)-(2-pyrrolidin-1-ylethoxy)methyl]piperidin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(Cl)=CC=C1[C@@H](C1CCN(CC1)C=1C=2C(Br)=NNC=2N=CN=1)OCCN1CCCC1 OFSTUOUKEPYZHT-FQEVSTJZSA-N 0.000 description 1
- SHZNSNDAIKQSQV-UHFFFAOYSA-N 3-bromo-4-[4-[2-(trifluoromethyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC(F)(F)C1=CC=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 SHZNSNDAIKQSQV-UHFFFAOYSA-N 0.000 description 1
- DYGAFJNIWKKLRO-UHFFFAOYSA-N 3-bromo-4-[4-[2-chloro-5-[2-(2-pyrrolidin-1-ylethoxy)phenyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(Cl)=CC=C1C1=CC=CC=C1OCCN1CCCC1 DYGAFJNIWKKLRO-UHFFFAOYSA-N 0.000 description 1
- RAQLRASZPYFRHR-UHFFFAOYSA-N 3-bromo-4-[4-[2-chloro-5-[4-fluoro-2-(2-pyrrolidin-1-ylethoxy)phenyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=1C(F)=CC=C(C=2C=C(C(Cl)=CC=2)N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=1OCCN1CCCC1 RAQLRASZPYFRHR-UHFFFAOYSA-N 0.000 description 1
- DCAOYMUUNJOKSB-UHFFFAOYSA-N 3-bromo-4-[4-[2-methyl-5-(2-methylpropoxy)-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(OCC(C)C)=CC=1CCCN1CCCC1 DCAOYMUUNJOKSB-UHFFFAOYSA-N 0.000 description 1
- WBNGOBJGEOGHKO-UHFFFAOYSA-N 3-bromo-4-[4-[2-methyl-5-[2-(2-pyrrolidin-1-ylethoxy)phenyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC=C1OCCN1CCCC1 WBNGOBJGEOGHKO-UHFFFAOYSA-N 0.000 description 1
- APSONKVXTVHOIR-UHFFFAOYSA-N 3-bromo-4-[4-[2-methyl-5-[3-(2-pyrrolidin-1-ylethoxy)phenyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C(C=1)=CC=CC=1OCCN1CCCC1 APSONKVXTVHOIR-UHFFFAOYSA-N 0.000 description 1
- GZQAOQAIVFTXBT-UHFFFAOYSA-N 3-bromo-4-[4-[2-methyl-5-phenyl-3-(3-pyridin-1-ium-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(C=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCC[N+]1=CC=CC=C1 GZQAOQAIVFTXBT-UHFFFAOYSA-N 0.000 description 1
- GHUFQOINANIXTK-UHFFFAOYSA-N 3-bromo-4-[4-[3-(2-piperidin-1-ylethoxy)pyrazin-2-yl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=NC=CN=C1OCCN1CCCCC1 GHUFQOINANIXTK-UHFFFAOYSA-N 0.000 description 1
- JLMAYHBMKURLET-UHFFFAOYSA-N 3-bromo-4-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 JLMAYHBMKURLET-UHFFFAOYSA-N 0.000 description 1
- WSFCJBDCDVWWPR-UHFFFAOYSA-N 3-bromo-4-[4-[3-bromo-5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=C(Br)C=C(OCC(F)(CF)CF)C=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 WSFCJBDCDVWWPR-UHFFFAOYSA-N 0.000 description 1
- WTRRDUPRZHYBMD-UHFFFAOYSA-N 3-bromo-4-[4-[4-(furan-2-yl)pyrimidin-2-yl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C(N=1)=NC=CC=1C1=CC=CO1 WTRRDUPRZHYBMD-UHFFFAOYSA-N 0.000 description 1
- RQVHKXWGBFPZNU-UHFFFAOYSA-N 3-bromo-4-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(C(F)(F)F)=CC=C1N1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 RQVHKXWGBFPZNU-UHFFFAOYSA-N 0.000 description 1
- UQXOTKGBLBLLEJ-UHFFFAOYSA-N 3-bromo-4-[4-[4-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=C1OCCN1CCCC1 UQXOTKGBLBLLEJ-UHFFFAOYSA-N 0.000 description 1
- FDYRBFONKISFFU-UHFFFAOYSA-N 3-bromo-4-[4-[4-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=C1CCCN1CCCC1 FDYRBFONKISFFU-UHFFFAOYSA-N 0.000 description 1
- JBRKDJZHLSVLLA-UHFFFAOYSA-N 3-bromo-4-[4-[5-[2,3-difluoro-2-(fluoromethyl)propoxy]-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(OCC(F)(CF)CF)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 JBRKDJZHLSVLLA-UHFFFAOYSA-N 0.000 description 1
- NCUIHEKCQCSDGR-UHFFFAOYSA-N 3-bromo-4-[4-[5-[3-fluoro-2-(2-pyrrolidin-1-ylethoxy)phenyl]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC(F)=C1OCCN1CCCC1 NCUIHEKCQCSDGR-UHFFFAOYSA-N 0.000 description 1
- BKEGNPFOPJZHEG-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCCCC1 BKEGNPFOPJZHEG-UHFFFAOYSA-N 0.000 description 1
- QTGCAQPANBHFRY-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 QTGCAQPANBHFRY-UHFFFAOYSA-N 0.000 description 1
- MGZUHAQRVCAGIQ-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[(1-methylpiperidin-4-yl)methoxy]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCC1COC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C MGZUHAQRVCAGIQ-UHFFFAOYSA-N 0.000 description 1
- BWKXOAKSFYCWNB-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[2-(1-methylpiperidin-4-yl)ethoxy]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCC1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C BWKXOAKSFYCWNB-UHFFFAOYSA-N 0.000 description 1
- BXUHUHGWLOFGKA-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C BXUHUHGWLOFGKA-UHFFFAOYSA-N 0.000 description 1
- PGMCBJLKJSZOQM-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C PGMCBJLKJSZOQM-UHFFFAOYSA-N 0.000 description 1
- AYSQAXKKEIXBFU-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propyl]phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCCC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C AYSQAXKKEIXBFU-UHFFFAOYSA-N 0.000 description 1
- RZIMJZUGEXCLDX-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-3-[2-(4-ethylpiperazin-1-yl)ethoxy]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C RZIMJZUGEXCLDX-UHFFFAOYSA-N 0.000 description 1
- UZQJMNDBBURGNW-UHFFFAOYSA-N 3-bromo-4-[4-[5-chloro-3-[3-(4-ethylpiperazin-1-yl)propoxy]-2-methylphenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1C UZQJMNDBBURGNW-UHFFFAOYSA-N 0.000 description 1
- JRCOATCNMDGXOI-UHFFFAOYSA-N 3-bromo-4-[4-[5-fluoro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(F)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 JRCOATCNMDGXOI-UHFFFAOYSA-N 0.000 description 1
- JBCAWLLNHZVSQS-UHFFFAOYSA-N 3-bromo-4-[4-[[4-(4-chlorophenoxy)-3-nitrophenyl]methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound [O-][N+](=O)C1=CC(CN2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC=C1OC1=CC=C(Cl)C=C1 JBCAWLLNHZVSQS-UHFFFAOYSA-N 0.000 description 1
- LJPHVHKCGRWKOW-UHFFFAOYSA-N 3-bromo-4-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=CC(C(F)(F)F)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 LJPHVHKCGRWKOW-UHFFFAOYSA-N 0.000 description 1
- MBYGSMUFVUTPIB-UHFFFAOYSA-N 3-bromo-5-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C(C=1)=CC(Br)=CC=1NCCN1CCCC1 MBYGSMUFVUTPIB-UHFFFAOYSA-N 0.000 description 1
- LTUABJAYJRTHEH-UHFFFAOYSA-N 3-ethyl-1,2-oxazole Chemical compound CCC=1C=CON=1 LTUABJAYJRTHEH-UHFFFAOYSA-N 0.000 description 1
- ZUGWVLCGKRAMCK-UHFFFAOYSA-N 3-ethyl-4-(4-phenylpiperazin-1-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC=C1 ZUGWVLCGKRAMCK-UHFFFAOYSA-N 0.000 description 1
- DSUZVNZHENWVEH-UHFFFAOYSA-N 3-ethyl-4-[4-(3-methoxyphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=CC(OC)=C1 DSUZVNZHENWVEH-UHFFFAOYSA-N 0.000 description 1
- WHNOKDNCUNZBLW-UHFFFAOYSA-N 3-ethylpent-1-yn-3-amine Chemical compound CCC(N)(CC)C#C WHNOKDNCUNZBLW-UHFFFAOYSA-N 0.000 description 1
- JLEIRAYWBMNMKU-UHFFFAOYSA-N 3-ethylpentan-3-amine Chemical compound CCC(N)(CC)CC JLEIRAYWBMNMKU-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- CVMGWJJUNNHKEO-UHFFFAOYSA-N 3-methyl-4-[4-[4-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1)=CC=C(C)C=1OCCN1CCCC1 CVMGWJJUNNHKEO-UHFFFAOYSA-N 0.000 description 1
- VQMPTVQCADWACQ-UHFFFAOYSA-N 3-methylpentan-3-amine Chemical compound CCC(C)(N)CC VQMPTVQCADWACQ-UHFFFAOYSA-N 0.000 description 1
- MATIWBMCPVBIJK-UHFFFAOYSA-N 3-n'-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-n'-(4-fluorophenyl)azetidine-3,3-dicarboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C=1C=CC(F)=CC=1)C(=O)C1(C(N)=O)CNC1 MATIWBMCPVBIJK-UHFFFAOYSA-N 0.000 description 1
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 description 1
- OXKGFXZLEVBMRZ-UHFFFAOYSA-N 4-(2-cyclohexylethyl)-2-[[4-[(3,4-dichlorophenyl)methyl]-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-oxazepane Chemical compound N1=CN=C2C=C(OCC3OCCCN(CCC4CCCCC4)C3)C(OC)=CC2=C1CC1=CC=C(Cl)C(Cl)=C1 OXKGFXZLEVBMRZ-UHFFFAOYSA-N 0.000 description 1
- XYNKEFOTYHJQFS-UHFFFAOYSA-N 4-(3,4-dichloroanilino)-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-6-ol Chemical compound C1N(C)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1O XYNKEFOTYHJQFS-UHFFFAOYSA-N 0.000 description 1
- JXJSQQWPUMCYGJ-UHFFFAOYSA-N 4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-1-[(4-chlorophenyl)methyl]piperazin-2-one Chemical compound C1=CC(Cl)=CC=C1CN1C(=O)CN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 JXJSQQWPUMCYGJ-UHFFFAOYSA-N 0.000 description 1
- MJHOIOGRBDZMLR-UHFFFAOYSA-N 4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-n-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide Chemical compound FC(F)(F)C1=CC=CC(NC(=O)N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 MJHOIOGRBDZMLR-UHFFFAOYSA-N 0.000 description 1
- RPGYWHYWENYQGY-UHFFFAOYSA-N 4-(4-phenylpiperazin-1-yl)-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C=2C=3C=NNC=3N=CN=2)CCN1C1=CC=CC=C1 RPGYWHYWENYQGY-UHFFFAOYSA-N 0.000 description 1
- YOMXRYXICGNVKI-UHFFFAOYSA-N 4-(4-phenylpiperazin-1-yl)-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1CN(C=2C=3C=CNC=3N=CN=2)CCN1C1=CC=CC=C1 YOMXRYXICGNVKI-UHFFFAOYSA-N 0.000 description 1
- BDTHLNIELWBJML-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoro-n-(2-phenoxyethyl)benzenesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1S(=O)(=O)NCCOC1=CC=CC=C1 BDTHLNIELWBJML-UHFFFAOYSA-N 0.000 description 1
- INHSKSLKIOVZAH-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoro-n-(2-phenylethyl)benzenesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1S(=O)(=O)NCCC1=CC=CC=C1 INHSKSLKIOVZAH-UHFFFAOYSA-N 0.000 description 1
- LTCFSMLHPAQRAW-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoro-n-(3-phenylpropyl)benzenesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1S(=O)(=O)NCCCC1=CC=CC=C1 LTCFSMLHPAQRAW-UHFFFAOYSA-N 0.000 description 1
- BJVZTOVSAVGCDK-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoro-n-methyl-n-(2-phenylethyl)benzenesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1S(=O)(=O)N(C)CCC1=CC=CC=C1 BJVZTOVSAVGCDK-UHFFFAOYSA-N 0.000 description 1
- OMIZMBFGWKLLKH-UHFFFAOYSA-N 4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoro-n-methyl-n-(3-phenylpropyl)benzenesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1S(=O)(=O)N(C)CCCC1=CC=CC=C1 OMIZMBFGWKLLKH-UHFFFAOYSA-N 0.000 description 1
- OOGRHMWWVSLRGA-UHFFFAOYSA-N 4-(cyclohexylmethyl)-2-[[4-[(3,4-dichlorophenyl)methyl]-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-oxazepane Chemical compound N1=CN=C2C=C(OCC3OCCCN(CC4CCCCC4)C3)C(OC)=CC2=C1CC1=CC=C(Cl)C(Cl)=C1 OOGRHMWWVSLRGA-UHFFFAOYSA-N 0.000 description 1
- GVQGFWPYHOLEEM-UHFFFAOYSA-N 4-[(6,7-dimethoxyquinolin-4-yl)amino]-n-(3-phenylpropyl)benzamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1NC(C=C1)=CC=C1C(=O)NCCCC1=CC=CC=C1 GVQGFWPYHOLEEM-UHFFFAOYSA-N 0.000 description 1
- BDOGXIABZYTOLP-UHFFFAOYSA-N 4-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-4-(4-chlorophenyl)-n,n-dimethylbutan-1-amine Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(CCCN(C)C)C1=CC=C(Cl)C=C1 BDOGXIABZYTOLP-UHFFFAOYSA-N 0.000 description 1
- DANLZOIRUUHIIX-UHFFFAOYSA-N 4-[1-[2-chloro-6-(trifluoromethyl)benzoyl]indazol-3-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C(C1=CC=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C(F)(F)F DANLZOIRUUHIIX-UHFFFAOYSA-N 0.000 description 1
- KOAXHLWOMYXZIN-FQEVSTJZSA-N 4-[2-[(r)-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methoxy]ethyl]morpholine Chemical compound C1=CC(Cl)=CC=C1[C@@H](C1CCN(CC1)C=1C=2C(Br)=NNC=2N=CN=1)OCCN1CCOCC1 KOAXHLWOMYXZIN-FQEVSTJZSA-N 0.000 description 1
- TVFXHYIMTMBBRN-UHFFFAOYSA-N 4-[2-[2-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylphenyl]phenoxy]ethyl]morpholine Chemical compound C1=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=CC=C1C1=CC=CC=C1OCCN1CCOCC1 TVFXHYIMTMBBRN-UHFFFAOYSA-N 0.000 description 1
- DDSNBPYIVBWXGB-UHFFFAOYSA-N 4-[2-[5-chloro-2-methyl-3-[4-[3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]phenoxy]ethyl]morpholine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCN1CCOCC1 DDSNBPYIVBWXGB-UHFFFAOYSA-N 0.000 description 1
- CFLVHNKVJHQBJP-UHFFFAOYSA-N 4-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]butanenitrile Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCC#N)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 CFLVHNKVJHQBJP-UHFFFAOYSA-N 0.000 description 1
- XYOGGDREGYYWPA-UHFFFAOYSA-N 4-[3-[3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-5-chloro-2-methylphenyl]propyl]morpholine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1CCCN1CCOCC1 XYOGGDREGYYWPA-UHFFFAOYSA-N 0.000 description 1
- HGBLQEPBGGAPAW-UHFFFAOYSA-N 4-[3-[5-chloro-2-methyl-3-[4-[3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidin-4-yl]piperazin-1-yl]phenoxy]propyl]morpholine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCCN1CCOCC1 HGBLQEPBGGAPAW-UHFFFAOYSA-N 0.000 description 1
- UODYUPMNTWUFNK-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-3-bromo-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C2OCOC2=CC(CN2CCN(CC2)C=2N=CN=C3NN=C(C=23)Br)=C1 UODYUPMNTWUFNK-UHFFFAOYSA-N 0.000 description 1
- YRKKQVKSWQLXBZ-UHFFFAOYSA-N 4-[4-(2-chlorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound ClC1=CC=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 YRKKQVKSWQLXBZ-UHFFFAOYSA-N 0.000 description 1
- IBXALBYOWBTGRR-UHFFFAOYSA-N 4-[4-(2-fluorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound FC1=CC=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 IBXALBYOWBTGRR-UHFFFAOYSA-N 0.000 description 1
- PNKDJCFGTHLQCJ-UHFFFAOYSA-N 4-[4-(2-methoxyphenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound COC1=CC=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 PNKDJCFGTHLQCJ-UHFFFAOYSA-N 0.000 description 1
- CTJVUQNXXFJPAN-UHFFFAOYSA-N 4-[4-(2-methylphenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound CC1=CC=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 CTJVUQNXXFJPAN-UHFFFAOYSA-N 0.000 description 1
- KNOFIZHBESOPPI-UHFFFAOYSA-N 4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-(trifluoromethyl)quinoline Chemical compound C1=CC=CC2=NC(C(F)(F)F)=CC(N3CCN(CC3)C=3C=4C(Br)=NNC=4N=CN=3)=C21 KNOFIZHBESOPPI-UHFFFAOYSA-N 0.000 description 1
- YIDPQUCBGBVPJQ-UHFFFAOYSA-N 4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methylquinoline Chemical compound C1=CC=CC2=NC(C)=CC(N3CCN(CC3)C=3C=4C(Br)=NNC=4N=CN=3)=C21 YIDPQUCBGBVPJQ-UHFFFAOYSA-N 0.000 description 1
- TXVYVJXMZMPYMX-UHFFFAOYSA-N 4-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]benzonitrile Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1C1=CC=C(C#N)C=C1 TXVYVJXMZMPYMX-UHFFFAOYSA-N 0.000 description 1
- LVOGLFHZHNTLSS-UHFFFAOYSA-N 4-[4-(3-bromo-5-chloro-2-methylphenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound CC1=C(Br)C=C(Cl)C=C1N1CCN(C=2C=3C=NNC=3N=C(N)N=2)CC1 LVOGLFHZHNTLSS-UHFFFAOYSA-N 0.000 description 1
- LCGMENDABLGZBC-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound ClC1=CC=CC(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)=C1 LCGMENDABLGZBC-UHFFFAOYSA-N 0.000 description 1
- WUWSJZJZLJLZJJ-UHFFFAOYSA-N 4-[4-(3-chlorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound ClC1=CC=CC(N2CCN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 WUWSJZJZLJLZJJ-UHFFFAOYSA-N 0.000 description 1
- FWECWZKFGBIJMK-UHFFFAOYSA-N 4-[4-(3-methoxyphenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound COC1=CC=CC(N2CCN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 FWECWZKFGBIJMK-UHFFFAOYSA-N 0.000 description 1
- WXKYRSUNXSAMCM-UHFFFAOYSA-N 4-[4-(4-benzylpiperazin-1-yl)phenoxy]-6,7-dimethoxyquinoline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(CC1)CCN1CC1=CC=CC=C1 WXKYRSUNXSAMCM-UHFFFAOYSA-N 0.000 description 1
- GQVBUIUWBXICGT-UHFFFAOYSA-N 4-[4-(4-benzylpiperidin-1-yl)phenoxy]-6,7-dimethoxyquinoline Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(CC1)CCC1CC1=CC=CC=C1 GQVBUIUWBXICGT-UHFFFAOYSA-N 0.000 description 1
- BKUPEAMZZKHYFG-UHFFFAOYSA-N 4-[4-(4-chlorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1=CC(Cl)=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 BKUPEAMZZKHYFG-UHFFFAOYSA-N 0.000 description 1
- MGAUNJWDDNBFEB-UHFFFAOYSA-N 4-[4-(4-fluorophenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1=CC(F)=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 MGAUNJWDDNBFEB-UHFFFAOYSA-N 0.000 description 1
- AAICARCSHFYCBL-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=3C=CNC=3N=CN=2)CC1 AAICARCSHFYCBL-UHFFFAOYSA-N 0.000 description 1
- WENXGABSSNOICL-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidin-6-amine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C=NNC=3N=C(N)N=2)CC1 WENXGABSSNOICL-UHFFFAOYSA-N 0.000 description 1
- OJSJVZOGAFBPJE-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C=NNC=3N=CN=2)CC1 OJSJVZOGAFBPJE-UHFFFAOYSA-N 0.000 description 1
- UWHHNRRWMAAGMX-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(1,2,3,6-tetrahydropyridin-4-yl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4CCNCC=4)=NNC=3N=CN=2)CC1 UWHHNRRWMAAGMX-UHFFFAOYSA-N 0.000 description 1
- WSDIKTCRDBJNEZ-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(3-pyrrolidin-1-ylpropyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(CCCN4CCCC4)=NNC=3N=CN=2)CC1 WSDIKTCRDBJNEZ-UHFFFAOYSA-N 0.000 description 1
- PEXFLFCCUBQENE-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-(4-methylpiperazin-1-yl)-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 PEXFLFCCUBQENE-UHFFFAOYSA-N 0.000 description 1
- DBBPQRUDHSGXGI-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-phenyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4C=CC=CC=4)=NNC=3N=CN=2)CC1 DBBPQRUDHSGXGI-UHFFFAOYSA-N 0.000 description 1
- NNMOENYDTWNVJF-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-piperazin-1-yl-1h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(N4CCNCC4)=NNC=3N=CN=2)CC1 NNMOENYDTWNVJF-UHFFFAOYSA-N 0.000 description 1
- KFJYAVVIRNQQKI-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-propyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CCC)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C KFJYAVVIRNQQKI-UHFFFAOYSA-N 0.000 description 1
- BQVOBOKTPDRMQV-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-thiophen-2-yl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(C=4SC=CC=4)=NNC=3N=CN=2)CC1 BQVOBOKTPDRMQV-UHFFFAOYSA-N 0.000 description 1
- CUTHWLLCENKSGW-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-6-ethyl-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C=NNC2=NC(CC)=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C CUTHWLLCENKSGW-UHFFFAOYSA-N 0.000 description 1
- PRVDHIXOOBBJFD-UHFFFAOYSA-N 4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-6-methyl-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C=NNC2=NC(C)=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C PRVDHIXOOBBJFD-UHFFFAOYSA-N 0.000 description 1
- MOWCFUDCJQIYNA-UHFFFAOYSA-N 4-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)=C1 MOWCFUDCJQIYNA-UHFFFAOYSA-N 0.000 description 1
- YISGVHBBSBDPLQ-UHFFFAOYSA-N 4-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-7h-pyrrolo[2,3-d]pyrimidine Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC2)C=2C=3C=CNC=3N=CN=2)=C1 YISGVHBBSBDPLQ-UHFFFAOYSA-N 0.000 description 1
- FIBUNCPXQUWYHP-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-piperidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCN1CCCCC1 FIBUNCPXQUWYHP-UHFFFAOYSA-N 0.000 description 1
- SWUHHIRFMYRIJB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)C(C)=C1OCCN1CCCC1 SWUHHIRFMYRIJB-UHFFFAOYSA-N 0.000 description 1
- UPRIVIWOZLARIH-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-(2-methylpropyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC(C)C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCCC1 UPRIVIWOZLARIH-UHFFFAOYSA-N 0.000 description 1
- BPGKERZGJLJMED-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCN1CCCC1 BPGKERZGJLJMED-UHFFFAOYSA-N 0.000 description 1
- AQZAQRSOINDPNL-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-cyclopropyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(C4CC4)=NNC=3N=CN=2)C(C)=C1OCCN1CCCC1 AQZAQRSOINDPNL-UHFFFAOYSA-N 0.000 description 1
- IXFLVBJXEDPMNN-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(2-pyrrolidin-1-ylethoxy)phenyl]piperazin-1-yl]-3-propan-2-yl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(C(C)C)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCCC1 IXFLVBJXEDPMNN-UHFFFAOYSA-N 0.000 description 1
- XBGWSDJSVVDITQ-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropoxy)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCCN1CCCCC1 XBGWSDJSVVDITQ-UHFFFAOYSA-N 0.000 description 1
- HFMZMDXFDNLWCB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-piperidin-1-ylpropyl)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1CCCN1CCCCC1 HFMZMDXFDNLWCB-UHFFFAOYSA-N 0.000 description 1
- YNEHNQLNJHUVNL-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropoxy)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1OCCCN1CCCC1 YNEHNQLNJHUVNL-UHFFFAOYSA-N 0.000 description 1
- MAWNYUYBGKUWRX-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-1h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)C(C)=C1CCCN1CCCC1 MAWNYUYBGKUWRX-UHFFFAOYSA-N 0.000 description 1
- ASGJAACMIIQVBB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-(3-pyrrolidin-1-ylpropyl)phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)C(C)=C1CCCN1CCCC1 ASGJAACMIIQVBB-UHFFFAOYSA-N 0.000 description 1
- LYIFKMWHZVCOEB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[(1-methylpiperidin-4-yl)methoxy]phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCC1COC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C LYIFKMWHZVCOEB-UHFFFAOYSA-N 0.000 description 1
- WPMSKZBISRKCCA-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[(1-methylpiperidin-4-yl)methoxy]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCC1CCN(C)CC1 WPMSKZBISRKCCA-UHFFFAOYSA-N 0.000 description 1
- DARRPJUVNRFGQX-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[2-(1-methylpiperidin-4-yl)ethoxy]phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCC1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C DARRPJUVNRFGQX-UHFFFAOYSA-N 0.000 description 1
- XCOVTQGGVHMDFB-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[2-(1-methylpiperidin-4-yl)ethoxy]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCC1CCN(C)CC1 XCOVTQGGVHMDFB-UHFFFAOYSA-N 0.000 description 1
- MREHXQMHLRHSEM-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C MREHXQMHLRHSEM-UHFFFAOYSA-N 0.000 description 1
- XCFTYDOZRKVXNM-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCN1CCN(C)CC1 XCFTYDOZRKVXNM-UHFFFAOYSA-N 0.000 description 1
- NMYJCDPLLFGHEJ-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C NMYJCDPLLFGHEJ-UHFFFAOYSA-N 0.000 description 1
- RHHDBYUITDSZOI-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1OCCCN1CCN(C)CC1 RHHDBYUITDSZOI-UHFFFAOYSA-N 0.000 description 1
- UIIOSEYTZDZNAG-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propyl]phenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(C)CCN1CCCC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C UIIOSEYTZDZNAG-UHFFFAOYSA-N 0.000 description 1
- WYQXCFRWJKGILM-UHFFFAOYSA-N 4-[4-[5-chloro-2-methyl-3-[3-(4-methylpiperazin-1-yl)propyl]phenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1C)=CC(Cl)=CC=1CCCN1CCN(C)CC1 WYQXCFRWJKGILM-UHFFFAOYSA-N 0.000 description 1
- IEGMLOPFLQNVPN-UHFFFAOYSA-N 4-[4-[5-chloro-3-[2-(4-ethylpiperazin-1-yl)ethoxy]-2-methylphenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C IEGMLOPFLQNVPN-UHFFFAOYSA-N 0.000 description 1
- DZFNNPOBVMURRI-UHFFFAOYSA-N 4-[4-[5-chloro-3-[2-(4-ethylpiperazin-1-yl)ethoxy]-2-methylphenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=C1C DZFNNPOBVMURRI-UHFFFAOYSA-N 0.000 description 1
- ORHSSASUVVWACH-UHFFFAOYSA-N 4-[4-[5-chloro-3-[3-(4-ethylpiperazin-1-yl)propoxy]-2-methylphenyl]piperazin-1-yl]-3-(trifluoromethyl)-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(=NNC=3N=CN=2)C(F)(F)F)=C1C ORHSSASUVVWACH-UHFFFAOYSA-N 0.000 description 1
- AFQIYWYPUWYCCT-UHFFFAOYSA-N 4-[4-[5-chloro-3-[3-(4-ethylpiperazin-1-yl)propoxy]-2-methylphenyl]piperazin-1-yl]-3-ethyl-2h-pyrazolo[3,4-d]pyrimidine Chemical compound C1CN(CC)CCN1CCCOC1=CC(Cl)=CC(N2CCN(CC2)C=2C=3C(CC)=NNC=3N=CN=2)=C1C AFQIYWYPUWYCCT-UHFFFAOYSA-N 0.000 description 1
- DGOBVCDUGLUZMU-UHFFFAOYSA-N 4-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-n,n-dimethyl-1,3-thiazol-2-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)N(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 DGOBVCDUGLUZMU-UHFFFAOYSA-N 0.000 description 1
- IQZYTWZJCLWWMX-UHFFFAOYSA-N 4-[[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]methyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 IQZYTWZJCLWWMX-UHFFFAOYSA-N 0.000 description 1
- XIEWMCNYJOKYHZ-UHFFFAOYSA-N 4-[[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]methyl]-n-(3-methoxypropyl)benzamide Chemical compound C1=CC(C(=O)NCCCOC)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 XIEWMCNYJOKYHZ-UHFFFAOYSA-N 0.000 description 1
- ZGUBPDDTURINDY-UHFFFAOYSA-N 4-[[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]methyl]-n-(3-morpholin-4-ylpropyl)benzamide Chemical compound C=12C(Br)=NNC2=NC=NC=1N(CC1)CCN1CC(C=C1)=CC=C1C(=O)NCCCN1CCOCC1 ZGUBPDDTURINDY-UHFFFAOYSA-N 0.000 description 1
- BLPHPXYTDDFZER-UHFFFAOYSA-N 4-[[4-(4-bromo-2-fluoroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-n'-cyanopiperidine-1-carboximidamide Chemical compound N1=CN=C2C=C(OCC3CCN(CC3)C(N)=NC#N)C(OC)=CC2=C1NC1=CC=C(Br)C=C1F BLPHPXYTDDFZER-UHFFFAOYSA-N 0.000 description 1
- BQZSITGLBLNHBE-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-(4-methylphenyl)sulfonylimidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C(N1S(=O)(=O)C=2C=CC(C)=CC=2)=O)CC1CC1=CC=CC=C1 BQZSITGLBLNHBE-UHFFFAOYSA-N 0.000 description 1
- DFFYYHCIQMERJE-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C(N1)=O)CC1CC1=CC=CC=C1 DFFYYHCIQMERJE-UHFFFAOYSA-N 0.000 description 1
- VWIYIAHIOHEFJL-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1,3-diazinan-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C(N1)=O)CCC1CC1=CC=CC=C1 VWIYIAHIOHEFJL-UHFFFAOYSA-N 0.000 description 1
- TWIBKSKGAXIZLL-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(4-methylphenyl)sulfonylimidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C(N1S(=O)(=O)C=2C=CC(C)=CC=2)=O)CC1CC1=CC=CC=C1 TWIBKSKGAXIZLL-UHFFFAOYSA-N 0.000 description 1
- XQALDUDLHLHAOH-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]imidazolidin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C(N1)=O)CC1CC1=CC=CC=C1 XQALDUDLHLHAOH-UHFFFAOYSA-N 0.000 description 1
- DLXLPGRDLGVFAP-UHFFFAOYSA-N 4-benzyl-1-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]piperazin-2-one Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1N(C(C1)=O)CCN1CC1=CC=CC=C1 DLXLPGRDLGVFAP-UHFFFAOYSA-N 0.000 description 1
- OJFCYUGKFBRLDI-UHFFFAOYSA-N 4-benzyl-n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-4,5-dihydro-1,3-oxazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(OC1)=NC1CC1=CC=CC=C1 OJFCYUGKFBRLDI-UHFFFAOYSA-N 0.000 description 1
- RNOVGJWJVRESAA-UHFFFAOYSA-N 4-fluoro-2-(trifluoromethyl)phenol Chemical group OC1=CC=C(F)C=C1C(F)(F)F RNOVGJWJVRESAA-UHFFFAOYSA-N 0.000 description 1
- BIUDHHGROGJSHN-UHFFFAOYSA-N 4-fluoro-3-(trifluoromethyl)benzaldehyde Chemical group FC1=CC=C(C=O)C=C1C(F)(F)F BIUDHHGROGJSHN-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- PHOLLAGTGGRDBH-UHFFFAOYSA-N 4-methyl-8h-pyrido[2,3-d]pyrimidin-7-one Chemical compound N1C(=O)C=CC2=C1N=CN=C2C PHOLLAGTGGRDBH-UHFFFAOYSA-N 0.000 description 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000005986 4-piperidonyl group Chemical group 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- AVVWPBAENSWJCB-UHFFFAOYSA-N 5-(1,2-dihydroxyethyl)oxolane-2,3,4-triol Chemical compound OCC(O)C1OC(O)C(O)C1O AVVWPBAENSWJCB-UHFFFAOYSA-N 0.000 description 1
- VATKWVNDCITFEB-UHFFFAOYSA-N 5-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,3-thiazol-4-yl]-2-hydroxybenzamide Chemical compound N1=CN=C2C=C(OCC=3SC=C(N=3)C=3C=C(C(O)=CC=3)C(N)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VATKWVNDCITFEB-UHFFFAOYSA-N 0.000 description 1
- CNANJBQGWVKXDT-UHFFFAOYSA-N 5-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound CC1=CC=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C=C1NCCN1CCCC1 CNANJBQGWVKXDT-UHFFFAOYSA-N 0.000 description 1
- QJMKYRIHQWAKSM-UHFFFAOYSA-N 5-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-n,n-dimethyl-1,2,4-oxadiazol-3-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)N(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QJMKYRIHQWAKSM-UHFFFAOYSA-N 0.000 description 1
- IDPUKCWIGUEADI-UHFFFAOYSA-N 5-[bis(2-chloroethyl)amino]uracil Chemical compound ClCCN(CCCl)C1=CNC(=O)NC1=O IDPUKCWIGUEADI-UHFFFAOYSA-N 0.000 description 1
- 125000004539 5-benzimidazolyl group Chemical group N1=CNC2=C1C=CC(=C2)* 0.000 description 1
- RZOWKJSGXXYLBF-UHFFFAOYSA-N 5-bromo-3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(Br)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 RZOWKJSGXXYLBF-UHFFFAOYSA-N 0.000 description 1
- JTLPCDMHGTVANG-UHFFFAOYSA-N 5-chloro-2-methyl-3-[4-(1h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 JTLPCDMHGTVANG-UHFFFAOYSA-N 0.000 description 1
- ICZBXKGLNSAERJ-UHFFFAOYSA-N 5-chloro-3-[4-(3-cyclopropyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methyl-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C1=C(Cl)C=C(N2CCN(CC2)C=2C=3C(C4CC4)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 ICZBXKGLNSAERJ-UHFFFAOYSA-N 0.000 description 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 description 1
- RXYIYUOOCZCTQP-UHFFFAOYSA-N 5-methylpyrimidine-2,4-diamine Chemical compound CC1=CN=C(N)N=C1N RXYIYUOOCZCTQP-UHFFFAOYSA-N 0.000 description 1
- OOGSQHIRMPONOF-UHFFFAOYSA-N 6-(1-hydroxy-3-oxo-2-phenylisoindol-1-yl)-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC=C1 OOGSQHIRMPONOF-UHFFFAOYSA-N 0.000 description 1
- LQZJCFXJMJHXNY-UHFFFAOYSA-N 6-(1-hydroxy-3-oxo-2-piperidin-4-ylisoindol-1-yl)-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1CCNCC1 LQZJCFXJMJHXNY-UHFFFAOYSA-N 0.000 description 1
- NWPFPQYENBBIDA-UHFFFAOYSA-N 6-(1-hydroxy-3-oxo-2-propan-2-ylisoindol-1-yl)-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(C3(O)C4=CC=CC=C4C(=O)N3C(C)C)=CC=C21 NWPFPQYENBBIDA-UHFFFAOYSA-N 0.000 description 1
- PDJBXTTYRLDGSW-UHFFFAOYSA-N 6-(2-butyl-1-hydroxy-3-oxoisoindol-1-yl)-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(C3(O)C4=CC=CC=C4C(=O)N3CCCC)=CC=C21 PDJBXTTYRLDGSW-UHFFFAOYSA-N 0.000 description 1
- JHIWJXNUTCUPEF-UHFFFAOYSA-N 6-(4-phenylpiperazin-1-yl)-7h-purine Chemical compound C1CN(C=2C=3NC=NC=3N=CN=2)CCN1C1=CC=CC=C1 JHIWJXNUTCUPEF-UHFFFAOYSA-N 0.000 description 1
- MGAGAOYTZWXURQ-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-(2-phenoxyethyl)-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NCCOC1=CC=CC=C1 MGAGAOYTZWXURQ-UHFFFAOYSA-N 0.000 description 1
- FBRYOIAHOXXTIO-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-[2-[3-(trifluoromethyl)phenyl]ethyl]-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NCCC1=CC=CC(C(F)(F)F)=C1 FBRYOIAHOXXTIO-UHFFFAOYSA-N 0.000 description 1
- YTHCCOCZRQGJEZ-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-[[3-(trifluoromethyl)phenyl]methyl]-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2NCC1=CC=CC(C(F)(F)F)=C1 YTHCCOCZRQGJEZ-UHFFFAOYSA-N 0.000 description 1
- ISXYCOVIHXIWQD-UHFFFAOYSA-N 6-(6,7-dimethoxyquinolin-4-yl)oxy-5-fluoro-n-methyl-n-(2-phenylethyl)-1,3-benzothiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=CC=1N=2)F)=CC=1SC=2N(C)CCC1=CC=CC=C1 ISXYCOVIHXIWQD-UHFFFAOYSA-N 0.000 description 1
- OGZILHKYGPBSCN-UHFFFAOYSA-N 6-[1-hydroxy-2-[(2-methoxyphenyl)methyl]-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound COC1=CC=CC=C1CN1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O OGZILHKYGPBSCN-UHFFFAOYSA-N 0.000 description 1
- UAZUXSFSGVRVKK-UHFFFAOYSA-N 6-[1-hydroxy-2-[(2-methylsulfanylphenyl)methyl]-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound CSC1=CC=CC=C1CN1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O UAZUXSFSGVRVKK-UHFFFAOYSA-N 0.000 description 1
- JDVCGAJFPQHGNY-UHFFFAOYSA-N 6-[1-hydroxy-2-[(3-methoxyphenyl)methyl]-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound COC1=CC=CC(CN2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1 JDVCGAJFPQHGNY-UHFFFAOYSA-N 0.000 description 1
- UGYKHAJFULXEHC-UHFFFAOYSA-N 6-[1-hydroxy-2-[(4-methoxyphenyl)methyl]-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound C1=CC(OC)=CC=C1CN1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O UGYKHAJFULXEHC-UHFFFAOYSA-N 0.000 description 1
- JLQMMWOZLOLVOO-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-(3-phenylmethoxyphenyl)isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C(C=1)=CC=CC=1OCC1=CC=CC=C1 JLQMMWOZLOLVOO-UHFFFAOYSA-N 0.000 description 1
- BGQGTRGQDGNRIO-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-(3-phenylphenyl)isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C(C=1)=CC=CC=1C1=CC=CC=C1 BGQGTRGQDGNRIO-UHFFFAOYSA-N 0.000 description 1
- JZWBUQUSKAZPJJ-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-(3-phenylpropyl)isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CCCC1=CC=CC=C1 JZWBUQUSKAZPJJ-UHFFFAOYSA-N 0.000 description 1
- DNRFXBUMZWJERG-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-[3-(trifluoromethoxy)phenyl]isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC(OC(F)(F)F)=C1 DNRFXBUMZWJERG-UHFFFAOYSA-N 0.000 description 1
- HCYONTZUEGBGOR-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-[[2-(trifluoromethyl)phenyl]methyl]isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC=C1C(F)(F)F HCYONTZUEGBGOR-UHFFFAOYSA-N 0.000 description 1
- NOYYKRBTVXBWHO-UHFFFAOYSA-N 6-[1-hydroxy-3-oxo-2-[[3-(trifluoromethyl)phenyl]methyl]isoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=CC(C(F)(F)F)=C1 NOYYKRBTVXBWHO-UHFFFAOYSA-N 0.000 description 1
- VSZVLZXSAYSPHV-UHFFFAOYSA-N 6-[2-(1h-benzimidazol-2-yl)benzoyl]-4h-1,4-benzoxazin-3-one Chemical compound C1=CC=C2NC(C3=CC=CC=C3C(C=3C=C4NC(=O)COC4=CC=3)=O)=NC2=C1 VSZVLZXSAYSPHV-UHFFFAOYSA-N 0.000 description 1
- HGKZDQUOOVLCDL-UHFFFAOYSA-N 6-[2-(2-aminophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound NC1=CC=CC=C1N1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O HGKZDQUOOVLCDL-UHFFFAOYSA-N 0.000 description 1
- RUKPVCRQZBPQLI-UHFFFAOYSA-N 6-[2-(2-chlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC=C1Cl RUKPVCRQZBPQLI-UHFFFAOYSA-N 0.000 description 1
- ZWMKDNCUCVQBHY-UHFFFAOYSA-N 6-[2-(2-fluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC=C1F ZWMKDNCUCVQBHY-UHFFFAOYSA-N 0.000 description 1
- HEBSEJYDCRBKHO-UHFFFAOYSA-N 6-[2-(3,4-dichlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=C(Cl)C(Cl)=C1 HEBSEJYDCRBKHO-UHFFFAOYSA-N 0.000 description 1
- OIIZNSUWICCJEB-UHFFFAOYSA-N 6-[2-(3,4-difluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=C(F)C(F)=C1 OIIZNSUWICCJEB-UHFFFAOYSA-N 0.000 description 1
- IZSWTIJTAJZGOC-UHFFFAOYSA-N 6-[2-(3,5-dichlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC(Cl)=CC(Cl)=C1 IZSWTIJTAJZGOC-UHFFFAOYSA-N 0.000 description 1
- YMLLEMATODMZJH-UHFFFAOYSA-N 6-[2-(3,5-difluorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC(F)=CC(F)=C1 YMLLEMATODMZJH-UHFFFAOYSA-N 0.000 description 1
- RWJGXHSKKVZYLI-UHFFFAOYSA-N 6-[2-(3-aminophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound NC1=CC=CC(N2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1 RWJGXHSKKVZYLI-UHFFFAOYSA-N 0.000 description 1
- NPMXBHGHCRPSIO-UHFFFAOYSA-N 6-[2-(3-chlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC(Cl)=C1 NPMXBHGHCRPSIO-UHFFFAOYSA-N 0.000 description 1
- WQHRIAMIDMJBME-UHFFFAOYSA-N 6-[2-(3-ethylphenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound CCC1=CC=CC(N2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1 WQHRIAMIDMJBME-UHFFFAOYSA-N 0.000 description 1
- VSPPJOMXMRUQBJ-UHFFFAOYSA-N 6-[2-(3-ethynylphenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=CC(C#C)=C1 VSPPJOMXMRUQBJ-UHFFFAOYSA-N 0.000 description 1
- BOYORSYSOCEJAM-UHFFFAOYSA-N 6-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)benzoyl]-4h-1,4-benzoxazin-3-one Chemical compound C=1C=C2OCC(=O)NC2=CC=1C(=O)C1=CC=CC=C1C(ON=1)=NC=1C1=CC=CC=C1 BOYORSYSOCEJAM-UHFFFAOYSA-N 0.000 description 1
- XVIOTDHIXUDJOH-UHFFFAOYSA-N 6-[2-(4-chlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=C(Cl)C=C1 XVIOTDHIXUDJOH-UHFFFAOYSA-N 0.000 description 1
- KKWVJTOMPUCLJP-UHFFFAOYSA-N 6-[2-(5-chloro-2-methoxyphenyl)-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound COC1=CC=C(Cl)C=C1N1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O KKWVJTOMPUCLJP-UHFFFAOYSA-N 0.000 description 1
- RAGSECJYBJNDNT-UHFFFAOYSA-N 6-[2-[(2,3-dimethoxyphenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound COC1=CC=CC(CN2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1OC RAGSECJYBJNDNT-UHFFFAOYSA-N 0.000 description 1
- PRFRFUUDXFZJBY-UHFFFAOYSA-N 6-[2-[(4-chlorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC=C(Cl)C=C1 PRFRFUUDXFZJBY-UHFFFAOYSA-N 0.000 description 1
- SBWPMGUCBLOOTR-UHFFFAOYSA-N 6-[2-[(5-bromo-2-fluorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1CC1=CC(Br)=CC=C1F SBWPMGUCBLOOTR-UHFFFAOYSA-N 0.000 description 1
- LKIILXJTZLQLGF-UHFFFAOYSA-N 6-[2-[3-[(dimethylamino)methyl]phenyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound CN(C)CC1=CC=CC(N2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1 LKIILXJTZLQLGF-UHFFFAOYSA-N 0.000 description 1
- FUZOXHWXAYGCHT-UHFFFAOYSA-N 6-[2-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]pyrimidin-4-yl]-4h-1,4-benzoxazin-3-one Chemical compound O1CC(=O)NC2=CC(C=3C=CN=C(N=3)N3CCN(CC3)C=3N=CN=C4NN=C(C=34)Br)=CC=C21 FUZOXHWXAYGCHT-UHFFFAOYSA-N 0.000 description 1
- ODOWXUUIDMYMAO-UHFFFAOYSA-N 6-[2-[4-fluoro-3-(trifluoromethyl)phenyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)COC3=CC=2)N1C1=CC=C(F)C(C(F)(F)F)=C1 ODOWXUUIDMYMAO-UHFFFAOYSA-N 0.000 description 1
- LZFVWERIFXVTMC-UHFFFAOYSA-N 6-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]hexan-1-ol Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCCCCO)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LZFVWERIFXVTMC-UHFFFAOYSA-N 0.000 description 1
- AVADFQHEIADTFF-UHFFFAOYSA-N 6-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]hexanenitrile Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCCCC#N)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 AVADFQHEIADTFF-UHFFFAOYSA-N 0.000 description 1
- PTYLEJLWZCBEGW-UHFFFAOYSA-N 6-[2-[[4-(dimethylamino)phenyl]methyl]-1-hydroxy-3-oxoisoindol-1-yl]-4h-1,4-benzoxazin-3-one Chemical compound C1=CC(N(C)C)=CC=C1CN1C(C=2C=C3NC(=O)COC3=CC=2)(O)C2=CC=CC=C2C1=O PTYLEJLWZCBEGW-UHFFFAOYSA-N 0.000 description 1
- KDYPEARPZJFJBV-UHFFFAOYSA-N 6-[4-(2-chlorophenyl)piperazin-1-yl]-7h-purine Chemical compound ClC1=CC=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 KDYPEARPZJFJBV-UHFFFAOYSA-N 0.000 description 1
- ZMJKIUCPJALXPF-UHFFFAOYSA-N 6-[4-(2-fluorophenyl)piperazin-1-yl]-7h-purine Chemical compound FC1=CC=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 ZMJKIUCPJALXPF-UHFFFAOYSA-N 0.000 description 1
- KWLXRQFZEOGTIH-UHFFFAOYSA-N 6-[4-(2-methoxyphenyl)piperazin-1-yl]-7h-purine Chemical compound COC1=CC=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 KWLXRQFZEOGTIH-UHFFFAOYSA-N 0.000 description 1
- MWRLTPXFGZXUKB-UHFFFAOYSA-N 6-[4-(2-methylphenyl)piperazin-1-yl]-7h-purine Chemical compound CC1=CC=CC=C1N1CCN(C=2C=3N=CNC=3N=CN=2)CC1 MWRLTPXFGZXUKB-UHFFFAOYSA-N 0.000 description 1
- QIXXACAFRCQPFS-UHFFFAOYSA-N 6-[4-(3-chlorophenyl)piperazin-1-yl]-7h-purine Chemical compound ClC1=CC=CC(N2CCN(CC2)C=2C=3NC=NC=3N=CN=2)=C1 QIXXACAFRCQPFS-UHFFFAOYSA-N 0.000 description 1
- IQFNNPBWPNNACU-UHFFFAOYSA-N 6-[4-(4-chlorophenyl)piperazin-1-yl]-7h-purine Chemical compound C1=CC(Cl)=CC=C1N1CCN(C=2C=3N=CNC=3N=CN=2)CC1 IQFNNPBWPNNACU-UHFFFAOYSA-N 0.000 description 1
- MBRQCVJHJOVNLO-UHFFFAOYSA-N 6-[4-(4-fluorophenyl)piperazin-1-yl]-7h-purine Chemical compound C1=CC(F)=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 MBRQCVJHJOVNLO-UHFFFAOYSA-N 0.000 description 1
- ICAARADRKONXBF-UHFFFAOYSA-N 6-[4-(4-methoxyphenyl)piperazin-1-yl]-7h-purine Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=3NC=NC=3N=CN=2)CC1 ICAARADRKONXBF-UHFFFAOYSA-N 0.000 description 1
- AQKCWTXVJVQGDX-UHFFFAOYSA-N 6-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]-7h-purine Chemical compound FC(F)(F)C1=CC=CC(N2CCN(CC2)C=2C=3NC=NC=3N=CN=2)=C1 AQKCWTXVJVQGDX-UHFFFAOYSA-N 0.000 description 1
- NWWPZALFLBATKW-UHFFFAOYSA-N 6-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-3,3,4-trimethylmorpholin-2-one Chemical compound N1=CN=C2C=C(OCC3OC(=O)C(C)(C)N(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 NWWPZALFLBATKW-UHFFFAOYSA-N 0.000 description 1
- NOPCEBVBRDCASN-UHFFFAOYSA-N 6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]-n-(2,3,4-trichlorophenyl)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1Cl NOPCEBVBRDCASN-UHFFFAOYSA-N 0.000 description 1
- TWMPXXRMSJFJSY-UHFFFAOYSA-N 6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]-n-(3,4,5-trichlorophenyl)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC(Cl)=C(Cl)C(Cl)=C1 TWMPXXRMSJFJSY-UHFFFAOYSA-N 0.000 description 1
- CPAWJWKJKMWUDJ-UHFFFAOYSA-N 6-methoxy-7-[(4-pentyl-1,4-oxazepan-2-yl)methoxy]quinazolin-4-amine Chemical compound C1N(CCCCC)CCCOC1COC1=CC2=NC=NC(N)=C2C=C1OC CPAWJWKJKMWUDJ-UHFFFAOYSA-N 0.000 description 1
- TZOPEIOUJFXKQZ-UHFFFAOYSA-N 7-(1,3-benzothiazol-2-ylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC4=CC=CC=C4N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 TZOPEIOUJFXKQZ-UHFFFAOYSA-N 0.000 description 1
- HLDHNATWCDWAML-UHFFFAOYSA-N 7-(2,1,3-benzothiadiazol-4-ylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C4=NSN=C4C=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HLDHNATWCDWAML-UHFFFAOYSA-N 0.000 description 1
- BDXLOYXFMUPOIW-UHFFFAOYSA-N 7-(2,1,3-benzoxadiazol-5-ylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3=CC4=NON=C4C=C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 BDXLOYXFMUPOIW-UHFFFAOYSA-N 0.000 description 1
- ICONQZBKGMYHET-UHFFFAOYSA-N 7-(2-benzyl-1-hydroxy-3-oxoisoindol-1-yl)-3,4-dihydro-1h-quinoxalin-2-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)CNC3=CC=2)N1CC1=CC=CC=C1 ICONQZBKGMYHET-UHFFFAOYSA-N 0.000 description 1
- WYZCWZRHCBLLRQ-UHFFFAOYSA-N 7-(2-cyclohexylethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCC3CCCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 WYZCWZRHCBLLRQ-UHFFFAOYSA-N 0.000 description 1
- ZJFHLSCSEWIASA-UHFFFAOYSA-N 7-(3,4,6,7,9,9a-hexahydro-1h-[1,4]oxazino[3,4-c][1,4]oxazin-3-ylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCC4COCCN4C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZJFHLSCSEWIASA-UHFFFAOYSA-N 0.000 description 1
- GOTKNVOMZNDPKT-UHFFFAOYSA-N 7-(cyclobutylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3CCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 GOTKNVOMZNDPKT-UHFFFAOYSA-N 0.000 description 1
- SDPXNCYWHLAZJC-UHFFFAOYSA-N 7-(cyclopropylmethoxy)-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3CC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SDPXNCYWHLAZJC-UHFFFAOYSA-N 0.000 description 1
- PVTTWYOJLADNCZ-UHFFFAOYSA-N 7-[(1-benzylimidazol-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N(C=CN=3)CC=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PVTTWYOJLADNCZ-UHFFFAOYSA-N 0.000 description 1
- YETQQFMHUDZVIA-UHFFFAOYSA-N 7-[(3,5-dibromophenyl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=C(Br)C=C(Br)C=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 YETQQFMHUDZVIA-UHFFFAOYSA-N 0.000 description 1
- QUDDVDXFQIWBKM-UHFFFAOYSA-N 7-[(4-benzylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC=4C=CC=CC=4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QUDDVDXFQIWBKM-UHFFFAOYSA-N 0.000 description 1
- WTOQAKRNPRFBML-UHFFFAOYSA-N 7-[(4-benzylsulfonylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)S(=O)(=O)CC=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 WTOQAKRNPRFBML-UHFFFAOYSA-N 0.000 description 1
- WRVHLDXCHAGIMA-UHFFFAOYSA-N 7-[(4-butyl-1,4-oxazepan-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound C1N(CCCC)CCCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC WRVHLDXCHAGIMA-UHFFFAOYSA-N 0.000 description 1
- CHESBDRRLQCAEW-UHFFFAOYSA-N 7-[(4-butylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound C1N(CCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC CHESBDRRLQCAEW-UHFFFAOYSA-N 0.000 description 1
- CKIBKYNCWLLXRU-UHFFFAOYSA-N 7-[(4-butylsulfonylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound C1N(S(=O)(=O)CCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC CKIBKYNCWLLXRU-UHFFFAOYSA-N 0.000 description 1
- YJHVTCUKZLXENT-UHFFFAOYSA-N 7-[(4-cyclobutylmorpholin-2-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C3CCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 YJHVTCUKZLXENT-UHFFFAOYSA-N 0.000 description 1
- QQGZOWNAHJAXCG-UHFFFAOYSA-N 7-[(5-chloro-1-benzothiophen-3-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C4=CC(Cl)=CC=C4SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QQGZOWNAHJAXCG-UHFFFAOYSA-N 0.000 description 1
- ZCRLDBQMLFBFFN-UHFFFAOYSA-N 7-[(5-chloro-1-methyl-3-phenylpyrazol-4-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C(=NN(C)C=3Cl)C=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZCRLDBQMLFBFFN-UHFFFAOYSA-N 0.000 description 1
- DICBCRYPBMEARO-UHFFFAOYSA-N 7-[(6-bromo-2-methoxynaphthalen-1-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound COC1=CC=C2C=C(Br)C=CC2=C1COC(C(=CC1=2)OC)=CC1=NC=NC=2NC1=CC=C(Cl)C(Cl)=C1 DICBCRYPBMEARO-UHFFFAOYSA-N 0.000 description 1
- XUECJUQSSNVQPA-UHFFFAOYSA-N 7-[(6-chloro-4h-1,3-benzodioxin-8-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=4OCOCC=4C=C(Cl)C=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 XUECJUQSSNVQPA-UHFFFAOYSA-N 0.000 description 1
- TUQBWKPRXZNXMC-UHFFFAOYSA-N 7-[(6-chloropyridin-3-yl)methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=NC(Cl)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 TUQBWKPRXZNXMC-UHFFFAOYSA-N 0.000 description 1
- VBZSFJIAULDMFO-UHFFFAOYSA-N 7-[2-(3-chlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-3,4-dihydro-1h-quinoxalin-2-one Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3NC(=O)CNC3=CC=2)N1C1=CC=CC(Cl)=C1 VBZSFJIAULDMFO-UHFFFAOYSA-N 0.000 description 1
- RFGYFZFUMBQSCW-GICMACPYSA-N 7-[[(8ar)-1,3,5,6,8,8a-hexahydro-[1,3]thiazolo[4,3-c][1,4]oxazin-6-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OC[C@@H]4CSCN4C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 RFGYFZFUMBQSCW-GICMACPYSA-N 0.000 description 1
- BDVHNGIDDSJCCD-UHFFFAOYSA-N 7-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)C=3C=CC(Cl)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 BDVHNGIDDSJCCD-UHFFFAOYSA-N 0.000 description 1
- ZBNFVHQEUFIFJM-UHFFFAOYSA-N 7-[[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)C=3C=CC(=CC=3)C(C)(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZBNFVHQEUFIFJM-UHFFFAOYSA-N 0.000 description 1
- GVQHNFSUVYXILE-UHFFFAOYSA-N 7-[[4-(2-cyclohexylethyl)morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCC4CCCCC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 GVQHNFSUVYXILE-UHFFFAOYSA-N 0.000 description 1
- PFWWSXZJVNFSKD-UHFFFAOYSA-N 7-[[4-(3-chloropropylsulfonyl)morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)S(=O)(=O)CCCCl)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PFWWSXZJVNFSKD-UHFFFAOYSA-N 0.000 description 1
- KPUHDJMEVYIACF-UHFFFAOYSA-N 7-[[4-(cyclohexylmethyl)morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC4CCCCC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KPUHDJMEVYIACF-UHFFFAOYSA-N 0.000 description 1
- XNADADUSWUFNQO-UHFFFAOYSA-N 7-[[4-(cyclopropylmethyl)-1,4-oxazepan-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCCN(CC4CC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 XNADADUSWUFNQO-UHFFFAOYSA-N 0.000 description 1
- MNXNBCHIKSVTIG-UHFFFAOYSA-N 7-[[4-(cyclopropylmethyl)morpholin-2-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC4CC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 MNXNBCHIKSVTIG-UHFFFAOYSA-N 0.000 description 1
- QEIAACVSNFOMGZ-UHFFFAOYSA-N 7-[[4-chloro-2-(trifluoromethyl)quinolin-6-yl]methoxy]-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=C4C(Cl)=CC(=NC4=CC=3)C(F)(F)F)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QEIAACVSNFOMGZ-UHFFFAOYSA-N 0.000 description 1
- SNZSSCZJMVIOCR-UHFFFAOYSA-N 7-azabicyclo[2.2.1]heptane Chemical compound C1CC2CCC1N2 SNZSSCZJMVIOCR-UHFFFAOYSA-N 0.000 description 1
- VOQVXZHQBTXEHV-UHFFFAOYSA-N 7-cyclopentyloxy-n-(3,4-dichlorophenyl)-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OC3CCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VOQVXZHQBTXEHV-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NIFBNIANYCOETB-UHFFFAOYSA-N 8-methyl-n-(2-phenylethyl)-8-azabicyclo[3.2.1]octan-3-amine Chemical compound CN1C(C2)CCC1CC2NCCC1=CC=CC=C1 NIFBNIANYCOETB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- 108090000644 Angiozyme Proteins 0.000 description 1
- 229930091051 Arenine Natural products 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003571 Astrocytoma Diseases 0.000 description 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
- 206010004146 Basal cell carcinoma Diseases 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 206010073106 Bone giant cell tumour malignant Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- MZMJIWMEUUDANY-UHFFFAOYSA-N C1=C(C(N)=O)C(OC)=CC=C1NCCN1CCCC1 Chemical compound C1=C(C(N)=O)C(OC)=CC=C1NCCN1CCCC1 MZMJIWMEUUDANY-UHFFFAOYSA-N 0.000 description 1
- IOCGSDASERHQNY-UHFFFAOYSA-N C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)CC(N)=O)C1=CC=C(Cl)C=C1 Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)CC(N)=O)C1=CC=C(Cl)C=C1 IOCGSDASERHQNY-UHFFFAOYSA-N 0.000 description 1
- 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
- 125000006519 CCH3 Chemical group 0.000 description 1
- 108010065524 CD52 Antigen Proteins 0.000 description 1
- DEKBNWDGQFYDBX-UHFFFAOYSA-N COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)C1CCCC2=CC=CC=C12)F Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)C1CCCC2=CC=CC=C12)F DEKBNWDGQFYDBX-UHFFFAOYSA-N 0.000 description 1
- 101100322915 Caenorhabditis elegans akt-1 gene Proteins 0.000 description 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
- 208000009458 Carcinoma in Situ Diseases 0.000 description 1
- 206010008263 Cervical dysplasia Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 201000005262 Chondroma Diseases 0.000 description 1
- 208000005243 Chondrosarcoma Diseases 0.000 description 1
- 201000009047 Chordoma Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 description 1
- 206010048832 Colon adenoma Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102100036883 Cyclin-H Human genes 0.000 description 1
- ZGRQPKYPJYNOKX-XUXIUFHCSA-N Cys-Cys-His-His Chemical compound C([C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 ZGRQPKYPJYNOKX-XUXIUFHCSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 208000007033 Dysgerminoma Diseases 0.000 description 1
- 208000000471 Dysplastic Nevus Syndrome Diseases 0.000 description 1
- 201000009051 Embryonal Carcinoma Diseases 0.000 description 1
- 206010014967 Ependymoma Diseases 0.000 description 1
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 description 1
- 208000006168 Ewing Sarcoma Diseases 0.000 description 1
- LZPTVSXEQAZVNY-UHFFFAOYSA-N FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCN(CC1)C)N(C(C(=O)N)=O)CC(C)C Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCN(CC1)C)N(C(C(=O)N)=O)CC(C)C LZPTVSXEQAZVNY-UHFFFAOYSA-N 0.000 description 1
- FHNNGUHFOLIRRB-UHFFFAOYSA-N FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CC(C)C1=CC=CC=C1 Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CC(C)C1=CC=CC=C1 FHNNGUHFOLIRRB-UHFFFAOYSA-N 0.000 description 1
- 208000007659 Fibroadenoma Diseases 0.000 description 1
- 206010053717 Fibrous histiocytoma Diseases 0.000 description 1
- 108010029961 Filgrastim Proteins 0.000 description 1
- 208000000527 Germinoma Diseases 0.000 description 1
- 208000007569 Giant Cell Tumors Diseases 0.000 description 1
- 201000005409 Gliomatosis cerebri Diseases 0.000 description 1
- 206010018404 Glucagonoma Diseases 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 208000002927 Hamartoma Diseases 0.000 description 1
- 206010019629 Hepatic adenoma Diseases 0.000 description 1
- 102100034535 Histone H3.1 Human genes 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
- 101000713120 Homo sapiens Cyclin-H Proteins 0.000 description 1
- 101001067844 Homo sapiens Histone H3.1 Proteins 0.000 description 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 1
- XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102100020873 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000002118 L01XE12 - Vandetanib Substances 0.000 description 1
- CZQHHVNHHHRRDU-UHFFFAOYSA-N LY294002 Chemical compound C1=CC=C2C(=O)C=C(N3CCOCC3)OC2=C1C1=CC=CC=C1 CZQHHVNHHHRRDU-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000002404 Liver Cell Adenoma Diseases 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000006644 Malignant Fibrous Histiocytoma Diseases 0.000 description 1
- 208000000172 Medulloblastoma Diseases 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
- 208000014767 Myeloproliferative disease Diseases 0.000 description 1
- AOJHSTBXOYQDKL-UHFFFAOYSA-N N'-(2,2-diphenylethyl)-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1(=CC=CC=C1)C(CN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F)C1=CC=CC=C1 AOJHSTBXOYQDKL-UHFFFAOYSA-N 0.000 description 1
- GSDDSHPPAMLUQK-UHFFFAOYSA-N N'-(2,3-dihydro-1H-inden-1-yl)-N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)C1CCC2=CC=CC=C12)F GSDDSHPPAMLUQK-UHFFFAOYSA-N 0.000 description 1
- QANDDOAGOAYEMD-UHFFFAOYSA-N N'-(2,3-dihydro-1H-inden-2-yl)-N'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCN(CC1)C)N(C(C(=O)N)=O)C1CC2=CC=CC=C2C1 QANDDOAGOAYEMD-UHFFFAOYSA-N 0.000 description 1
- ZHPJDGBCPPPQSC-UHFFFAOYSA-N N'-(2,3-dihydro-1H-inden-2-yl)-N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)C1CC2=CC=CC=C2C1)F ZHPJDGBCPPPQSC-UHFFFAOYSA-N 0.000 description 1
- JYGXEHPZLZODKU-UHFFFAOYSA-N N'-(4-chloro-3-fluorophenyl)-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=C(C=C(C=C1)N(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F)F JYGXEHPZLZODKU-UHFFFAOYSA-N 0.000 description 1
- SHBRJGOJKCUXJD-UHFFFAOYSA-N N'-[(2,3-difluorophenyl)methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound FC1=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=CC=C1F SHBRJGOJKCUXJD-UHFFFAOYSA-N 0.000 description 1
- IDPUPNAYWVEHQL-UHFFFAOYSA-N N'-[(2,4-dichlorophenyl)methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=CC(=C1)Cl IDPUPNAYWVEHQL-UHFFFAOYSA-N 0.000 description 1
- MJCWLQPVRMUNCB-UHFFFAOYSA-N N'-[(3,5-dichlorophenyl)methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC=1C=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=C(C1)Cl MJCWLQPVRMUNCB-UHFFFAOYSA-N 0.000 description 1
- WWIXWCNBCIYDPW-UHFFFAOYSA-N N'-[(3-chlorophenyl)methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC=1C=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=CC1 WWIXWCNBCIYDPW-UHFFFAOYSA-N 0.000 description 1
- KCVASSGFLZLEHF-UHFFFAOYSA-N N'-[2-(1,3-benzodioxol-5-yl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound O1COC2=C1C=CC(=C2)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F KCVASSGFLZLEHF-UHFFFAOYSA-N 0.000 description 1
- BRVANNJFPHCTLN-UHFFFAOYSA-N N'-[2-(2,4-dimethylphenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound CC1=C(C=CC(=C1)C)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F BRVANNJFPHCTLN-UHFFFAOYSA-N 0.000 description 1
- AQWFQRTUESWNMZ-UHFFFAOYSA-N N'-[2-(2,5-dimethylphenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound CC1=C(C=C(C=C1)C)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F AQWFQRTUESWNMZ-UHFFFAOYSA-N 0.000 description 1
- ZJOVUVCWUCVORP-UHFFFAOYSA-N N'-[2-(2-chloro-6-fluorophenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=C(C(=CC=C1)F)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F ZJOVUVCWUCVORP-UHFFFAOYSA-N 0.000 description 1
- LVBHPSXHOHCWKX-UHFFFAOYSA-N N'-[2-(2-chlorophenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=C(C=CC=C1)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F LVBHPSXHOHCWKX-UHFFFAOYSA-N 0.000 description 1
- QNIFXBJDTMYGPA-UHFFFAOYSA-N N'-[2-(3-bromo-4-methoxyphenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound BrC=1C=C(C=CC1OC)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F QNIFXBJDTMYGPA-UHFFFAOYSA-N 0.000 description 1
- SGIRDFOIYLKJQR-UHFFFAOYSA-N N'-[2-(3-chlorophenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC=1C=C(C=CC1)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F SGIRDFOIYLKJQR-UHFFFAOYSA-N 0.000 description 1
- FZCCERLEMXKCRO-UHFFFAOYSA-N N'-[2-(4-aminophenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound NC1=CC=C(C=C1)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F FZCCERLEMXKCRO-UHFFFAOYSA-N 0.000 description 1
- GNYRYWWOYFIWKU-UHFFFAOYSA-N N'-[2-(4-chlorophenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=CC=C(C=C1)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F GNYRYWWOYFIWKU-UHFFFAOYSA-N 0.000 description 1
- OWJQRCKMDNDTCX-UHFFFAOYSA-N N'-[2-(4-ethoxyphenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C(C)OC1=CC=C(C=C1)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F OWJQRCKMDNDTCX-UHFFFAOYSA-N 0.000 description 1
- SLEPSYNLAGIOQU-UHFFFAOYSA-N N'-[2-(4-tert-butylphenyl)ethyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C(C)(C)(C)C1=CC=C(C=C1)CCN(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)F SLEPSYNLAGIOQU-UHFFFAOYSA-N 0.000 description 1
- KJBAKUXGHRZGFQ-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-N'-(2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCOCC1)N(C(C(=O)N)=O)CCC1=CC=CC=C1 KJBAKUXGHRZGFQ-UHFFFAOYSA-N 0.000 description 1
- CUHFKKHWKYNIBZ-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinolin-4-yl]oxyphenyl]-N'-(2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN1CCCCC1)N(C(C(=O)N)=O)CCC1=CC=CC=C1 CUHFKKHWKYNIBZ-UHFFFAOYSA-N 0.000 description 1
- GUOMYCUWNVYIAU-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-yl]oxyphenyl]-N'-(2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=NC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC=CC=C1 GUOMYCUWNVYIAU-UHFFFAOYSA-N 0.000 description 1
- TZWUMSSNEHVFDA-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(2-hydroxy-2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CC(C1=CC=CC=C1)O TZWUMSSNEHVFDA-UHFFFAOYSA-N 0.000 description 1
- RQWNGPCPOMYOSD-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(2-phenoxyethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCOC1=CC=CC=C1 RQWNGPCPOMYOSD-UHFFFAOYSA-N 0.000 description 1
- MRARMJHFYBCMBJ-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(2-phenylethyl)oxamide Chemical compound COc1cc2c(Oc3ccc(cc3F)N(CCc3ccccc3)C(=O)C(N)=O)ccnc2cc1OCC1CCNCC1 MRARMJHFYBCMBJ-UHFFFAOYSA-N 0.000 description 1
- PSYAQEPXKRMVFQ-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(2-pyridin-3-ylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC=1C=NC=CC1 PSYAQEPXKRMVFQ-UHFFFAOYSA-N 0.000 description 1
- KVXNIXCBQWJMIU-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-(3-methylbutyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC(C)C KVXNIXCBQWJMIU-UHFFFAOYSA-N 0.000 description 1
- SSCSSUHQRPDGOI-HXUWFJFHSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[(1R)-1-phenylethyl]oxamide Chemical compound FC=1C=C(C=CC=1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)[C@H](C)C1=CC=CC=C1 SSCSSUHQRPDGOI-HXUWFJFHSA-N 0.000 description 1
- JHFXEMHVHJEXEM-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[(2-fluorophenyl)methyl]oxamide Chemical compound FC1=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=CC=C1 JHFXEMHVHJEXEM-UHFFFAOYSA-N 0.000 description 1
- UBOLFIMFOLUPNC-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[(2-methylphenyl)methyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CC1=C(C=CC=C1)C UBOLFIMFOLUPNC-UHFFFAOYSA-N 0.000 description 1
- FHNNGUHFOLIRRB-NRFANRHFSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[(2R)-2-phenylpropyl]oxamide Chemical compound FC=1C=C(C=CC=1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)C[C@H](C)C1=CC=CC=C1 FHNNGUHFOLIRRB-NRFANRHFSA-N 0.000 description 1
- LUPWFUZOUOGVPD-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[(4-fluorophenyl)methyl]oxamide Chemical compound FC1=CC=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=C1 LUPWFUZOUOGVPD-UHFFFAOYSA-N 0.000 description 1
- AKWCWLMHWBFYKL-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(2-methylphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=C(C=CC=C1)C AKWCWLMHWBFYKL-UHFFFAOYSA-N 0.000 description 1
- KDKVAIBOMQVGRL-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(3-hydroxy-4-methoxyphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC(=C(C=C1)OC)O KDKVAIBOMQVGRL-UHFFFAOYSA-N 0.000 description 1
- JNBMJGDYYQVTTB-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(4-fluorophenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC=C(C=C1)F JNBMJGDYYQVTTB-UHFFFAOYSA-N 0.000 description 1
- PYCYCPBXZZINIA-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(4-hydroxy-3-methoxyphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC(=C(C=C1)O)OC PYCYCPBXZZINIA-UHFFFAOYSA-N 0.000 description 1
- NTTNWCDUUDLYCW-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(4-methoxyphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC=C(C=C1)OC NTTNWCDUUDLYCW-UHFFFAOYSA-N 0.000 description 1
- CLFPTPMBLVTAMA-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-(4-sulfamoylphenyl)ethyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=CC=C(C=C1)S(N)(=O)=O CLFPTPMBLVTAMA-UHFFFAOYSA-N 0.000 description 1
- QFQBUONVWCZDNM-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[2-[2-(trifluoromethyl)phenyl]ethyl]oxamide Chemical compound FC=1C=C(C=CC=1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CCC1=C(C=CC=C1)C(F)(F)F QFQBUONVWCZDNM-UHFFFAOYSA-N 0.000 description 1
- UQEBZRGOCBSPOH-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-[[4-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)CC1=CC=C(C=C1)C(F)(F)F UQEBZRGOCBSPOH-UHFFFAOYSA-N 0.000 description 1
- HIGXLZBHNMFNMX-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-N'-propan-2-yloxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCNCC1)N(C(C(=O)N)=O)C(C)C HIGXLZBHNMFNMX-UHFFFAOYSA-N 0.000 description 1
- JGYSJPOSQLNGAC-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-[(1-methylazetidin-3-yl)methoxy]quinolin-4-yl]oxyphenyl]-N'-(2-phenylethyl)oxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CN(C1)C)N(C(C(=O)N)=O)CCC1=CC=CC=C1 JGYSJPOSQLNGAC-UHFFFAOYSA-N 0.000 description 1
- WMXAIQDXTZNFFB-UHFFFAOYSA-N N'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-N'-phenyloxamide Chemical compound FC=1C=C(C=CC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCN(CC1)C)N(C(C(=O)N)=O)C1=CC=CC=C1 WMXAIQDXTZNFFB-UHFFFAOYSA-N 0.000 description 1
- LGKCOPJSURTSNG-UHFFFAOYSA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-N'-(1,2,3,4-tetrahydronaphthalen-2-yl)oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)C1CC2=CC=CC=C2CC1)F LGKCOPJSURTSNG-UHFFFAOYSA-N 0.000 description 1
- DFUBCRNKKZFRTF-UHFFFAOYSA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-N'-(2-phenylpropyl)oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)CC(C)C1=CC=CC=C1)F DFUBCRNKKZFRTF-UHFFFAOYSA-N 0.000 description 1
- XOKVUNXENCKGMY-UHFFFAOYSA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-N'-[(2-ethyl-3,4-dihydro-1H-isoquinolin-1-yl)methyl]oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)CC1N(CCC2=CC=CC=C12)CC)F XOKVUNXENCKGMY-UHFFFAOYSA-N 0.000 description 1
- DAGPGIWGYBJKGR-UHFFFAOYSA-N N'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-N'-[(2-propan-2-yl-3,4-dihydro-1H-isoquinolin-1-yl)methyl]oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)CC1N(CCC2=CC=CC=C12)C(C)C)F DAGPGIWGYBJKGR-UHFFFAOYSA-N 0.000 description 1
- FUOXJZNXDMVOKJ-UHFFFAOYSA-N N'-[4-[7-[2-(diethylamino)ethoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-N'-(2-phenylethyl)oxamide Chemical compound C(C)N(CCOC1=C(C=C2C(=CC=NC2=C1)OC1=C(C=C(C=C1)N(C(C(=O)N)=O)CCC1=CC=CC=C1)F)OC)CC FUOXJZNXDMVOKJ-UHFFFAOYSA-N 0.000 description 1
- HABKVYKGOXZOAL-UHFFFAOYSA-N N'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-N'-(2,4-difluorophenyl)propanediamide Chemical compound ClC=1C=C(C=NC1OC1=CC=NC2=CC(=C(C=C12)OC)OC)N(C(CC(=O)N)=O)C1=C(C=C(C=C1)F)F HABKVYKGOXZOAL-UHFFFAOYSA-N 0.000 description 1
- QCXBSIOOTXNALO-UHFFFAOYSA-N N'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-N'-(2-phenylethyl)oxamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=N1)N(C(C(=O)N)=O)CCC1=CC=CC=C1)Cl QCXBSIOOTXNALO-UHFFFAOYSA-N 0.000 description 1
- UVCZDEPACFHYOL-UHFFFAOYSA-N N'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-N'-(3-fluorophenyl)propanediamide Chemical compound ClC=1C=C(C=NC1OC1=CC=NC2=CC(=C(C=C12)OC)OC)N(C(CC(=O)N)=O)C1=CC(=CC=C1)F UVCZDEPACFHYOL-UHFFFAOYSA-N 0.000 description 1
- PRKPWFLDQNSCAX-UHFFFAOYSA-N N'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-N'-(4-fluorophenyl)propanediamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=N1)N(C(CC(=O)N)=O)C1=CC=C(C=C1)F)Cl PRKPWFLDQNSCAX-UHFFFAOYSA-N 0.000 description 1
- BRHQBHLXEVUWKR-UHFFFAOYSA-N N'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-N'-[3-(trifluoromethyl)phenyl]propanediamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=C(C=C(C=N1)N(C(CC(=O)N)=O)C1=CC(=CC=C1)C(F)(F)F)Cl BRHQBHLXEVUWKR-UHFFFAOYSA-N 0.000 description 1
- YQHZFBZIMPUUNE-UHFFFAOYSA-N N'-[5-chloro-6-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxypyridin-3-yl]-N'-(4-fluorophenyl)propanediamide Chemical compound ClC=1C=C(C=NC1OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCN(CC1)C)N(C(CC(=O)N)=O)C1=CC=C(C=C1)F YQHZFBZIMPUUNE-UHFFFAOYSA-N 0.000 description 1
- NMUORFMLPBHECQ-UHFFFAOYSA-N N'-[5-chloro-6-[7-[3-(diethylamino)propoxy]-6-methoxyquinolin-4-yl]oxypyridin-3-yl]-N'-(4-fluorophenyl)propanediamide Chemical compound ClC=1C=C(C=NC1OC1=CC=NC2=CC(=C(C=C12)OC)OCCCN(CC)CC)N(C(CC(=O)N)=O)C1=CC=C(C=C1)F NMUORFMLPBHECQ-UHFFFAOYSA-N 0.000 description 1
- GMYSTEHZXYWNSK-UHFFFAOYSA-N N'-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridazin-3-yl]-N'-(4-fluorophenyl)propanediamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=CC=C(N=N1)N(C(CC(=O)N)=O)C1=CC=C(C=C1)F GMYSTEHZXYWNSK-UHFFFAOYSA-N 0.000 description 1
- BHKFJVPSVUKZIB-UHFFFAOYSA-N N'-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-N'-(4-fluorophenyl)propanediamide Chemical compound COC=1C=C2C(=CC=NC2=CC1OC)OC1=CC=C(C=N1)N(C(CC(=O)N)=O)C1=CC=C(C=C1)F BHKFJVPSVUKZIB-UHFFFAOYSA-N 0.000 description 1
- MXKYMGXRGFJPAR-UHFFFAOYSA-N N'-[[3,5-bis(trifluoromethyl)phenyl]methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound FC(C=1C=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=C(C1)C(F)(F)F)(F)F MXKYMGXRGFJPAR-UHFFFAOYSA-N 0.000 description 1
- YMKDWDPLUGMEHP-UHFFFAOYSA-N N'-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]-N'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound ClC1=C(C=C(CN(C(C(=O)N)=O)C2=CC(=C(C=C2)OC2=CC=NC3=CC(=C(C=C23)OC)OCC2CCNCC2)F)C=C1)C(F)(F)F YMKDWDPLUGMEHP-UHFFFAOYSA-N 0.000 description 1
- YKCAUVJVQBVSGI-UHFFFAOYSA-N N'-benzyl-N'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]oxamide Chemical compound C(C1=CC=CC=C1)N(C(C(=O)N)=O)C1=CC(=C(C=C1)OC1=CC=NC2=CC(=C(C=C12)OC)OCC1CCN(CC1)C)F YKCAUVJVQBVSGI-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SEIDASZGSSSTAB-UHFFFAOYSA-N N-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(pyridin-2-ylsulfonylmethyl)-1,3,4-oxadiazol-4-ium-2-yl]methoxy]quinazolin-4-amine Chemical compound COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1n[n+](CS(=O)(=O)c2ccccn2)co1 SEIDASZGSSSTAB-UHFFFAOYSA-N 0.000 description 1
- BWSQVEGNUBKUSM-UHFFFAOYSA-N N-(3,4-dichlorophenyl)-6-methoxy-7-[[5-(4-methoxypyridin-1-ium-1-yl)-1,2,4-oxadiazol-3-yl]methoxy]quinazolin-4-amine Chemical compound COc1cc[n+](cc1)-c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)no1 BWSQVEGNUBKUSM-UHFFFAOYSA-N 0.000 description 1
- GCIKSSRWRFVXBI-UHFFFAOYSA-N N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide Chemical compound C1CN(C)CCN1C1=CC(NC2=NNC(C)=C2)=NC(SC=2C=CC(NC(=O)C3CC3)=CC=2)=N1 GCIKSSRWRFVXBI-UHFFFAOYSA-N 0.000 description 1
- DVWGKCNCWJGJHU-UHFFFAOYSA-N N-cyano-2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-N-methylmorpholine-4-carboximidamide Chemical compound C(#N)N(C(=N)N1CC(OCC1)COC1=C(C=C2C(=NC=NC2=C1)NC1=CC(=C(C=C1)Cl)Cl)OC)C DVWGKCNCWJGJHU-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- QJAVIUBTUQKSFE-UHFFFAOYSA-N N-ethyl-4-methylpyrido[2,3-d]pyrimidin-2-amine Chemical compound C(C)NC=1N=C(C2=C(N1)N=CC=C2)C QJAVIUBTUQKSFE-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 201000004404 Neurofibroma Diseases 0.000 description 1
- ILUJQPXNXACGAN-UHFFFAOYSA-N O-methylsalicylic acid Chemical compound COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 description 1
- 108010016076 Octreotide Proteins 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 206010031149 Osteitis Diseases 0.000 description 1
- 208000000035 Osteochondroma Diseases 0.000 description 1
- TUVCWJQQGGETHL-UHFFFAOYSA-N PI-103 Chemical compound OC1=CC=CC(C=2N=C3C4=CC=CN=C4OC3=C(N3CCOCC3)N=2)=C1 TUVCWJQQGGETHL-UHFFFAOYSA-N 0.000 description 1
- 102000038030 PI3Ks Human genes 0.000 description 1
- 101150073900 PTEN gene Proteins 0.000 description 1
- 208000034038 Pathologic Neovascularization Diseases 0.000 description 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
- 208000007641 Pinealoma Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 101710113459 RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
- 229940127361 Receptor Tyrosine Kinase Inhibitors Drugs 0.000 description 1
- 201000000582 Retinoblastoma Diseases 0.000 description 1
- 208000005678 Rhabdomyoma Diseases 0.000 description 1
- 201000010208 Seminoma Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102220504163 Testis-specific XK-related protein, Y-linked 2_H31L_mutation Human genes 0.000 description 1
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- IVTVGDXNLFLDRM-HNNXBMFYSA-N Tomudex Chemical compound C=1C=C2NC(C)=NC(=O)C2=CC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)S1 IVTVGDXNLFLDRM-HNNXBMFYSA-N 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 208000015778 Undifferentiated pleomorphic sarcoma Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 108091008605 VEGF receptors Proteins 0.000 description 1
- 208000009311 VIPoma Diseases 0.000 description 1
- 206010048214 Xanthoma Diseases 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- IXRXEXNQINCIRZ-UHFFFAOYSA-N [1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-chlorophenyl)methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 IXRXEXNQINCIRZ-UHFFFAOYSA-N 0.000 description 1
- SUMHHCMWZBLBCC-UHFFFAOYSA-N [1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-fluorophenyl)methanol Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1C(O)C1=CC=C(F)C=C1 SUMHHCMWZBLBCC-UHFFFAOYSA-N 0.000 description 1
- DAQIGAFHULTFIF-UHFFFAOYSA-N [1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-(4-fluorophenyl)methanone Chemical compound C1=CC(F)=CC=C1C(=O)C1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 DAQIGAFHULTFIF-UHFFFAOYSA-N 0.000 description 1
- VNKOLNHCWLKONF-UHFFFAOYSA-N [2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-(2,3,6-trifluorophenyl)methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C=3C(=C(F)C=CC=3F)F)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VNKOLNHCWLKONF-UHFFFAOYSA-N 0.000 description 1
- DGJOZXUZTUDBOH-UHFFFAOYSA-N [2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-(3,5-dimethyl-1,2-oxazol-4-yl)methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C3=C(ON=C3C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 DGJOZXUZTUDBOH-UHFFFAOYSA-N 0.000 description 1
- HKKAQXNDAFGPHA-UHFFFAOYSA-N [2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-(furan-3-yl)methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C3=COC=C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HKKAQXNDAFGPHA-UHFFFAOYSA-N 0.000 description 1
- CJQXHWIFGRLKGH-UHFFFAOYSA-N [2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]-naphthalen-1-ylmethanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C=3C4=CC=CC=C4C=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 CJQXHWIFGRLKGH-UHFFFAOYSA-N 0.000 description 1
- URDNYNTUOXZTMC-UHFFFAOYSA-N [3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-cyclopropylmethanone Chemical compound C1=C(C(=O)C2CC2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 URDNYNTUOXZTMC-UHFFFAOYSA-N 0.000 description 1
- QMSVBRCEGLXJLU-UHFFFAOYSA-N [3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-phenylmethanone Chemical compound C1=C(C(=O)C=2C=CC=CC=2)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 QMSVBRCEGLXJLU-UHFFFAOYSA-N 0.000 description 1
- KXAKPLZFCFFJSW-UHFFFAOYSA-N [3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]methanol Chemical compound C1=C(CO)C=C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)C(C)=C1NCCN1CCCC1 KXAKPLZFCFFJSW-UHFFFAOYSA-N 0.000 description 1
- BSMOPWRSRTXLSN-UHFFFAOYSA-N [4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)-1-[(4-chlorophenyl)methyl]piperazin-2-yl]methanol Chemical compound OCC1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCN1CC1=CC=C(Cl)C=C1 BSMOPWRSRTXLSN-UHFFFAOYSA-N 0.000 description 1
- SHCDCCGKHSNKHI-UHFFFAOYSA-N [4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl] n-benzylcarbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1OC(=O)NCC1=CC=CC=C1 SHCDCCGKHSNKHI-UHFFFAOYSA-N 0.000 description 1
- ATNQJIZWZJGBST-UHFFFAOYSA-N [4-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,3-thiazol-2-yl]methanol Chemical compound N1=CN=C2C=C(OCC=3N=C(CO)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ATNQJIZWZJGBST-UHFFFAOYSA-N 0.000 description 1
- SROSEDFOBYVYCH-UHFFFAOYSA-N [4-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,3-thiazol-2-yl]methyl benzoate Chemical compound N1=CN=C2C=C(OCC=3N=C(COC(=O)C=4C=CC=CC=4)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SROSEDFOBYVYCH-UHFFFAOYSA-N 0.000 description 1
- BKYQHYYQDPBHJM-UHFFFAOYSA-N [5-chloro-3-[4-(3-ethyl-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-2-methoxyphenyl]-(4-methylpiperazin-1-yl)methanone Chemical compound C=12C(CC)=NNC2=NC=NC=1N(CC1)CCN1C(C=1OC)=CC(Cl)=CC=1C(=O)N1CCN(C)CC1 BKYQHYYQDPBHJM-UHFFFAOYSA-N 0.000 description 1
- 229940028652 abraxane Drugs 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000002718 adenomatoid tumor Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 229940060265 aldara Drugs 0.000 description 1
- 125000006524 alkoxy alkyl amino group Chemical group 0.000 description 1
- 125000005084 alkoxyalkylaminoalkyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229960000473 altretamine Drugs 0.000 description 1
- 229960003437 aminoglutethimide Drugs 0.000 description 1
- ROBVIMPUHSLWNV-UHFFFAOYSA-N aminoglutethimide Chemical compound C=1C=C(N)C=CC=1C1(CC)CCC(=O)NC1=O ROBVIMPUHSLWNV-UHFFFAOYSA-N 0.000 description 1
- XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 description 1
- 229960001220 amsacrine Drugs 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940046844 aromatase inhibitors Drugs 0.000 description 1
- 238000007080 aromatic substitution reaction Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000001119 benign fibrous histiocytoma Diseases 0.000 description 1
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 125000004532 benzofuran-3-yl group Chemical group O1C=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000004533 benzofuran-5-yl group Chemical group O1C=CC2=C1C=CC(=C2)* 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- PLNPXRUNNRKKPG-UHFFFAOYSA-N benzyl 2-[2-(methoxycarbonylamino)-3h-benzimidazole-5-carbonyl]benzoate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(=O)C1=CC=CC=C1C(=O)OCC1=CC=CC=C1 PLNPXRUNNRKKPG-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000018339 bone inflammation disease Diseases 0.000 description 1
- 201000009480 botryoid rhabdomyosarcoma Diseases 0.000 description 1
- 238000002725 brachytherapy Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000003149 breast fibroadenoma Diseases 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 201000002143 bronchus adenoma Diseases 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 229940088954 camptosar Drugs 0.000 description 1
- 229940127093 camptothecin Drugs 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004709 cell invasion Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000010109 chemoembolization Effects 0.000 description 1
- 239000012829 chemotherapy agent Substances 0.000 description 1
- 239000000460 chlorine Chemical group 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 201000005217 chondroblastoma Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 229960002436 cladribine Drugs 0.000 description 1
- 208000009060 clear cell adenocarcinoma Diseases 0.000 description 1
- WDDPHFBMKLOVOX-AYQXTPAHSA-N clofarabine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F WDDPHFBMKLOVOX-AYQXTPAHSA-N 0.000 description 1
- 229960000928 clofarabine Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 201000010305 cutaneous fibrous histiocytoma Diseases 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- KSFMKTNHEIDMFI-UHFFFAOYSA-N cyclopentyl-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]methanone Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)C3CCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KSFMKTNHEIDMFI-UHFFFAOYSA-N 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 229960001140 cyproheptadine Drugs 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000003436 cytoskeletal effect Effects 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- 229940026692 decadron Drugs 0.000 description 1
- 125000005507 decahydroisoquinolyl group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
- 229940064790 dilantin Drugs 0.000 description 1
- 125000005805 dimethoxy phenyl group Chemical group 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
- UZZWBUYVTBPQIV-UHFFFAOYSA-N dme dimethoxyethane Chemical compound COCCOC.COCCOC UZZWBUYVTBPQIV-UHFFFAOYSA-N 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 229940115080 doxil Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 201000009409 embryonal rhabdomyosarcoma Diseases 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960001904 epirubicin Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- BTGGKWOJEKOLEQ-UHFFFAOYSA-N ethyl 2-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]propanoate Chemical compound C1N(C(C)C(=O)OCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC BTGGKWOJEKOLEQ-UHFFFAOYSA-N 0.000 description 1
- XMEXJHXCTNGKBH-UHFFFAOYSA-N ethyl 3-[1-hydroxy-3-oxo-1-(3-oxo-4h-1,4-benzoxazin-6-yl)isoindol-2-yl]benzoate Chemical compound CCOC(=O)C1=CC=CC(N2C(C3=CC=CC=C3C2=O)(O)C=2C=C3NC(=O)COC3=CC=2)=C1 XMEXJHXCTNGKBH-UHFFFAOYSA-N 0.000 description 1
- 229940012017 ethylenediamine Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- LIQODXNTTZAGID-OCBXBXKTSA-N etoposide phosphate Chemical compound COC1=C(OP(O)(O)=O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 LIQODXNTTZAGID-OCBXBXKTSA-N 0.000 description 1
- 229960000752 etoposide phosphate Drugs 0.000 description 1
- ZVYVPGLRVWUPMP-FYSMJZIKSA-N exatecan Chemical compound C1C[C@H](N)C2=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC3=CC(F)=C(C)C1=C32 ZVYVPGLRVWUPMP-FYSMJZIKSA-N 0.000 description 1
- 229950009429 exatecan Drugs 0.000 description 1
- 238000002710 external beam radiation therapy Methods 0.000 description 1
- 229940087861 faslodex Drugs 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 1
- YAKWPXVTIGTRJH-UHFFFAOYSA-N fotemustine Chemical compound CCOP(=O)(OCC)C(C)NC(=O)N(CCCl)N=O YAKWPXVTIGTRJH-UHFFFAOYSA-N 0.000 description 1
- 229960004783 fotemustine Drugs 0.000 description 1
- 229960002258 fulvestrant Drugs 0.000 description 1
- 208000015419 gastrin-producing neuroendocrine tumor Diseases 0.000 description 1
- 201000000052 gastrinoma Diseases 0.000 description 1
- 229940020967 gemzar Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 201000003115 germ cell cancer Diseases 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 230000036433 growing body Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 125000005291 haloalkenyloxy group Chemical group 0.000 description 1
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 210000002767 hepatic artery Anatomy 0.000 description 1
- 208000006359 hepatoblastoma Diseases 0.000 description 1
- 201000002735 hepatocellular adenoma Diseases 0.000 description 1
- 125000004475 heteroaralkyl group Chemical group 0.000 description 1
- UUVWYPNAQBNQJQ-UHFFFAOYSA-N hexamethylmelamine Chemical compound CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1 UUVWYPNAQBNQJQ-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 1
- 229940096120 hydrea Drugs 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 229940099279 idamycin Drugs 0.000 description 1
- 229960000908 idarubicin Drugs 0.000 description 1
- 229960003685 imatinib mesylate Drugs 0.000 description 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 229960002751 imiquimod Drugs 0.000 description 1
- 201000004933 in situ carcinoma Diseases 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 description 1
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 1
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000010985 invasive ductal carcinoma Diseases 0.000 description 1
- 239000011630 iodine Chemical group 0.000 description 1
- XMBWDFGMSWQBCA-RNFDNDRNSA-M iodine-131(1-) Chemical group [131I-] XMBWDFGMSWQBCA-RNFDNDRNSA-M 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229960005386 ipilimumab Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- SANOUVWGPVYVAV-UHFFFAOYSA-N isovaleramide Chemical compound CC(C)CC(N)=O SANOUVWGPVYVAV-UHFFFAOYSA-N 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000022013 kidney Wilms tumor Diseases 0.000 description 1
- 229960002437 lanreotide Drugs 0.000 description 1
- 108010021336 lanreotide Proteins 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229940087875 leukine Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 206010024627 liposarcoma Diseases 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- NDAZATDQFDPQBD-UHFFFAOYSA-N luminespib Chemical compound CCNC(=O)C1=NOC(C=2C(=CC(O)=C(C(C)C)C=2)O)=C1C(C=C1)=CC=C1CN1CCOCC1 NDAZATDQFDPQBD-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- RVFGKBWWUQOIOU-NDEPHWFRSA-N lurtotecan Chemical compound O=C([C@]1(O)CC)OCC(C(N2CC3=4)=O)=C1C=C2C3=NC1=CC=2OCCOC=2C=C1C=4CN1CCN(C)CC1 RVFGKBWWUQOIOU-NDEPHWFRSA-N 0.000 description 1
- 229950002654 lurtotecan Drugs 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 201000004593 malignant giant cell tumor Diseases 0.000 description 1
- 201000000289 malignant teratoma Diseases 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229960002985 medroxyprogesterone acetate Drugs 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 1
- 229960001428 mercaptopurine Drugs 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- ZEIOSBCSTUSZSU-UHFFFAOYSA-N methyl 3-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]propanoate Chemical compound C1N(CCC(=O)OC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC ZEIOSBCSTUSZSU-UHFFFAOYSA-N 0.000 description 1
- UUZYXVMMMLOUNS-UHFFFAOYSA-N methyl 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)benzoate Chemical compound CC=1C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=CC(C(=O)OC)=CC=1NCCN1CCCC1 UUZYXVMMMLOUNS-UHFFFAOYSA-N 0.000 description 1
- PRGBKZSNTIVFOY-UHFFFAOYSA-N methyl 3-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 PRGBKZSNTIVFOY-UHFFFAOYSA-N 0.000 description 1
- DUAMSJLUECLRIC-UHFFFAOYSA-N methyl 3-bromo-5-[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methylbenzoate Chemical compound COC(=O)C1=CC(Br)=C(C)C(N2CCN(CC2)C=2C=3C(Br)=NNC=3N=CN=2)=C1 DUAMSJLUECLRIC-UHFFFAOYSA-N 0.000 description 1
- RCSTZMIKNBYKFF-UHFFFAOYSA-N methyl 4-[[4-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1CN1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 RCSTZMIKNBYKFF-UHFFFAOYSA-N 0.000 description 1
- GQBGDMIPLRKLGO-UHFFFAOYSA-N methyl 5-[2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholin-4-yl]pentanoate Chemical compound C1N(CCCCC(=O)OC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC GQBGDMIPLRKLGO-UHFFFAOYSA-N 0.000 description 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 description 1
- RGVJCTNUQFLEIU-UHFFFAOYSA-N methyl n-[6-(1-hydroxy-3-oxo-2-phenylisoindol-1-yl)-1h-benzimidazol-2-yl]carbamate Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(C1=CC=CC=C1C1=O)(O)N1C1=CC=CC=C1 RGVJCTNUQFLEIU-UHFFFAOYSA-N 0.000 description 1
- XUVBCCAHCFQSCS-UHFFFAOYSA-N methyl n-[6-[1-hydroxy-2-(3-methoxyphenyl)-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1C1=CC=CC(OC)=C1 XUVBCCAHCFQSCS-UHFFFAOYSA-N 0.000 description 1
- BIWSAOSOLYQECL-UHFFFAOYSA-N methyl n-[6-[1-hydroxy-2-(4-methoxyphenyl)-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1C1=CC=C(OC)C=C1 BIWSAOSOLYQECL-UHFFFAOYSA-N 0.000 description 1
- LYMMTPSTEKSFSS-UHFFFAOYSA-N methyl n-[6-[1-hydroxy-2-[(2-methylphenyl)methyl]-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC=C1C LYMMTPSTEKSFSS-UHFFFAOYSA-N 0.000 description 1
- KRIIHSSPOMTJPP-UHFFFAOYSA-N methyl n-[6-[1-hydroxy-2-[(3-iodophenyl)methyl]-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC(I)=C1 KRIIHSSPOMTJPP-UHFFFAOYSA-N 0.000 description 1
- VKKLDAOMDIUYCR-UHFFFAOYSA-N methyl n-[6-[1-hydroxy-2-[(3-methylphenyl)methyl]-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC(C)=C1 VKKLDAOMDIUYCR-UHFFFAOYSA-N 0.000 description 1
- ACJKPTOGQNRUEV-UHFFFAOYSA-N methyl n-[6-[1-hydroxy-2-[(4-methylphenyl)methyl]-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=C(C)C=C1 ACJKPTOGQNRUEV-UHFFFAOYSA-N 0.000 description 1
- RVLJHRWJRHOYNC-FXBVVIMESA-N methyl n-[6-[1-hydroxy-3-oxo-2-[(1r)-1-phenylethyl]isoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C1([C@@H](C)N2C(C3=CC=CC=C3C2=O)(O)C=2C=C3N=C(NC3=CC=2)NC(=O)OC)=CC=CC=C1 RVLJHRWJRHOYNC-FXBVVIMESA-N 0.000 description 1
- BSEOJSOGDLPQSE-UHFFFAOYSA-N methyl n-[6-[1-hydroxy-3-oxo-2-[3-(trifluoromethyl)phenyl]isoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1C1=CC=CC(C(F)(F)F)=C1 BSEOJSOGDLPQSE-UHFFFAOYSA-N 0.000 description 1
- ABOWVCATJOQIKV-UHFFFAOYSA-N methyl n-[6-[2-(2,2-dimethylpropyl)-1-hydroxy-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound CC(C)(C)CN1C(=O)C2=CC=CC=C2C1(O)C1=CC=C(NC(NC(=O)OC)=N2)C2=C1 ABOWVCATJOQIKV-UHFFFAOYSA-N 0.000 description 1
- AMMSHLPKSWMPMO-UHFFFAOYSA-N methyl n-[6-[2-(3,5-dichlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1C1=CC(Cl)=CC(Cl)=C1 AMMSHLPKSWMPMO-UHFFFAOYSA-N 0.000 description 1
- XPSYGUCHJYBCCD-UHFFFAOYSA-N methyl n-[6-[2-(3-amino-5-chlorophenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(C1=CC=CC=C1C1=O)(O)N1C1=CC(N)=CC(Cl)=C1 XPSYGUCHJYBCCD-UHFFFAOYSA-N 0.000 description 1
- YMQPILNOMZNRKU-UHFFFAOYSA-N methyl n-[6-[2-(cyclopropylmethyl)-1-hydroxy-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1CC1 YMQPILNOMZNRKU-UHFFFAOYSA-N 0.000 description 1
- NZHHWGVDFUTQAW-UHFFFAOYSA-N methyl n-[6-[2-[(2-bromophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC=C1Br NZHHWGVDFUTQAW-UHFFFAOYSA-N 0.000 description 1
- ZFXYMFJMJILFMH-UHFFFAOYSA-N methyl n-[6-[2-[(2-chlorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC=C1Cl ZFXYMFJMJILFMH-UHFFFAOYSA-N 0.000 description 1
- SECJLNJZQAQYIL-UHFFFAOYSA-N methyl n-[6-[2-[(3-chlorophenyl)methyl]-1-hydroxy-3-oxoisoindol-1-yl]-1h-benzimidazol-2-yl]carbamate Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1C(C1=CC=CC=C1C1=O)(O)N1CC1=CC=CC(Cl)=C1 SECJLNJZQAQYIL-UHFFFAOYSA-N 0.000 description 1
- VNXBKJFUJUWOCW-UHFFFAOYSA-N methylcyclopropane Chemical compound CC1CC1 VNXBKJFUJUWOCW-UHFFFAOYSA-N 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
- 229960001156 mitoxantrone Drugs 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- ZDZOTLJHXYCWBA-BSEPLHNVSA-N molport-006-823-826 Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-BSEPLHNVSA-N 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 208000010492 mucinous cystadenocarcinoma Diseases 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 208000009091 myxoma Diseases 0.000 description 1
- QRFBJPHWCGAUIE-UHFFFAOYSA-N n'-(1,2-diphenylethyl)-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C(C=1C=CC=CC=1)CC1=CC=CC=C1 QRFBJPHWCGAUIE-UHFFFAOYSA-N 0.000 description 1
- BMDVPIBEYFYGMC-UHFFFAOYSA-N n'-(2,3-dihydro-1h-inden-1-yl)-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound COC1=CC2=C(OC=3C(=CC(=CC=3)N(C3C4=CC=CC=C4CC3)C(=O)C(N)=O)F)C=CN=C2C=C1OCC1CCNCC1 BMDVPIBEYFYGMC-UHFFFAOYSA-N 0.000 description 1
- MHUHNLOKYAFLLC-UHFFFAOYSA-N n'-(3,4-dimethoxyphenyl)-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=C(OC)C(OC)=CC=C1N(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 MHUHNLOKYAFLLC-UHFFFAOYSA-N 0.000 description 1
- BIHVKQQJFHZSMV-UHFFFAOYSA-N n'-[(2,6-difluorophenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=C(F)C=CC=C1F BIHVKQQJFHZSMV-UHFFFAOYSA-N 0.000 description 1
- JGYQXYDNCSGXBK-UHFFFAOYSA-N n'-[(3,5-dimethoxyphenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound COC1=CC(OC)=CC(CN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 JGYQXYDNCSGXBK-UHFFFAOYSA-N 0.000 description 1
- VAZQDLJATFXDQX-UHFFFAOYSA-N n'-[(3-chloro-4-fluorophenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(F)C(Cl)=C1 VAZQDLJATFXDQX-UHFFFAOYSA-N 0.000 description 1
- MSTJAWRMMMKFMF-UHFFFAOYSA-N n'-[(4-butylphenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CC(CCCC)=CC=C1CN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 MSTJAWRMMMKFMF-UHFFFAOYSA-N 0.000 description 1
- SHRIWHDIQWBKEQ-UHFFFAOYSA-N n'-[(4-chlorophenyl)methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(Cl)C=C1 SHRIWHDIQWBKEQ-UHFFFAOYSA-N 0.000 description 1
- OSUZDWTYUMJTHI-UHFFFAOYSA-N n'-[1-(4-bromophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C(C)C1=CC=C(Br)C=C1 OSUZDWTYUMJTHI-UHFFFAOYSA-N 0.000 description 1
- NDXJRCHJNQGCII-UHFFFAOYSA-N n'-[2-(2,4-dichlorophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=C(Cl)C=C1Cl NDXJRCHJNQGCII-UHFFFAOYSA-N 0.000 description 1
- HIRSMSDTEBUGQB-UHFFFAOYSA-N n'-[2-(2,5-dimethoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound COC1=CC=C(OC)C(CCN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 HIRSMSDTEBUGQB-UHFFFAOYSA-N 0.000 description 1
- ADHUJWPENAXHHO-UHFFFAOYSA-N n'-[2-(2,6-dichlorophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=C(Cl)C=CC=C1Cl ADHUJWPENAXHHO-UHFFFAOYSA-N 0.000 description 1
- CYLXBEFNXOIJPG-UHFFFAOYSA-N n'-[2-(2-bromo-6-methoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound COC1=CC=CC(Br)=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 CYLXBEFNXOIJPG-UHFFFAOYSA-N 0.000 description 1
- BJAQGIFSUNQBIK-UHFFFAOYSA-N n'-[2-(2-bromophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1Br BJAQGIFSUNQBIK-UHFFFAOYSA-N 0.000 description 1
- DAIRSSPCAFQSFW-UHFFFAOYSA-N n'-[2-(3,4-dichlorophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=C(Cl)C(Cl)=C1 DAIRSSPCAFQSFW-UHFFFAOYSA-N 0.000 description 1
- PDDFBCUXJRDYMD-UHFFFAOYSA-N n'-[2-(3,4-dimethoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 PDDFBCUXJRDYMD-UHFFFAOYSA-N 0.000 description 1
- UJVMZIXXQGHOAU-UHFFFAOYSA-N n'-[2-(3,4-dimethylphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=C(C)C(C)=C1 UJVMZIXXQGHOAU-UHFFFAOYSA-N 0.000 description 1
- AIPGADKGZOELQN-UHFFFAOYSA-N n'-[2-(3,5-dimethoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound COC1=CC(OC)=CC(CCN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 AIPGADKGZOELQN-UHFFFAOYSA-N 0.000 description 1
- HXDRSIHFHWJUTM-UHFFFAOYSA-N n'-[2-(3-chloro-4-propoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=C(Cl)C(OCCC)=CC=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 HXDRSIHFHWJUTM-UHFFFAOYSA-N 0.000 description 1
- VDWUMLNMGJWNGE-UHFFFAOYSA-N n'-[2-(3-ethoxy-4-methoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=C(OC)C(OCC)=CC(CCN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 VDWUMLNMGJWNGE-UHFFFAOYSA-N 0.000 description 1
- MIONBUGKIMNZDK-UHFFFAOYSA-N n'-[2-(3-ethoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound CCOC1=CC=CC(CCN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 MIONBUGKIMNZDK-UHFFFAOYSA-N 0.000 description 1
- TZAWEIAVZCSVFW-UHFFFAOYSA-N n'-[2-(4-bromophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=C(Br)C=C1 TZAWEIAVZCSVFW-UHFFFAOYSA-N 0.000 description 1
- XKFJSSXAWGOPAH-UHFFFAOYSA-N n'-[2-(4-butoxy-3-chlorophenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=C(Cl)C(OCCCC)=CC=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 XKFJSSXAWGOPAH-UHFFFAOYSA-N 0.000 description 1
- OARSLOGGCXJZEQ-UHFFFAOYSA-N n'-[2-(4-ethylphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CC(CC)=CC=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 OARSLOGGCXJZEQ-UHFFFAOYSA-N 0.000 description 1
- UXFDYZMSAGLGQI-UHFFFAOYSA-N n'-[2-(5-bromo-2-methoxyphenyl)ethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound COC1=CC=C(Br)C=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 UXFDYZMSAGLGQI-UHFFFAOYSA-N 0.000 description 1
- PHQQAUMJFTZRAS-UHFFFAOYSA-N n'-[2-(dimethylamino)-2-phenylethyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC(N(C)C)C1=CC=CC=C1 PHQQAUMJFTZRAS-UHFFFAOYSA-N 0.000 description 1
- HSAAXFCSCVUISQ-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(1-naphthalen-2-ylethyl)oxamide Chemical compound COC1=CC2=C(OC=3C(=CC(=CC=3)N(C(C)C=3C=C4C=CC=CC4=CC=3)C(=O)C(N)=O)F)C=CN=C2C=C1OCC1CCNCC1 HSAAXFCSCVUISQ-UHFFFAOYSA-N 0.000 description 1
- WEDJHNSKRMELGF-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(2-morpholin-4-ylethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCN1CCOCC1 WEDJHNSKRMELGF-UHFFFAOYSA-N 0.000 description 1
- YFWANCDGUONXJQ-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(2-pyridin-2-ylethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=N1 YFWANCDGUONXJQ-UHFFFAOYSA-N 0.000 description 1
- WEQVTWVTLULNMV-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(2-pyridin-4-ylethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=NC=C1 WEQVTWVTLULNMV-UHFFFAOYSA-N 0.000 description 1
- GUFMREBOILTMHX-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(3-fluorophenyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C1=CC=CC(F)=C1 GUFMREBOILTMHX-UHFFFAOYSA-N 0.000 description 1
- PRBUXCUVQDBAEH-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-(pyrazin-2-ylmethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CN=CC=N1 PRBUXCUVQDBAEH-UHFFFAOYSA-N 0.000 description 1
- JCXUHAKBNMQBOK-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[(2-methoxyphenyl)methyl]oxamide Chemical compound COC1=CC=CC=C1CN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 JCXUHAKBNMQBOK-UHFFFAOYSA-N 0.000 description 1
- JBLRNTDNUUTQTR-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[(3-methoxyphenyl)methyl]oxamide Chemical compound COC1=CC=CC(CN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 JBLRNTDNUUTQTR-UHFFFAOYSA-N 0.000 description 1
- BDHHSCRHWMZSSA-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[(3-methylphenyl)methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC(C)=C1 BDHHSCRHWMZSSA-UHFFFAOYSA-N 0.000 description 1
- ICUXBZZGZQFJAP-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[(4-methoxyphenyl)methyl]oxamide Chemical compound C1=CC(OC)=CC=C1CN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 ICUXBZZGZQFJAP-UHFFFAOYSA-N 0.000 description 1
- BJGOTWWSPXOSDC-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[2-(2-fluorophenyl)ethyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1F BJGOTWWSPXOSDC-UHFFFAOYSA-N 0.000 description 1
- UYERONFVMOQSNI-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[2-(2-methoxyphenyl)ethyl]oxamide Chemical compound COC1=CC=CC=C1CCN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 UYERONFVMOQSNI-UHFFFAOYSA-N 0.000 description 1
- PALTWRMZEGEKBK-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[2-(3-methoxyphenyl)ethyl]oxamide Chemical compound COC1=CC=CC(CCN(C(=O)C(N)=O)C=2C=C(F)C(OC=3C4=CC(OC)=C(OCC5CCNCC5)C=C4N=CC=3)=CC=2)=C1 PALTWRMZEGEKBK-UHFFFAOYSA-N 0.000 description 1
- QIPQSMSNFKRHRD-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[2-(3-methylphenyl)ethyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC(C)=C1 QIPQSMSNFKRHRD-UHFFFAOYSA-N 0.000 description 1
- YKUSYUMKJUNFKW-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[2-(4-methylphenyl)ethyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=C(C)C=C1 YKUSYUMKJUNFKW-UHFFFAOYSA-N 0.000 description 1
- SAQSBEAOAXKHOY-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[2-(trifluoromethoxy)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC=C1OC(F)(F)F SAQSBEAOAXKHOY-UHFFFAOYSA-N 0.000 description 1
- RFCGTWIISNFCDF-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[2-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC=C1C(F)(F)F RFCGTWIISNFCDF-UHFFFAOYSA-N 0.000 description 1
- DTAWMBGWJXIPHG-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[2-fluoro-3-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC(C(F)(F)F)=C1F DTAWMBGWJXIPHG-UHFFFAOYSA-N 0.000 description 1
- AHGKJVQWGDQNJJ-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[2-fluoro-5-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC(C(F)(F)F)=CC=C1F AHGKJVQWGDQNJJ-UHFFFAOYSA-N 0.000 description 1
- DFAXDPFCELKJKE-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[3-(trifluoromethoxy)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC(OC(F)(F)F)=C1 DFAXDPFCELKJKE-UHFFFAOYSA-N 0.000 description 1
- ACUCLSVOWBUYTE-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[3-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC(C(F)(F)F)=C1 ACUCLSVOWBUYTE-UHFFFAOYSA-N 0.000 description 1
- VHVQDPDVJSMCGN-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[3-fluoro-4-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(C(F)(F)F)C(F)=C1 VHVQDPDVJSMCGN-UHFFFAOYSA-N 0.000 description 1
- ACAMPJRXLLWJQY-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC(F)=CC(C(F)(F)F)=C1 ACAMPJRXLLWJQY-UHFFFAOYSA-N 0.000 description 1
- AMAWTSSJAPQBAS-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[4-(trifluoromethoxy)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(OC(F)(F)F)C=C1 AMAWTSSJAPQBAS-UHFFFAOYSA-N 0.000 description 1
- GSGZYCQNRMNINF-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[4-fluoro-2-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(F)C=C1C(F)(F)F GSGZYCQNRMNINF-UHFFFAOYSA-N 0.000 description 1
- FZCRGPHMVIUIKR-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-[[6-(trifluoromethyl)pyridin-3-yl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(C(F)(F)F)N=C1 FZCRGPHMVIUIKR-UHFFFAOYSA-N 0.000 description 1
- HOAPRTSJSQDTEC-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-n'-phenacyloxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC(=O)C1=CC=CC=C1 HOAPRTSJSQDTEC-UHFFFAOYSA-N 0.000 description 1
- CRQXWCFHUHGRIH-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-yl]oxyphenyl]-n'-(2-phenylethyl)oxamide Chemical compound N1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1 CRQXWCFHUHGRIH-UHFFFAOYSA-N 0.000 description 1
- PTUAKBITUGWEJK-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-(2-phenylpropyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC(C)C1=CC=CC=C1 PTUAKBITUGWEJK-UHFFFAOYSA-N 0.000 description 1
- YEBVMRNEJPVYMT-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-(3-methylbutyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC1=CC=C(N(CCC(C)C)C(=O)C(N)=O)C=C1F YEBVMRNEJPVYMT-UHFFFAOYSA-N 0.000 description 1
- PTUAKBITUGWEJK-QFIPXVFZSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-[(2r)-2-phenylpropyl]oxamide Chemical compound C1([C@@H](C)CN(C2=CC=C(C(=C2)F)OC2=C3C=C(C(=CC3=NC=C2)OCC2CCN(C)CC2)OC)C(=O)C(N)=O)=CC=CC=C1 PTUAKBITUGWEJK-QFIPXVFZSA-N 0.000 description 1
- FYBFXHFOIXQGGQ-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-[2-(4-fluorophenyl)ethyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=C(F)C=C1 FYBFXHFOIXQGGQ-UHFFFAOYSA-N 0.000 description 1
- WEWCSGQKQILLHC-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-[[4-(trifluoromethyl)phenyl]methyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCN(C)CC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=C(C(F)(F)F)C=C1 WEWCSGQKQILLHC-UHFFFAOYSA-N 0.000 description 1
- YMBAFIDCPGOUTH-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(2-methyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-5-yl)methoxy]quinazolin-4-yl]oxyphenyl]-n'-(2-phenylethyl)oxamide Chemical compound N1=CN=C2C=C(OCC3CC4CN(C)CC4C3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1 YMBAFIDCPGOUTH-UHFFFAOYSA-N 0.000 description 1
- ITHMYMMFEFNYSR-UHFFFAOYSA-N n'-[3-fluoro-4-[6-methoxy-7-[(2-methyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-5-yl)methoxy]quinolin-4-yl]oxyphenyl]-n'-(2-phenylethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CC4CN(C)CC4C3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1 ITHMYMMFEFNYSR-UHFFFAOYSA-N 0.000 description 1
- YVEUTDRRXHTSAK-UHFFFAOYSA-N n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-n'-(1,2,3,4-tetrahydroisoquinolin-1-ylmethyl)oxamide Chemical compound N1CCC2=CC=CC=C2C1CN(C(=O)C(N)=O)C(C=C1F)=CC=C1OC1=C(C=C(C(OC)=C2)OC)C2=NC=C1 YVEUTDRRXHTSAK-UHFFFAOYSA-N 0.000 description 1
- IZLATPSQJMKMLY-UHFFFAOYSA-N n'-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-n'-[2-(dimethylamino)-2-phenylethyl]oxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC(N(C)C)C1=CC=CC=C1 IZLATPSQJMKMLY-UHFFFAOYSA-N 0.000 description 1
- SSVUFQNLKPYGMV-UHFFFAOYSA-N n'-[4-[7-(1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-5-ylmethoxy)-6-methoxyquinazolin-4-yl]oxy-3-fluorophenyl]-n'-(2-phenylethyl)oxamide Chemical compound N1=CN=C2C=C(OCC3CC4CNCC4C3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1 SSVUFQNLKPYGMV-UHFFFAOYSA-N 0.000 description 1
- FXVKXMPLCGOGOJ-UHFFFAOYSA-N n'-[4-[7-(azetidin-3-ylmethoxy)-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-n'-(2-phenylethyl)oxamide Chemical compound C1=CN=C2C=C(OCC3CNC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1 FXVKXMPLCGOGOJ-UHFFFAOYSA-N 0.000 description 1
- YZUVYDVSWWSUHJ-UHFFFAOYSA-N n'-[4-[7-[3-(diethylamino)propoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]-n'-(2-phenylethyl)oxamide Chemical compound C=12C=C(OC)C(OCCCN(CC)CC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CCC1=CC=CC=C1 YZUVYDVSWWSUHJ-UHFFFAOYSA-N 0.000 description 1
- WMWYFIPYHAOQOZ-UHFFFAOYSA-N n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-2,2-difluoro-n'-(4-fluorophenyl)propanediamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)C(F)(F)C(N)=O)C1=CC=C(F)C=C1 WMWYFIPYHAOQOZ-UHFFFAOYSA-N 0.000 description 1
- XHIMDSBXPZOCFR-UHFFFAOYSA-N n'-[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-n'-(4-fluorophenyl)-2,2-dimethylpropanediamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1N(C(=O)C(C)(C)C(N)=O)C1=CC=C(F)C=C1 XHIMDSBXPZOCFR-UHFFFAOYSA-N 0.000 description 1
- RBHLXTJIJYFKPJ-UHFFFAOYSA-N n'-[5-chloro-6-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxypyridin-3-yl]-n'-(4-fluorophenyl)propanediamide Chemical compound C1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1OC(C(=C1)Cl)=NC=C1N(C(=O)CC(N)=O)C1=CC=C(F)C=C1 RBHLXTJIJYFKPJ-UHFFFAOYSA-N 0.000 description 1
- XUVYWFMXJVOUGT-UHFFFAOYSA-N n'-[5-chloro-6-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinolin-4-yl]oxypyridin-3-yl]-n'-(4-fluorophenyl)propanediamide Chemical compound C1=CN=C2C=C(OCCCN3CCCCC3)C(OC)=CC2=C1OC(C(=C1)Cl)=NC=C1N(C(=O)CC(N)=O)C1=CC=C(F)C=C1 XUVYWFMXJVOUGT-UHFFFAOYSA-N 0.000 description 1
- IQZXEWHZDPQPOU-UHFFFAOYSA-N n'-[[2-chloro-5-(trifluoromethyl)phenyl]methyl]-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC(C(F)(F)F)=CC=C1Cl IQZXEWHZDPQPOU-UHFFFAOYSA-N 0.000 description 1
- UYQHCSWNVKEYCB-UHFFFAOYSA-N n'-benzyl-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)CC1=CC=CC=C1 UYQHCSWNVKEYCB-UHFFFAOYSA-N 0.000 description 1
- QTLZZEJLDIJMQW-UHFFFAOYSA-N n'-benzyloxamide Chemical compound NC(=O)C(=O)NCC1=CC=CC=C1 QTLZZEJLDIJMQW-UHFFFAOYSA-N 0.000 description 1
- WNGDKIMBSDJUGG-UHFFFAOYSA-N n'-butyl-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound FC1=CC(N(C(=O)C(N)=O)CCCC)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 WNGDKIMBSDJUGG-UHFFFAOYSA-N 0.000 description 1
- VDLKICQCFYOZEZ-UHFFFAOYSA-N n'-cyano-2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]-1,4-oxazepane-4-carboximidamide Chemical compound N1=CN=C2C=C(OCC3OCCCN(C3)C(=N)NC#N)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VDLKICQCFYOZEZ-UHFFFAOYSA-N 0.000 description 1
- JICNDHPWMNFSTI-UHFFFAOYSA-N n'-cyano-2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholine-4-carboximidamide Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(N)=NC#N)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 JICNDHPWMNFSTI-UHFFFAOYSA-N 0.000 description 1
- QUHXFAXDRHMTPJ-UHFFFAOYSA-N n'-cyclopentyl-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1N(C(=O)C(N)=O)C1CCCC1 QUHXFAXDRHMTPJ-UHFFFAOYSA-N 0.000 description 1
- QWXUAOCALLPNKH-UHFFFAOYSA-N n'-ethyl-n'-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]oxamide Chemical compound FC1=CC(N(C(=O)C(N)=O)CC)=CC=C1OC1=CC=NC2=CC(OCC3CCNCC3)=C(OC)C=C12 QWXUAOCALLPNKH-UHFFFAOYSA-N 0.000 description 1
- JAGHRSZQQGMOBS-UHFFFAOYSA-N n-(2,3-dichloro-4-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(C)C(Cl)=C1Cl JAGHRSZQQGMOBS-UHFFFAOYSA-N 0.000 description 1
- NJUOOEIYXARLMK-UHFFFAOYSA-N n-(2,4-dibromophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C=C1Br NJUOOEIYXARLMK-UHFFFAOYSA-N 0.000 description 1
- SVJQCEUABCZTGM-UHFFFAOYSA-N n-(2,4-dichlorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1Cl SVJQCEUABCZTGM-UHFFFAOYSA-N 0.000 description 1
- RPBDUWRBSLOZCQ-UHFFFAOYSA-N n-(2-amino-2-oxoethyl)-2,2,2-trifluoroacetamide Chemical compound NC(=O)CNC(=O)C(F)(F)F RPBDUWRBSLOZCQ-UHFFFAOYSA-N 0.000 description 1
- NOJMAMCOSWQCTO-UHFFFAOYSA-N n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=1C=CC=CC=1NCCN1CCCC1 NOJMAMCOSWQCTO-UHFFFAOYSA-N 0.000 description 1
- TUJFKJGLVWEALU-UHFFFAOYSA-N n-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCC(C)(C)N(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1F TUJFKJGLVWEALU-UHFFFAOYSA-N 0.000 description 1
- ZICKZGLGKIDMEJ-UHFFFAOYSA-N n-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1F ZICKZGLGKIDMEJ-UHFFFAOYSA-N 0.000 description 1
- JRGYGHIKWBYTFJ-UHFFFAOYSA-N n-(3,4-dichloro-2-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1C JRGYGHIKWBYTFJ-UHFFFAOYSA-N 0.000 description 1
- QZBVKLMNPZNSEU-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-(2-methoxyethoxy)-7-(morpholin-2-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCNC3)C(OCCOC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QZBVKLMNPZNSEU-UHFFFAOYSA-N 0.000 description 1
- SBYHOEZLNRTZNU-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-(2-methoxyethoxy)-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OCCOC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SBYHOEZLNRTZNU-UHFFFAOYSA-N 0.000 description 1
- KHSCTMVMPMKLGB-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-ethoxy-7-(morpholin-2-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCNC3)C(OCC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KHSCTMVMPMKLGB-UHFFFAOYSA-N 0.000 description 1
- JANIOAYQNYPQSP-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-ethoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OCC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 JANIOAYQNYPQSP-UHFFFAOYSA-N 0.000 description 1
- SHQICENFGOEXMY-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(1,3-thiazol-4-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=CSC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SHQICENFGOEXMY-UHFFFAOYSA-N 0.000 description 1
- ZPDJVHLHIVCBBN-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(1,4-oxazepan-2-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCCNC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZPDJVHLHIVCBBN-UHFFFAOYSA-N 0.000 description 1
- FAJVOBZBVGQKFD-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(2-morpholin-4-ylethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCN3CCOCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FAJVOBZBVGQKFD-UHFFFAOYSA-N 0.000 description 1
- QOLKGXDWVMWHLS-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(2-piperidin-1-ylethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCN3CCCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QOLKGXDWVMWHLS-UHFFFAOYSA-N 0.000 description 1
- INTICWGTKLQPSH-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(2-pyrrolidin-1-ylethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCN3CCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 INTICWGTKLQPSH-UHFFFAOYSA-N 0.000 description 1
- WVCAYXOTVLLXMU-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(4,5,6,7-tetrahydro-[1,3]thiazolo[5,4-c]pyridin-2-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=4CNCCC=4N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 WVCAYXOTVLLXMU-UHFFFAOYSA-N 0.000 description 1
- PRVHVZIMFXZSQV-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(morpholin-2-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCNC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PRVHVZIMFXZSQV-UHFFFAOYSA-N 0.000 description 1
- QNPKKOXYJDZPQK-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(oxolan-2-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QNPKKOXYJDZPQK-UHFFFAOYSA-N 0.000 description 1
- LUAHOZHPDVOBIY-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(pyridin-3-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=NC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LUAHOZHPDVOBIY-UHFFFAOYSA-N 0.000 description 1
- DTTUCRMZJFXMJK-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-(pyridin-4-ylmethoxy)quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=CN=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 DTTUCRMZJFXMJK-UHFFFAOYSA-N 0.000 description 1
- KUIMRYDCYVFWRI-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(1-phenylpyrazol-4-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3=CN(N=C3)C=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KUIMRYDCYVFWRI-UHFFFAOYSA-N 0.000 description 1
- LUJNSRUBIXBUOM-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(2,4,6-trimethylphenyl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C(=CC(C)=CC=3C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LUJNSRUBIXBUOM-UHFFFAOYSA-N 0.000 description 1
- FJUIAQIBGJSIJS-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(2-methyl-1,3-thiazol-4-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(C)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FJUIAQIBGJSIJS-UHFFFAOYSA-N 0.000 description 1
- ZENVNCDRHBGTNB-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(2-phenyl-1,3-thiazol-4-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)C=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZENVNCDRHBGTNB-UHFFFAOYSA-N 0.000 description 1
- FZGGLLMOLZVRHY-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(2-piperidin-2-yl-1,3-thiazol-4-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)C3NCCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FZGGLLMOLZVRHY-UHFFFAOYSA-N 0.000 description 1
- NYIGUQNAOHAUFR-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(2-piperidin-4-yl-1,3-thiazol-4-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)C3CCNCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 NYIGUQNAOHAUFR-UHFFFAOYSA-N 0.000 description 1
- UJKCNZDTMJJLEP-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(2-pyrrolidin-2-yl-1,3-thiazol-4-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)C3NCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 UJKCNZDTMJJLEP-UHFFFAOYSA-N 0.000 description 1
- NDLDFIBPOXYBOA-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(2-thiophen-2-yl-1,3-thiazol-4-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)C=3SC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 NDLDFIBPOXYBOA-UHFFFAOYSA-N 0.000 description 1
- DACWWGSNTVRALQ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(3-morpholin-4-yl-1,2,4-oxadiazol-5-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)N3CCOCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 DACWWGSNTVRALQ-UHFFFAOYSA-N 0.000 description 1
- LUKFTCWBIWCAMK-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(3-phenyl-1,2-oxazol-5-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(C=3)C=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LUKFTCWBIWCAMK-UHFFFAOYSA-N 0.000 description 1
- XRTAZINADDFLOG-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(3-piperazin-1-yl-1,2,4-oxadiazol-5-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)N3CCNCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 XRTAZINADDFLOG-UHFFFAOYSA-N 0.000 description 1
- HFDJFCJNMFTWOT-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(3-pyrrolidin-2-yl-1,2,4-oxadiazol-5-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)C3NCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HFDJFCJNMFTWOT-UHFFFAOYSA-N 0.000 description 1
- ZWRRWHLGGOBSMY-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-methyl-1,4-oxazepan-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZWRRWHLGGOBSMY-UHFFFAOYSA-N 0.000 description 1
- QMONPAAOIIDBIL-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QMONPAAOIIDBIL-UHFFFAOYSA-N 0.000 description 1
- USQQETNBKWVAHU-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-methylsulfonyl-1,4-oxazepan-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCCN(C3)S(C)(=O)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 USQQETNBKWVAHU-UHFFFAOYSA-N 0.000 description 1
- UAROZQSLEYSHPV-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-methylsulfonylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)S(C)(=O)=O)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 UAROZQSLEYSHPV-UHFFFAOYSA-N 0.000 description 1
- LLUVEMMROYJZEI-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-oct-7-enylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCCCCC=C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LLUVEMMROYJZEI-UHFFFAOYSA-N 0.000 description 1
- WEAZKUYDPMNZPH-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-octylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound C1N(CCCCCCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC WEAZKUYDPMNZPH-UHFFFAOYSA-N 0.000 description 1
- UHDUHDKGRPVSSW-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-pent-2-ynylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound C1N(CC#CCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC UHDUHDKGRPVSSW-UHFFFAOYSA-N 0.000 description 1
- HALFLHLCYNCWHV-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-pent-4-enylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCC=C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HALFLHLCYNCWHV-UHFFFAOYSA-N 0.000 description 1
- VETATMCQXNIHSE-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-pentylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound C1N(CCCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC VETATMCQXNIHSE-UHFFFAOYSA-N 0.000 description 1
- HZQVPHRLYRINCU-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-prop-2-enylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC=C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HZQVPHRLYRINCU-UHFFFAOYSA-N 0.000 description 1
- IITQZRHWHKBKFG-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-prop-2-ynylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC#C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 IITQZRHWHKBKFG-UHFFFAOYSA-N 0.000 description 1
- HYOURUDRVAZLAG-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-propan-2-ylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HYOURUDRVAZLAG-UHFFFAOYSA-N 0.000 description 1
- TUJUURQEVYFCIN-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-propyl-1,4-oxazepan-2-yl)methoxy]quinazolin-4-amine Chemical compound C1N(CCC)CCCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC TUJUURQEVYFCIN-UHFFFAOYSA-N 0.000 description 1
- CJQHDRRRDSNFOQ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-propylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound C1N(CCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC CJQHDRRRDSNFOQ-UHFFFAOYSA-N 0.000 description 1
- JFLJVHMCZLMBSN-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-pyridin-2-yl-1,3-thiazol-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=C(N=3)C=3N=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 JFLJVHMCZLMBSN-UHFFFAOYSA-N 0.000 description 1
- HSVSYWHNTHEXTN-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-pyridin-3-yl-1,3-thiazol-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=C(N=3)C=3C=NC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HSVSYWHNTHEXTN-UHFFFAOYSA-N 0.000 description 1
- VRXGZDANOSIHSR-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-pyridin-4-yl-1,3-thiazol-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=C(N=3)C=3C=CN=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VRXGZDANOSIHSR-UHFFFAOYSA-N 0.000 description 1
- GBWHKHICVCJEQW-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(4-pyridin-4-ylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C=3C=CN=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 GBWHKHICVCJEQW-UHFFFAOYSA-N 0.000 description 1
- JOGJAGGMXRVDDM-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(5-methyl-1,2-oxazol-3-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3=NOC(C)=C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 JOGJAGGMXRVDDM-UHFFFAOYSA-N 0.000 description 1
- ASUKBBADPXBJFR-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(5-methyl-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=4CN(C)CCC=4N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ASUKBBADPXBJFR-UHFFFAOYSA-N 0.000 description 1
- ABQLLFONNKQLLB-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(5-phenyl-1,2,4-oxadiazol-3-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ABQLLFONNKQLLB-UHFFFAOYSA-N 0.000 description 1
- PCRLTROAULDNDE-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(5-piperidin-2-yl-1,2,4-oxadiazol-3-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3NCCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PCRLTROAULDNDE-UHFFFAOYSA-N 0.000 description 1
- SHKAUSIXYOWPKS-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(5-piperidin-3-yl-1,2,4-oxadiazol-3-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3CNCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SHKAUSIXYOWPKS-UHFFFAOYSA-N 0.000 description 1
- LFVVFUDFYJQWPX-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(5-piperidin-4-yl-1,2,4-oxadiazol-3-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3CCNCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LFVVFUDFYJQWPX-UHFFFAOYSA-N 0.000 description 1
- KOSFAPNTMAEMEM-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(5-pyrrolidin-2-yl-1,2,4-oxadiazol-3-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3NCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KOSFAPNTMAEMEM-UHFFFAOYSA-N 0.000 description 1
- UAHJYZIKOGTHIW-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3CC4CCC(N4C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 UAHJYZIKOGTHIW-UHFFFAOYSA-N 0.000 description 1
- AXFITPBCUMOSEI-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)oxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OC3CC4CCC(N4C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 AXFITPBCUMOSEI-UHFFFAOYSA-N 0.000 description 1
- YAEMBTULTQVMDI-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[2-(1-methylpyrrolidin-2-yl)ethoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCC3N(CCC3)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 YAEMBTULTQVMDI-UHFFFAOYSA-N 0.000 description 1
- XDESVXWYQFZXJJ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[2-(4,6,6-trimethylmorpholin-2-yl)ethoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCC3OC(C)(C)CN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 XDESVXWYQFZXJJ-UHFFFAOYSA-N 0.000 description 1
- KLDWSPPOKXJTIT-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[2-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)ethoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCC3CC4CCC(N4C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KLDWSPPOKXJTIT-UHFFFAOYSA-N 0.000 description 1
- AKMHKNCWEXBULW-OFQRWUPVSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[(2r,5s,6s)-4,5,6-trimethylmorpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OC[C@@H]3O[C@@H](C)[C@H](C)N(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 AKMHKNCWEXBULW-OFQRWUPVSA-N 0.000 description 1
- AKMHKNCWEXBULW-DZKIICNBSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[(2s,5s,6s)-4,5,6-trimethylmorpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OC[C@H]3O[C@@H](C)[C@H](C)N(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 AKMHKNCWEXBULW-DZKIICNBSA-N 0.000 description 1
- HGKMPGZSYWFSDT-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[1-methyl-3-(trifluoromethyl)thieno[2,3-c]pyrazol-5-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=4N(C)N=C(C=4C=3)C(F)(F)F)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HGKMPGZSYWFSDT-UHFFFAOYSA-N 0.000 description 1
- BQCYIIVLNTWNSU-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[2-(1-methylpiperidin-2-yl)-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)C3N(CCCC3)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 BQCYIIVLNTWNSU-UHFFFAOYSA-N 0.000 description 1
- STKWUQHKDUWIGO-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[2-(1-methylpiperidin-3-yl)-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)C3CN(C)CCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 STKWUQHKDUWIGO-UHFFFAOYSA-N 0.000 description 1
- NXAKWDCTFOBSDD-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[2-(morpholin-4-ylmethyl)-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(CN4CCOCC4)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 NXAKWDCTFOBSDD-UHFFFAOYSA-N 0.000 description 1
- PDWKXNAYFBPNOH-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[2-(pyrrolidin-1-ylmethyl)-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(CN4CCCC4)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PDWKXNAYFBPNOH-UHFFFAOYSA-N 0.000 description 1
- QHTZGTDGFHTCOG-FQEVSTJZSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[2-[(2s)-1-methylpyrrolidin-2-yl]-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)[C@H]3N(CCC3)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QHTZGTDGFHTCOG-FQEVSTJZSA-N 0.000 description 1
- XVTSCHKVNZMZDN-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[2-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(CN4CCN(C)CC4)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 XVTSCHKVNZMZDN-UHFFFAOYSA-N 0.000 description 1
- BYRDCUSCDUCHLA-SFHVURJKSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[2-[(4s)-1,3-thiazolidin-4-yl]-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)[C@H]3NCSC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 BYRDCUSCDUCHLA-SFHVURJKSA-N 0.000 description 1
- RSQKKUZJTBAHBG-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(SC=3)C=3C=CC(=CC=3)C(F)(F)F)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 RSQKKUZJTBAHBG-UHFFFAOYSA-N 0.000 description 1
- NHCXXCMLZIJGKZ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[3-(4-methoxyphenyl)-1,2-oxazol-5-yl]methoxy]quinazolin-4-amine Chemical compound C1=CC(OC)=CC=C1C1=NOC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=C1 NHCXXCMLZIJGKZ-UHFFFAOYSA-N 0.000 description 1
- UNVZWJFKXAEDKM-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[3-(4-methylpiperazin-1-yl)-1,2,4-oxadiazol-5-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)N3CCN(C)CC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 UNVZWJFKXAEDKM-UHFFFAOYSA-N 0.000 description 1
- RORFVUDLEIRGQY-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[3-(morpholin-4-ylmethyl)-1,2,4-oxadiazol-5-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(CN4CCOCC4)N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 RORFVUDLEIRGQY-UHFFFAOYSA-N 0.000 description 1
- QFHBQKXGJZQISJ-SFHVURJKSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[3-[(2s)-1-methylpyrrolidin-2-yl]-1,2,4-oxadiazol-5-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(N=3)[C@H]3N(CCC3)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QFHBQKXGJZQISJ-SFHVURJKSA-N 0.000 description 1
- OZDWKTRNNHXKQT-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[3-[(4-methylpiperazin-1-yl)methyl]-1,2,4-oxadiazol-5-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(CN4CCN(C)CC4)N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 OZDWKTRNNHXKQT-UHFFFAOYSA-N 0.000 description 1
- VAVQZIDKZKBTTR-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(1-methylpiperidin-4-yl)morpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C3CCN(C)CC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VAVQZIDKZKBTTR-UHFFFAOYSA-N 0.000 description 1
- KZIOAIIQBIYJTQ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(2-methoxyethyl)-1,4-oxazepan-2-yl]methoxy]quinazolin-4-amine Chemical compound C1N(CCOC)CCCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC KZIOAIIQBIYJTQ-UHFFFAOYSA-N 0.000 description 1
- ZTUNVYDNGSGYLT-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(2-methoxyethyl)morpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound C1N(CCOC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC ZTUNVYDNGSGYLT-UHFFFAOYSA-N 0.000 description 1
- BZYUMECEYCQIQF-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(2-phenylethyl)morpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCC=4C=CC=CC=4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 BZYUMECEYCQIQF-UHFFFAOYSA-N 0.000 description 1
- SFASAOFVHLMKPH-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(3-methylbutyl)-1,4-oxazepan-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCCN(CCC(C)C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SFASAOFVHLMKPH-UHFFFAOYSA-N 0.000 description 1
- QOEMXTGSYTXSBD-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(3-phenylpropyl)morpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCC=4C=CC=CC=4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QOEMXTGSYTXSBD-UHFFFAOYSA-N 0.000 description 1
- GNMRWTTWRQISEY-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(4-methylphenyl)sulfonylmorpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)S(=O)(=O)C=3C=CC(C)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 GNMRWTTWRQISEY-UHFFFAOYSA-N 0.000 description 1
- LARWQCXRXJJFLU-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(4-pyrrolidin-1-ylphenyl)-1,3-thiazol-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=C(N=3)C=3C=CC(=CC=3)N3CCCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LARWQCXRXJJFLU-UHFFFAOYSA-N 0.000 description 1
- FTIMKXNADWOPKE-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=C(CN4CCOCC4)N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FTIMKXNADWOPKE-UHFFFAOYSA-N 0.000 description 1
- FESPGWIGJSHOEM-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(oxan-2-ylmethyl)morpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC4OCCCC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FESPGWIGJSHOEM-UHFFFAOYSA-N 0.000 description 1
- GVKSFOCLIXUHCD-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(oxan-4-yl)morpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C3CCOCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 GVKSFOCLIXUHCD-UHFFFAOYSA-N 0.000 description 1
- KOHLHBQFFZUSET-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-(pyridin-2-ylmethyl)morpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CC=4N=CC=CC=4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KOHLHBQFFZUSET-UHFFFAOYSA-N 0.000 description 1
- VWLDHVBJTHRWJI-PYUWXLGESA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-[(2r)-2-methylbutyl]morpholin-2-yl]methoxy]quinazolin-4-amine Chemical compound C1N(C[C@H](C)CC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC VWLDHVBJTHRWJI-PYUWXLGESA-N 0.000 description 1
- FMLKNZKLRJRZQJ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-[(4-methyl-1,4-diazepan-1-yl)methyl]-1,3-thiazol-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=C(CN4CCN(C)CCC4)N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FMLKNZKLRJRZQJ-UHFFFAOYSA-N 0.000 description 1
- AYWUHPUXKGVOSD-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3SC=C(CN4CCN(C)CC4)N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 AYWUHPUXKGVOSD-UHFFFAOYSA-N 0.000 description 1
- JODXPOKDEXJWRJ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[4-[3-(oxan-2-yloxy)propyl]-1,4-oxazepan-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCCN(CCCOC4OCCCC4)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 JODXPOKDEXJWRJ-UHFFFAOYSA-N 0.000 description 1
- SUWHOJVHZNVYPL-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[5-(1-methylpiperidin-2-yl)-1,2,4-oxadiazol-3-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3N(CCCC3)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 SUWHOJVHZNVYPL-UHFFFAOYSA-N 0.000 description 1
- WUCSNTVXKXMTBP-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3CN(C)CCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 WUCSNTVXKXMTBP-UHFFFAOYSA-N 0.000 description 1
- NLASQQGOHZWAKY-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[5-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3CCN(C)CC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 NLASQQGOHZWAKY-UHFFFAOYSA-N 0.000 description 1
- IUMNCIHHFXUHBR-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[5-(1-methylpyrrolidin-2-yl)-1,2,4-oxadiazol-3-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3N(CCC3)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 IUMNCIHHFXUHBR-UHFFFAOYSA-N 0.000 description 1
- DTMZOKHWEQAEJP-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[5-(2-methoxyphenyl)-1,2,4-oxadiazol-3-yl]methoxy]quinazolin-4-amine Chemical compound COC1=CC=CC=C1C1=NC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=NO1 DTMZOKHWEQAEJP-UHFFFAOYSA-N 0.000 description 1
- ZNOFYQJDWNDHAI-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3OC(=NN=3)C=3C=CC(C)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZNOFYQJDWNDHAI-UHFFFAOYSA-N 0.000 description 1
- LHQPNVRFCKDYKG-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[5-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C=3C=C(C=CC=3)C(F)(F)F)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LHQPNVRFCKDYKG-UHFFFAOYSA-N 0.000 description 1
- PTLHFHNCPGNWKH-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-6-methoxy-7-[[5-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C=3C=CC(=CC=3)C(F)(F)F)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PTLHFHNCPGNWKH-UHFFFAOYSA-N 0.000 description 1
- VKZGMXBQSCMMFS-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-(morpholin-2-ylmethoxy)-6-propan-2-yloxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCNC3)C(OC(C)C)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 VKZGMXBQSCMMFS-UHFFFAOYSA-N 0.000 description 1
- SHQDTJIUTBSGPO-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(1,4-diethylpiperazin-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CC)CCN(CC)C1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC SHQDTJIUTBSGPO-UHFFFAOYSA-N 0.000 description 1
- JHVXCKPKPWJTHM-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(1,4-dimethylpiperazin-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3N(CCN(C)C3)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 JHVXCKPKPWJTHM-UHFFFAOYSA-N 0.000 description 1
- WGVZZDSXBCCRPN-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(2,6-difluorophenyl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C(=CC=CC=3F)F)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 WGVZZDSXBCCRPN-UHFFFAOYSA-N 0.000 description 1
- GSHCUPMAYFOLLX-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(4-ethanimidoyl-1,4-oxazepan-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCCN(C3)C(C)=N)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 GSHCUPMAYFOLLX-UHFFFAOYSA-N 0.000 description 1
- BZLNIUFWAWPNOW-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(4-ethyl-1,4-oxazepan-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CC)CCCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC BZLNIUFWAWPNOW-UHFFFAOYSA-N 0.000 description 1
- HMNGFRURISAKFO-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(4-ethylmorpholin-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC HMNGFRURISAKFO-UHFFFAOYSA-N 0.000 description 1
- GSUPVNCLXYMNID-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(4-ethylsulfonylmorpholin-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(S(=O)(=O)CC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC GSUPVNCLXYMNID-UHFFFAOYSA-N 0.000 description 1
- OMTQJDUOTIRCBU-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(4-heptylmorpholin-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CCCCCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC OMTQJDUOTIRCBU-UHFFFAOYSA-N 0.000 description 1
- ZQCZQQPQOHFPCA-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(4-hex-5-enylmorpholin-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCCC=C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 ZQCZQQPQOHFPCA-UHFFFAOYSA-N 0.000 description 1
- JDSDNLQKCIMLFG-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(4-hexylmorpholin-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CCCCCC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC JDSDNLQKCIMLFG-UHFFFAOYSA-N 0.000 description 1
- HPSOKGKCQBAFCF-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(4-methylmorpholin-2-yl)methoxy]-6-propan-2-yloxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC(C)C)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 HPSOKGKCQBAFCF-UHFFFAOYSA-N 0.000 description 1
- UCKDEEMBVSBLKN-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(6,6-dimethylmorpholin-2-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OC(C)(C)CNC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 UCKDEEMBVSBLKN-UHFFFAOYSA-N 0.000 description 1
- AYHZKTTUBQETRW-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[(6-fluoro-4h-1,3-benzodioxin-8-yl)methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C=4OCOCC=4C=C(F)C=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 AYHZKTTUBQETRW-UHFFFAOYSA-N 0.000 description 1
- KBVAWHBMEYHTMD-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[2-(1,3-dioxan-2-yl)ethoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCC3OCCCO3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 KBVAWHBMEYHTMD-UHFFFAOYSA-N 0.000 description 1
- LDVUSEWLJKUPMB-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[2-(1,3-dioxolan-2-yl)ethoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCCC3OCCO3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 LDVUSEWLJKUPMB-UHFFFAOYSA-N 0.000 description 1
- WSAWKFMAOIQMRS-KCQAQPDRSA-N n-(3,4-dichlorophenyl)-7-[[(2r,5s,6s)-5,6-dimethylmorpholin-2-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OC[C@@H]3O[C@@H](C)[C@H](C)NC3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 WSAWKFMAOIQMRS-KCQAQPDRSA-N 0.000 description 1
- WVXLPNDNCDLCQW-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[2-(1-ethylpiperidin-2-yl)-1,3-thiazol-4-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound CCN1CCCCC1C1=NC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=CS1 WVXLPNDNCDLCQW-UHFFFAOYSA-N 0.000 description 1
- ILENFMLSOQJLGD-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[2-(1-ethylpiperidin-3-yl)-1,3-thiazol-4-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CC)CCCC1C1=NC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=CS1 ILENFMLSOQJLGD-UHFFFAOYSA-N 0.000 description 1
- BADQNHXUQWKUBJ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[2-(1-ethylpyrrolidin-2-yl)-1,3-thiazol-4-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound CCN1CCCC1C1=NC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=CS1 BADQNHXUQWKUBJ-UHFFFAOYSA-N 0.000 description 1
- IAICYTQZOAOBBB-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(CN(C)C)SC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 IAICYTQZOAOBBB-UHFFFAOYSA-N 0.000 description 1
- QYJJHEKFWCNKKZ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[3-(1-ethylpyrrolidin-2-yl)-1,2,4-oxadiazol-5-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound CCN1CCCC1C1=NOC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=N1 QYJJHEKFWCNKKZ-UHFFFAOYSA-N 0.000 description 1
- AHIOWTSQFILAEW-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3C(=NOC=3C)C=3C(=CC=CC=3Cl)Cl)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 AHIOWTSQFILAEW-UHFFFAOYSA-N 0.000 description 1
- FGHXOSBHGQKMBX-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[3-(4-ethylpiperazin-1-yl)-1,2,4-oxadiazol-5-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1CN(CC)CCN1C1=NOC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=N1 FGHXOSBHGQKMBX-UHFFFAOYSA-N 0.000 description 1
- DBXVNVVGMHBBOC-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[3-[(dimethylamino)methyl]-1,2,4-oxadiazol-5-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3ON=C(CN(C)C)N=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 DBXVNVVGMHBBOC-UHFFFAOYSA-N 0.000 description 1
- KNAPWFDGXYXHLO-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[4-(2-ethylbutyl)-1,4-oxazepan-2-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CC(CC)CC)CCCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC KNAPWFDGXYXHLO-UHFFFAOYSA-N 0.000 description 1
- KYGRLSQAAKVRBS-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[4-(2-ethylbutyl)morpholin-2-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CC(CC)CC)CCOC1COC1=CC2=NC=NC(NC=3C=C(Cl)C(Cl)=CC=3)=C2C=C1OC KYGRLSQAAKVRBS-UHFFFAOYSA-N 0.000 description 1
- FFDFDDSWSCPPMW-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[4-(2-fluoroethyl)morpholin-2-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCF)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 FFDFDDSWSCPPMW-UHFFFAOYSA-N 0.000 description 1
- PLAQSAIIUIJXRR-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[4-(4-fluorobutyl)morpholin-2-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(CCCCF)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PLAQSAIIUIJXRR-UHFFFAOYSA-N 0.000 description 1
- MFJPJXJGMGXYLR-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[4-(4-fluorophenyl)sulfonylmorpholin-2-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)S(=O)(=O)C=3C=CC(F)=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 MFJPJXJGMGXYLR-UHFFFAOYSA-N 0.000 description 1
- XCMSAHCDUHXACI-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[4-[4-(diethylamino)phenyl]-1,3-thiazol-2-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1=CC(N(CC)CC)=CC=C1C1=CSC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=N1 XCMSAHCDUHXACI-UHFFFAOYSA-N 0.000 description 1
- VYVLFCZOKFCBJQ-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[5-(1-ethylpiperidin-2-yl)-1,2,4-oxadiazol-3-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound CCN1CCCCC1C1=NC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=NO1 VYVLFCZOKFCBJQ-UHFFFAOYSA-N 0.000 description 1
- GCBUMMPSFVNQKY-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[5-(1-ethylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1N(CC)CCCC1C1=NC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=NO1 GCBUMMPSFVNQKY-UHFFFAOYSA-N 0.000 description 1
- QWTRRGLWVSSIML-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[5-(1-ethylpiperidin-4-yl)-1,2,4-oxadiazol-3-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound C1CN(CC)CCC1C1=NC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=NO1 QWTRRGLWVSSIML-UHFFFAOYSA-N 0.000 description 1
- OUPSOAXLJSDWRF-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[5-(1-ethylpyrrolidin-2-yl)-1,2,4-oxadiazol-3-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound CCN1CCCC1C1=NC(COC=2C(=CC3=C(NC=4C=C(Cl)C(Cl)=CC=4)N=CN=C3C=2)OC)=NO1 OUPSOAXLJSDWRF-UHFFFAOYSA-N 0.000 description 1
- NQWKXHZZPBXKGF-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1,2,4-oxadiazol-3-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(ON=3)C3=C(ON=C3C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 NQWKXHZZPBXKGF-UHFFFAOYSA-N 0.000 description 1
- PWCBBEMFFOGHOA-UHFFFAOYSA-N n-(3,4-dichlorophenyl)-7-[[5-[(dimethylamino)methyl]-1,2,4-oxadiazol-3-yl]methoxy]-6-methoxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC=3N=C(CN(C)C)ON=3)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 PWCBBEMFFOGHOA-UHFFFAOYSA-N 0.000 description 1
- MFZHNTIFSFFVQH-UHFFFAOYSA-N n-(3-bromo-2-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=CC(Br)=C1C MFZHNTIFSFFVQH-UHFFFAOYSA-N 0.000 description 1
- ZIKUMDQTYYWCRD-UHFFFAOYSA-N n-(3-bromo-4-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(C)C(Br)=C1 ZIKUMDQTYYWCRD-UHFFFAOYSA-N 0.000 description 1
- OAOAQAPAAXEKMZ-UHFFFAOYSA-N n-(3-chloro-2,4-difluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCC(C)(C)N(C)C3)C(OC)=CC2=C1NC1=CC=C(F)C(Cl)=C1F OAOAQAPAAXEKMZ-UHFFFAOYSA-N 0.000 description 1
- GQHKXXVKPUENOH-UHFFFAOYSA-N n-(3-chloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=CC(Cl)=C1F GQHKXXVKPUENOH-UHFFFAOYSA-N 0.000 description 1
- UJXWYUXIWOTHIU-UHFFFAOYSA-N n-(3-chloro-2-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=CC(Cl)=C1C UJXWYUXIWOTHIU-UHFFFAOYSA-N 0.000 description 1
- KLCMTXVLRHGAEO-UHFFFAOYSA-N n-(3-chloro-4-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(F)C(Cl)=C1 KLCMTXVLRHGAEO-UHFFFAOYSA-N 0.000 description 1
- UTCBITIGWNRGAW-UHFFFAOYSA-N n-(4,5-dichloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC(Cl)=C(Cl)C=C1F UTCBITIGWNRGAW-UHFFFAOYSA-N 0.000 description 1
- MGIPMVSOOMJZHR-UHFFFAOYSA-N n-(4-bromo-2,3-dichlorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCC(C)(C)N(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1Cl MGIPMVSOOMJZHR-UHFFFAOYSA-N 0.000 description 1
- FKFOSUXFCGMEJY-UHFFFAOYSA-N n-(4-bromo-2,3-difluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C(F)=C1F FKFOSUXFCGMEJY-UHFFFAOYSA-N 0.000 description 1
- HKHCOFOLZLSONC-UHFFFAOYSA-N n-(4-bromo-2,5-difluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC(F)=C(Br)C=C1F HKHCOFOLZLSONC-UHFFFAOYSA-N 0.000 description 1
- ZJOIMYDGIVGAMA-UHFFFAOYSA-N n-(4-bromo-2-chlorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C=C1Cl ZJOIMYDGIVGAMA-UHFFFAOYSA-N 0.000 description 1
- ZPNITDGPLQDXIJ-UHFFFAOYSA-N n-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C=C1F ZPNITDGPLQDXIJ-UHFFFAOYSA-N 0.000 description 1
- VTKBQOHBYWWZNL-UHFFFAOYSA-N n-(4-bromo-2-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C=C1C VTKBQOHBYWWZNL-UHFFFAOYSA-N 0.000 description 1
- FBKDSVZIPCLRHF-UHFFFAOYSA-N n-(4-bromo-3,5-difluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC(F)=C(Br)C(F)=C1 FBKDSVZIPCLRHF-UHFFFAOYSA-N 0.000 description 1
- VRHCWNJNOPLKGV-UHFFFAOYSA-N n-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCC(C)(C)N(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1F VRHCWNJNOPLKGV-UHFFFAOYSA-N 0.000 description 1
- WWKIMALVSPDSCC-UHFFFAOYSA-N n-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1F WWKIMALVSPDSCC-UHFFFAOYSA-N 0.000 description 1
- HSRGWYKQLJZSHT-UHFFFAOYSA-N n-(4-bromo-3-chloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine Chemical compound C12=CC(OC)=CC=C2N=CN=C1NC1=CC=C(Br)C(Cl)=C1F HSRGWYKQLJZSHT-UHFFFAOYSA-N 0.000 description 1
- DNTJORWEWRMHBN-UHFFFAOYSA-N n-(4-bromo-3-chloro-2-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1C DNTJORWEWRMHBN-UHFFFAOYSA-N 0.000 description 1
- UJTDMNARLIOVGT-UHFFFAOYSA-N n-(4-bromo-3-chlorophenyl)-6-methoxy-7-(1-methylpyrrolidin-3-yl)oxyquinazolin-4-amine Chemical compound N1=CN=C2C=C(OC3CN(C)CC3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1 UJTDMNARLIOVGT-UHFFFAOYSA-N 0.000 description 1
- LIMZIZABNQBAHK-MOPGFXCFSA-N n-(4-bromo-3-chlorophenyl)-6-methoxy-7-[(3s,4r)-4-methoxyoxolan-3-yl]oxyquinazolin-4-amine Chemical compound CO[C@@H]1COC[C@@H]1OC1=CC2=NC=NC(NC=3C=C(Cl)C(Br)=CC=3)=C2C=C1OC LIMZIZABNQBAHK-MOPGFXCFSA-N 0.000 description 1
- AITAJJAVEPMWPJ-UHFFFAOYSA-N n-(4-bromo-3-chlorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Br)C(Cl)=C1 AITAJJAVEPMWPJ-UHFFFAOYSA-N 0.000 description 1
- CBHGEOYZIGSNDM-UHFFFAOYSA-N n-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxy-7-[(4,5,5-trimethylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCC(C)(C)N(C)C3)C(OC)=CC2=C1NC1=CC(Cl)=C(Br)C=C1F CBHGEOYZIGSNDM-UHFFFAOYSA-N 0.000 description 1
- GXXMJGXWZZZBJK-UHFFFAOYSA-N n-(4-bromo-5-chloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC(Cl)=C(Br)C=C1F GXXMJGXWZZZBJK-UHFFFAOYSA-N 0.000 description 1
- ZKUNKJWGKBMFCR-UHFFFAOYSA-N n-(4-chloro-2,5-dimethoxyphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound C1=C(Cl)C(OC)=CC(NC=2C3=CC(OC)=C(OCC4OCCN(C)C4)C=C3N=CN=2)=C1OC ZKUNKJWGKBMFCR-UHFFFAOYSA-N 0.000 description 1
- PKMKYIJSZRWDDY-UHFFFAOYSA-N n-(4-chloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1F PKMKYIJSZRWDDY-UHFFFAOYSA-N 0.000 description 1
- QTMIYSYKAIPGKO-UHFFFAOYSA-N n-(4-chloro-3-methylphenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC=C(Cl)C(C)=C1 QTMIYSYKAIPGKO-UHFFFAOYSA-N 0.000 description 1
- YVZZAELYZKUMKK-UHFFFAOYSA-N n-(5-chloro-2-fluorophenyl)-6-methoxy-7-[(4-methylmorpholin-2-yl)methoxy]quinazolin-4-amine Chemical compound N1=CN=C2C=C(OCC3OCCN(C)C3)C(OC)=CC2=C1NC1=CC(Cl)=CC=C1F YVZZAELYZKUMKK-UHFFFAOYSA-N 0.000 description 1
- PURCZXCDZQICPW-UHFFFAOYSA-N n-(benzylsulfamoyl)-1-phenylmethanamine Chemical compound C=1C=CC=CC=1CNS(=O)(=O)NCC1=CC=CC=C1 PURCZXCDZQICPW-UHFFFAOYSA-N 0.000 description 1
- MMFAMNYCYRWGGR-UHFFFAOYSA-N n-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-n-(4-chlorophenyl)-2-(diethylamino)ethanesulfonamide Chemical compound C1CN(C=2C=3C(Br)=NNC=3N=CN=2)CCC1N(S(=O)(=O)CCN(CC)CC)C1=CC=C(Cl)C=C1 MMFAMNYCYRWGGR-UHFFFAOYSA-N 0.000 description 1
- XNUCDPCBPQGLQU-UHFFFAOYSA-N n-[1-(3-bromo-2h-pyrazolo[3,4-d]pyrimidin-4-yl)piperidin-4-yl]-n-(4-chlorophenyl)pent-4-enamide Chemical compound C1=CC(Cl)=CC=C1N(C(=O)CCC=C)C1CCN(C=2C=3C(Br)=NNC=3N=CN=2)CC1 XNUCDPCBPQGLQU-UHFFFAOYSA-N 0.000 description 1
- WBWOWVVMHMPZCL-UHFFFAOYSA-N n-[2-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoroanilino]-2-oxoethyl]benzamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)CNC(=O)C1=CC=CC=C1 WBWOWVVMHMPZCL-UHFFFAOYSA-N 0.000 description 1
- QPJAQDDXUMCFFT-UHFFFAOYSA-N n-[3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-ynyl]acetamide Chemical compound C=12C(C#CCNC(=O)C)=NNC2=NC=NC=1N(CC1)CCN1C1=CC(Cl)=CC=C1C QPJAQDDXUMCFFT-UHFFFAOYSA-N 0.000 description 1
- LQPDMTMOALUWFE-UHFFFAOYSA-N n-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-2-oxo-2-(2-phenylmorpholin-4-yl)acetamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1NC(=O)C(=O)N(C1)CCOC1C1=CC=CC=C1 LQPDMTMOALUWFE-UHFFFAOYSA-N 0.000 description 1
- IZLSPXYGGRLBOA-UHFFFAOYSA-N n-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-2-oxo-2-(3-phenylpyrrolidin-1-yl)acetamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1NC(=O)C(=O)N(C1)CCC1C1=CC=CC=C1 IZLSPXYGGRLBOA-UHFFFAOYSA-N 0.000 description 1
- TXLQIUCCMVAHPH-UHFFFAOYSA-N n-[3-fluoro-4-[6-methoxy-7-(piperidin-4-ylmethoxy)quinolin-4-yl]oxyphenyl]-2-oxo-2-pyrrolidin-1-ylacetamide Chemical compound C1=CN=C2C=C(OCC3CCNCC3)C(OC)=CC2=C1OC(C(=C1)F)=CC=C1NC(=O)C(=O)N1CCCC1 TXLQIUCCMVAHPH-UHFFFAOYSA-N 0.000 description 1
- CLHYZIJPOCRHLT-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1-phenylmethanesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NS(=O)(=O)CC1=CC=CC=C1 CLHYZIJPOCRHLT-UHFFFAOYSA-N 0.000 description 1
- BPBNPYIAQQQYEC-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-2-phenylethanesulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NS(=O)(=O)CCC1=CC=CC=C1 BPBNPYIAQQQYEC-UHFFFAOYSA-N 0.000 description 1
- FYPKKMXVPZRAMM-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-3-phenylpropane-1-sulfonamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NS(=O)(=O)CCCC1=CC=CC=C1 FYPKKMXVPZRAMM-UHFFFAOYSA-N 0.000 description 1
- ZIOKLLOGXHVZMP-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-4-phenyl-1,3-thiazol-2-amine Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(SC=1)=NC=1C1=CC=CC=C1 ZIOKLLOGXHVZMP-UHFFFAOYSA-N 0.000 description 1
- ROUZRAKVTWELMZ-UHFFFAOYSA-N n-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-2-phenyl-2-phenylmethoxyiminoacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)C(C=1C=CC=CC=1)=NOCC1=CC=CC=C1 ROUZRAKVTWELMZ-UHFFFAOYSA-N 0.000 description 1
- CXRSSJQLJNMMKA-UHFFFAOYSA-N n-[4-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1C1=NNC2=NC=NC(N3CCN(CC3)C=3C(=CC=C(Cl)C=3)C)=C12 CXRSSJQLJNMMKA-UHFFFAOYSA-N 0.000 description 1
- YZENPKZLUFXKQO-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxy-1,3-benzothiazol-2-yl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1S2)=CC=C1N=C2NC(=O)CC1=CC=CC=C1 YZENPKZLUFXKQO-UHFFFAOYSA-N 0.000 description 1
- YUHXUQHYLRJVGH-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CC1=CC=CC=C1 YUHXUQHYLRJVGH-UHFFFAOYSA-N 0.000 description 1
- CVUXGQSRZSNTQL-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-3-phenylpropanamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CCC1=CC=CC=C1 CVUXGQSRZSNTQL-UHFFFAOYSA-N 0.000 description 1
- ZTBPIFOODBSHSC-UHFFFAOYSA-N n-[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]-4-phenylbutanamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CCCC1=CC=CC=C1 ZTBPIFOODBSHSC-UHFFFAOYSA-N 0.000 description 1
- IMKFRXAZXQVUGC-UHFFFAOYSA-N n-[[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-methylcarbamothioyl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1N(C)C(=S)NC(=O)CC1=CC=CC=C1 IMKFRXAZXQVUGC-UHFFFAOYSA-N 0.000 description 1
- SBIWTBKGHBAUEG-UHFFFAOYSA-N n-[[4-[(6,7-dimethoxyquinazolin-4-yl)amino]-3-fluorophenyl]carbamothioyl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=NC=1NC(C(=C1)F)=CC=C1NC(=S)NC(=O)CC1=CC=CC=C1 SBIWTBKGHBAUEG-UHFFFAOYSA-N 0.000 description 1
- IENFVEIDSNCJNT-UHFFFAOYSA-N n-[[4-[(6,7-dimethoxyquinolin-4-yl)amino]phenyl]carbamothioyl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1NC(C=C1)=CC=C1NC(=S)NC(=O)CC1=CC=CC=C1 IENFVEIDSNCJNT-UHFFFAOYSA-N 0.000 description 1
- WUWHYGMWZVHKPH-UHFFFAOYSA-N n-[[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]carbamothioyl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1NC(=S)NC(=O)CC1=CC=CC=C1 WUWHYGMWZVHKPH-UHFFFAOYSA-N 0.000 description 1
- KABWMLBFENPJRD-UHFFFAOYSA-N n-[[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]carbamothioyl]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=S)NC(=O)CC1=CC=CC=C1 KABWMLBFENPJRD-UHFFFAOYSA-N 0.000 description 1
- XWAMOAZVZJDJQT-UHFFFAOYSA-N n-[amino-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoroanilino]methylidene]-2-phenylacetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=N)NC(=O)CC1=CC=CC=C1 XWAMOAZVZJDJQT-UHFFFAOYSA-N 0.000 description 1
- IRMIBJBZYSTAMI-UHFFFAOYSA-N n-phenylmethoxy-n-(2-pyrrolidin-1-ylethyl)aniline Chemical compound C=1C=CC=CC=1CON(C=1C=CC=CC=1)CCN1CCCC1 IRMIBJBZYSTAMI-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N n-propyl alcohol Natural products CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 201000008026 nephroblastoma Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229940029345 neupogen Drugs 0.000 description 1
- 208000007538 neurilemmoma Diseases 0.000 description 1
- 201000004662 neurofibroma of spinal cord Diseases 0.000 description 1
- 208000004649 neutrophil actin dysfunction Diseases 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- 125000005060 octahydroindolyl group Chemical group N1(CCC2CCCCC12)* 0.000 description 1
- 125000005061 octahydroisoindolyl group Chemical group C1(NCC2CCCCC12)* 0.000 description 1
- 229960002700 octreotide Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 208000003388 osteoid osteoma Diseases 0.000 description 1
- 208000008798 osteoma Diseases 0.000 description 1
- 229940127084 other anti-cancer agent Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000005968 oxazolinyl group Chemical group 0.000 description 1
- 125000005476 oxopyrrolidinyl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Chemical group 0.000 description 1
- 229950007318 ozogamicin Drugs 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 description 1
- 229940046231 pamidronate Drugs 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229960005415 pasireotide Drugs 0.000 description 1
- 108700017947 pasireotide Proteins 0.000 description 1
- NEEFMPSSNFRRNC-HQUONIRXSA-N pasireotide aspartate Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CC(O)=O.C([C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@H](C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@H](C(N[C@@H](CC=2C=CC(OCC=3C=CC=CC=3)=CC=2)C(=O)N1)=O)CCCCN)C=1C=CC=CC=1)OC(=O)NCCN)C1=CC=CC=C1 NEEFMPSSNFRRNC-HQUONIRXSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940046159 pegylated liposomal doxorubicin Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 150000003911 phosphatidylinositol 4-phosphates Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 125000005545 phthalimidyl group Chemical group 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 208000024724 pineal body neoplasm Diseases 0.000 description 1
- 201000004123 pineal gland cancer Diseases 0.000 description 1
- MUKCXROGIQHFNN-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1.O=C1CNCCN1 MUKCXROGIQHFNN-UHFFFAOYSA-N 0.000 description 1
- JSSXHAMIXJGYCS-UHFFFAOYSA-N piperazin-4-ium-2-carboxylate Chemical compound OC(=O)C1CNCCN1 JSSXHAMIXJGYCS-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229940063179 platinol Drugs 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 150000003140 primary amides Chemical class 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- YOESWAGAIFDFHR-UHFFFAOYSA-N prop-2-ynyl n-[6-(2-benzyl-1-hydroxy-3-oxoisoindol-1-yl)-1h-benzimidazol-2-yl]carbamate Chemical compound O=C1C2=CC=CC=C2C(O)(C=2C=C3N=C(NC(=O)OCC#C)NC3=CC=2)N1CC1=CC=CC=C1 YOESWAGAIFDFHR-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229940063222 provera Drugs 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- STWNGMSGPBZFMX-UHFFFAOYSA-N pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1.NC(=O)C1=CC=CN=C1 STWNGMSGPBZFMX-UHFFFAOYSA-N 0.000 description 1
- LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
- 238000009803 radical hysterectomy Methods 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 229960004432 raltitrexed Drugs 0.000 description 1
- 108010014186 ras Proteins Proteins 0.000 description 1
- 102000016914 ras Proteins Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000004176 reticulum cell Anatomy 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- HNMATTJJEPZZMM-BPKVFSPJSA-N s-[(2r,3s,4s,6s)-6-[[(2r,3s,4s,5r,6r)-5-[(2s,4s,5s)-5-[acetyl(ethyl)amino]-4-methoxyoxan-2-yl]oxy-6-[[(2s,5z,9r,13e)-13-[2-[[4-[(2e)-2-[1-[4-(4-amino-4-oxobutoxy)phenyl]ethylidene]hydrazinyl]-2-methyl-4-oxobutan-2-yl]disulfanyl]ethylidene]-9-hydroxy-12-(m Chemical compound C1[C@H](OC)[C@@H](N(CC)C(C)=O)CO[C@H]1O[C@H]1[C@H](O[C@@H]2C\3=C(NC(=O)OC)C(=O)C[C@@](C/3=C/CSSC(C)(C)CC(=O)N\N=C(/C)C=3C=CC(OCCCC(N)=O)=CC=3)(O)C#C\C=C/C#C2)O[C@H](C)[C@@H](NO[C@@H]2O[C@H](C)[C@@H](SC(=O)C=3C(=C(OC)C(O[C@H]4[C@@H]([C@H](OC)[C@@H](O)[C@H](C)O4)O)=C(I)C=3C)OC)[C@@H](O)C2)[C@@H]1O HNMATTJJEPZZMM-BPKVFSPJSA-N 0.000 description 1
- 108010038379 sargramostim Proteins 0.000 description 1
- 206010039667 schwannoma Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000004548 serous cystadenocarcinoma Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000002719 stereotactic radiosurgery Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940061353 temodar Drugs 0.000 description 1
- NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
- 229960001278 teniposide Drugs 0.000 description 1
- 208000001608 teratocarcinoma Diseases 0.000 description 1
- AZHZHOLJFMHYBJ-BQYQJAHWSA-N tert-butyl (e)-3-[4-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-2h-pyrazolo[3,4-d]pyrimidin-3-yl]prop-2-enoate Chemical compound CC1=CC=C(Cl)C=C1N1CCN(C=2C=3C(\C=C\C(=O)OC(C)(C)C)=NNC=3N=CN=2)CC1 AZHZHOLJFMHYBJ-BQYQJAHWSA-N 0.000 description 1
- QFEUXSBOVSOXOY-UHFFFAOYSA-N tert-butyl 2-[[4-(3,4-dichloroanilino)-6-methoxyquinazolin-7-yl]oxymethyl]morpholine-4-carboxylate Chemical compound N1=CN=C2C=C(OCC3OCCN(C3)C(=O)OC(C)(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C(Cl)=C1 QFEUXSBOVSOXOY-UHFFFAOYSA-N 0.000 description 1
- SLLUOPOEOBQREW-UHFFFAOYSA-N tert-butyl n-benzyl-n-[2-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluoroanilino]-2-oxoethyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)F)=CC=C1NC(=O)CN(C(=O)OC(C)(C)C)CC1=CC=CC=C1 SLLUOPOEOBQREW-UHFFFAOYSA-N 0.000 description 1
- PWGVSIWIAVUFHH-UHFFFAOYSA-N tert-butyl n-benzyl-n-[2-[[5-chloro-6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]amino]-2-oxoethyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C(=C1)Cl)=NC=C1NC(=O)CN(C(=O)OC(C)(C)C)CC1=CC=CC=C1 PWGVSIWIAVUFHH-UHFFFAOYSA-N 0.000 description 1
- GQYUKDJBUGAKLD-UHFFFAOYSA-N tert-butyl n-benzyl-n-[2-[[6-(6,7-dimethoxyquinolin-4-yl)oxypyridin-3-yl]amino]-2-oxoethyl]carbamate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(N=C1)=CC=C1NC(=O)CN(C(=O)OC(C)(C)C)CC1=CC=CC=C1 GQYUKDJBUGAKLD-UHFFFAOYSA-N 0.000 description 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 description 1
- 125000004523 tetrazol-1-yl group Chemical group N1(N=NN=C1)* 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- LAWUZBKFMNSOGG-UHFFFAOYSA-N thiophene-2-carbonitrile Chemical compound N#CC1=CC=[C]S1 LAWUZBKFMNSOGG-UHFFFAOYSA-N 0.000 description 1
- 229960001196 thiotepa Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 206010044412 transitional cell carcinoma Diseases 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 229940086542 triethylamine Drugs 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- KTONJXVERIJTRY-UHFFFAOYSA-N trifluoromethyl pyrimidine-5-carboxylate Chemical compound FC(F)(F)OC(=O)C1=CN=CN=C1 KTONJXVERIJTRY-UHFFFAOYSA-N 0.000 description 1
- 125000004953 trihalomethyl group Chemical group 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 208000022271 tubular adenoma Diseases 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229960001055 uracil mustard Drugs 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000028973 vesicle-mediated transport Effects 0.000 description 1
- 208000009540 villous adenoma Diseases 0.000 description 1
- UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 description 1
- 229960004355 vindesine Drugs 0.000 description 1
- NMDYYWFGPIMTKO-HBVLKOHWSA-N vinflunine Chemical compound C([C@@](C1=C(C2=CC=CC=C2N1)C1)(C2=C(OC)C=C3N(C)[C@@H]4[C@@]5(C3=C2)CCN2CC=C[C@]([C@@H]52)([C@H]([C@]4(O)C(=O)OC)OC(C)=O)CC)C(=O)OC)[C@H]2C[C@@H](C(C)(F)F)CN1C2 NMDYYWFGPIMTKO-HBVLKOHWSA-N 0.000 description 1
- 229960000922 vinflunine Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- XRASPMIURGNCCH-UHFFFAOYSA-N zoledronic acid Chemical compound OP(=O)(O)C(P(O)(O)=O)(O)CN1C=CN=C1 XRASPMIURGNCCH-UHFFFAOYSA-N 0.000 description 1
- 229960004276 zoledronic acid Drugs 0.000 description 1
- 150000008501 α-D-glucopyranosides Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92289907P | 2007-04-10 | 2007-04-10 | |
| US60/922,899 | 2007-04-10 | ||
| PCT/US2008/004573 WO2008124161A1 (en) | 2007-04-10 | 2008-04-09 | Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2008236562A1 AU2008236562A1 (en) | 2008-10-16 |
| AU2008236562B2 true AU2008236562B2 (en) | 2013-11-07 |
Family
ID=39627802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008236562A Ceased AU2008236562B2 (en) | 2007-04-10 | 2008-04-09 | Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha |
Country Status (31)
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200726767A (en) * | 2005-07-04 | 2007-07-16 | Astrazeneca Ab | Chemical compounds 2 |
| HRP20130902T1 (hr) * | 2005-10-07 | 2013-11-08 | Exelixis Inc. | PIRIDOPIRIMIDINONSKI INHIBITORI PI3Kalfa |
| NZ608667A (en) * | 2005-10-07 | 2014-08-29 | Exelixis Inc | N-(3-amino-quinoxalin-2-yl)-sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| CA2658725A1 (en) | 2006-08-16 | 2008-02-21 | Exelixis, Inc. | Using pi3k and mek modulators in treatments of cancer |
| US8188113B2 (en) * | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| SA08280783B1 (ar) * | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | مشتقات بيريدوبيريميدين كمثبطات pde4 |
| DK2139484T3 (da) | 2007-04-10 | 2013-10-21 | Exelixis Inc | Fremgangsmåder til behandling af cancer ved brug af pyridopyrimidinon-inhibitorer af PI3K-alfa |
| RS53020B (sr) * | 2007-04-11 | 2014-04-30 | Exelixis Inc. | Kombinovane terapije koje sadrže hinoksalin inhibitor pi3k-alfa za upotrebu u lečenju kancera |
| CA2734489C (en) * | 2008-08-20 | 2016-11-08 | Southern Research Institute | Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| CA2734487A1 (en) | 2008-08-20 | 2010-02-25 | Southern Research Institute | Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| WO2010022126A1 (en) | 2008-08-20 | 2010-02-25 | Schering Corporation | Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| JP5731976B2 (ja) | 2008-08-20 | 2015-06-10 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 置換ピリジン誘導体および置換ピリミジン誘導体ならびにそれらのウイルス感染の治療における使用 |
| WO2011100319A1 (en) | 2010-02-09 | 2011-08-18 | Exelixis, Inc. | Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k and mtor in combination with autophagy inhibitors |
| US20130156768A1 (en) * | 2010-08-26 | 2013-06-20 | Bristol-Myers Squibb Company | Combination of anti-ctla4 antibody with braf inhibitors for the synergistic treatment of proliferative diseases |
| CA2812089C (en) | 2010-09-14 | 2020-02-18 | Exelixis Inc. | Inhibitors of pi3k-delta and methods of their use and manufacture |
| WO2012065019A2 (en) | 2010-11-12 | 2012-05-18 | Exelixis, Inc. | Pyridopyrimidinone inhibitors of p13k alpha |
| US9441013B2 (en) * | 2011-05-17 | 2016-09-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanocortin 1 receptor ligands and methods of use |
| TW201306842A (zh) * | 2011-06-15 | 2013-02-16 | Exelixis Inc | 使用ｐｉ３ｋ／ｍｔｏｒ吡啶並嘧啶酮抑制劑及苯達莫司汀及／或利妥昔單抗治療惡性血液疾病之組合療法 |
| US20140298493A1 (en) * | 2011-07-28 | 2014-10-02 | Somasekar Seshagiri | PIK3CA H1047R Knock-In Non-Human Animal Breast Cancer Model |
| WO2013056067A1 (en) * | 2011-10-13 | 2013-04-18 | Exelixis, Inc. | Compounds for use in the treatment of basal cell carcinoma |
| KR20140096083A (ko) | 2011-11-01 | 2014-08-04 | 엑셀리시스, 인코포레이티드 | 림프증식성 악성종양의 치료를 위한 포스파티딜이노시톨 3-키나아제 저해제로서 ｎ（3｛［（3｛［2클로로5（메톡시）페닐］아미노｝퀴녹살린2일）아미노］설포닐｝페닐）2메틸알라닌아미드 |
| JP6126615B2 (ja) * | 2011-11-11 | 2017-05-10 | インテリカイン， エルエルシー | キナーゼ阻害剤の組み合わせおよびそれらの使用 |
| US20150010545A1 (en) * | 2011-12-27 | 2015-01-08 | Kadmon Corporation, Llc | Methods for treatment of breast cancer nonresponsive to trastuzumab |
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| MX367055B (es) | 2012-06-26 | 2019-08-02 | Del Mar Pharmaceuticals | El uso de una composición que comprende dianhidrogalactitol, diacetildianhidrogalactitol, y dibromodulcitol, y análogos o derivados de cada uno para el tratamiento de malignidades resistentes a inhibidores de tirosina cinasa. |
| US8980259B2 (en) * | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
| AU2013299841B8 (en) | 2012-08-07 | 2017-01-05 | Array Biopharma Inc. | Pharmaceutical combinations comprising a B-Raf inhibitor, an EGFR inhibitor and optionally a PI3K-alpha inhibitor |
| CN105492011A (zh) | 2013-04-08 | 2016-04-13 | 丹尼斯·M·布朗 | 不理想给药化学化合物的治疗增效 |
| US9950194B2 (en) | 2014-09-09 | 2018-04-24 | Mevion Medical Systems, Inc. | Patient positioning system |
| JP7085985B2 (ja) | 2016-03-04 | 2022-06-17 | 大鵬薬品工業株式会社 | 悪性腫瘍治療用製剤及び組成物 |
| US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
| CU24522B1 (es) * | 2016-08-15 | 2021-06-08 | Pfizer | PIRIDO[2,3-d]PIRIMIDIN-7(8H)-ONAS 6-FLUOROALQUIL-2-(ALQUILSULFONILPIPERIDIN-4-IL)AMINO SUSTITUIDAS |
| JP7027699B2 (ja) * | 2017-05-09 | 2022-03-02 | 住友ゴム工業株式会社 | タイヤトレッドおよびタイヤ |
| MX2020008015A (es) | 2018-01-31 | 2020-10-16 | Deciphera Pharmaceuticals Llc | Terapia de combinación para el tratamiento de la mastocitosis. |
| EP3746059A1 (en) | 2018-01-31 | 2020-12-09 | Deciphera Pharmaceuticals, LLC | Combination therapy for the treatment of gastrointestinal stromal tumors |
| KR102473372B1 (ko) | 2018-03-19 | 2022-12-05 | 다이호야쿠힌고교 가부시키가이샤 | 알킬황산나트륨을 포함하는 의약 조성물 |
| TWI878335B (zh) | 2019-08-12 | 2025-04-01 | 美商迪賽孚爾製藥有限公司 | 治療胃腸道基質瘤方法 |
| NZ784949A (en) | 2019-08-12 | 2025-09-26 | Deciphera Pharmaceuticals Llc | Ripretinib for treating gastrointestinal stromal tumors |
| US12486246B2 (en) | 2019-12-10 | 2025-12-02 | The Trustees Of Indiana University | Replication protein A (RPA)-DNA interaction inhibitors |
| KR20250057151A (ko) | 2019-12-30 | 2025-04-28 | 데시페라 파마슈티칼스, 엘엘씨 | 1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의조성물 |
| MX2022008103A (es) | 2019-12-30 | 2022-09-19 | Deciphera Pharmaceuticals Llc | Formulaciones de inhibidores de la cinasa amorfa y metodos de estas. |
| KR102195221B1 (ko) | 2019-12-31 | 2020-12-24 | 서울대학교산학협력단 | 포스파티딜이노시톨 3-키나아제 억제제 및 프로그램화 세포 사멸 단백질 1 억제제를 포함하는, 삼중음성 유방암의 방사선 병용 치료용 약학적 조성물 |
| CN111358952B (zh) * | 2020-04-15 | 2022-03-15 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种抗肿瘤药物组合物及其制剂和应用 |
| CN118678960A (zh) * | 2021-11-18 | 2024-09-20 | 安可诺瓦治疗公司 | 用于治疗癌症的方法和组合物 |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040009993A1 (en) * | 2001-12-11 | 2004-01-15 | Pharmacia Italia S.P.A. | Pyridopyrimidinones derivatives as telomerase inhibitors |
| WO2004006846A2 (en) * | 2002-07-15 | 2004-01-22 | Exelixis, Inc. | Receptor-type kinase modulators and methods of use |
| WO2005105801A1 (en) * | 2004-05-04 | 2005-11-10 | Warner-Lambert Company Llc | Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents |
| WO2007004698A1 (ja) * | 2005-07-06 | 2007-01-11 | Sbc Corporation | 漏洩電流検出装置及び漏洩電流検出方法 |
| WO2008021389A2 (en) * | 2006-08-16 | 2008-02-21 | Exelixis, Inc. | Using pi3k and mek modulators in treatments of cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1718645A1 (en) * | 2004-02-18 | 2006-11-08 | Warner-Lambert Company LLC | 2-(pyridin-3-ylamino)-pyrido 2,3-d pyrimidin-7-ones |
| HRP20130902T1 (hr) * | 2005-10-07 | 2013-11-08 | Exelixis Inc. | PIRIDOPIRIMIDINONSKI INHIBITORI PI3Kalfa |
| NZ608667A (en) * | 2005-10-07 | 2014-08-29 | Exelixis Inc | N-(3-amino-quinoxalin-2-yl)-sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| US8247408B2 (en) * | 2005-10-07 | 2012-08-21 | Exelixis, Inc. | Pyridopyrimidinone inhibitors of PI3Kα for the treatment of cancer |
| MY146420A (en) * | 2006-09-15 | 2012-08-15 | Pfizer Prod Inc | Pyrido (2, 3-d) pyrimidinone compounds and their use as pi3 inhibitors |
| DK2139484T3 (da) | 2007-04-10 | 2013-10-21 | Exelixis Inc | Fremgangsmåder til behandling af cancer ved brug af pyridopyrimidinon-inhibitorer af PI3K-alfa |
| RS53020B (sr) * | 2007-04-11 | 2014-04-30 | Exelixis Inc. | Kombinovane terapije koje sadrže hinoksalin inhibitor pi3k-alfa za upotrebu u lečenju kancera |
| AU2008239655B2 (en) | 2007-04-11 | 2013-06-20 | Exelixis, Inc. | Pyrido (2, 3-d) pyrimidin-7-one compounds as inhibitors of PI3k-alpha for the treatment of cancer |
| AU2008239596B2 (en) | 2007-04-11 | 2013-08-15 | Exelixis, Inc. | Pyrido [2,3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer |
| TW201018685A (en) * | 2008-09-30 | 2010-05-16 | Exelixis Inc | Pyridopyrimidinone inhibitors of PI3Kα and mTOR |
-
2008
- 2008-04-09 DK DK08742677.1T patent/DK2139484T3/da active
- 2008-04-09 WO PCT/US2008/004573 patent/WO2008124161A1/en not_active Ceased
- 2008-04-09 JP JP2010503045A patent/JP2010523670A/ja active Pending
- 2008-04-09 UA UAA200911419A patent/UA100979C2/ru unknown
- 2008-04-09 AU AU2008236562A patent/AU2008236562B2/en not_active Ceased
- 2008-04-09 EP EP08742677.1A patent/EP2139484B9/en active Active
- 2008-04-09 CN CN201210032620.4A patent/CN102727498B/zh not_active Expired - Fee Related
- 2008-04-09 PT PT87426771T patent/PT2139484E/pt unknown
- 2008-04-09 MX MX2009010930A patent/MX2009010930A/es active IP Right Grant
- 2008-04-09 ME MEP-2009-303A patent/ME00936B/me unknown
- 2008-04-09 BR BRPI0810206-6A2A patent/BRPI0810206A2/pt not_active IP Right Cessation
- 2008-04-09 KR KR1020097023351A patent/KR101626435B1/ko not_active Expired - Fee Related
- 2008-04-09 ES ES08742677T patent/ES2430614T3/es active Active
- 2008-04-09 US US12/595,219 patent/US8513266B2/en not_active Expired - Fee Related
- 2008-04-09 CN CN200880018725A patent/CN101715345A/zh active Pending
- 2008-04-09 PL PL08742677T patent/PL2139484T3/pl unknown
- 2008-04-09 SI SI200831004T patent/SI2139484T1/sl unknown
- 2008-04-09 CA CA2683641A patent/CA2683641C/en not_active Expired - Fee Related
- 2008-04-09 EA EA200970932A patent/EA020022B1/ru not_active IP Right Cessation
- 2008-04-09 RS RS20130384A patent/RS52939B/sr unknown
- 2008-04-09 MY MYPI20094214 patent/MY150697A/en unknown
- 2008-04-09 HR HRP20130688AT patent/HRP20130688T1/hr unknown
- 2008-04-09 NZ NZ580110A patent/NZ580110A/en not_active IP Right Cessation
-
2009
- 2009-09-29 ZA ZA200906764A patent/ZA200906764B/xx unknown
- 2009-09-30 TN TNP2009000400A patent/TN2009000400A1/fr unknown
- 2009-10-01 IL IL201284A patent/IL201284A/en active IP Right Grant
- 2009-10-09 HN HN2009003002A patent/HN2009003002A/es unknown
- 2009-10-09 DO DO2009000243A patent/DOP2009000243A/es unknown
- 2009-11-02 MA MA32318A patent/MA31358B1/fr unknown
- 2009-11-09 CR CR11100A patent/CR11100A/es unknown
- 2009-11-09 CO CO09126924A patent/CO6251254A2/es not_active Application Discontinuation
- 2009-11-09 EC EC2009009724A patent/ECSP099724A/es unknown
-
2013
- 2013-09-19 JP JP2013194611A patent/JP2014034576A/ja active Pending
-
2014
- 2014-03-24 JP JP2014059561A patent/JP2014139217A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040009993A1 (en) * | 2001-12-11 | 2004-01-15 | Pharmacia Italia S.P.A. | Pyridopyrimidinones derivatives as telomerase inhibitors |
| WO2004006846A2 (en) * | 2002-07-15 | 2004-01-22 | Exelixis, Inc. | Receptor-type kinase modulators and methods of use |
| WO2005105801A1 (en) * | 2004-05-04 | 2005-11-10 | Warner-Lambert Company Llc | Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents |
| WO2007004698A1 (ja) * | 2005-07-06 | 2007-01-11 | Sbc Corporation | 漏洩電流検出装置及び漏洩電流検出方法 |
| WO2008021389A2 (en) * | 2006-08-16 | 2008-02-21 | Exelixis, Inc. | Using pi3k and mek modulators in treatments of cancer |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008236562B2 (en) | Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha | |
| AU2008239668B2 (en) | Combination therapies comprising quinoxaline inhibitors of PI3K-alpha for use in the treatment of cancer | |
| AU2008239596B2 (en) | Pyrido [2,3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer | |
| EP2142543B1 (en) | Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer | |
| CA2671982A1 (en) | Methods of using mek inhibitors | |
| WO2014177915A1 (en) | Cancer combination therapy using imidazo[4,5-c]quinoline derivatives | |
| HK1139863B (en) | Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha | |
| HK1139941B (en) | Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer | |
| HK1139948B (en) | Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |